ECG Imaging of Ventricular Activity in Clinical Applications by Schulze, Walther H. W.
W
. H
. W
. S
ch
u
lz
e
22 
KaRlSRuhE TRaNSaCTIoNS 
oN BIoMEdICal ENGINEERING
EC
G
 Im
ag
in
g 
of
 V
en
tr
ic
ul
ar
 a
ct
iv
ity
 in
 C
lin
ic
al
 a
pp
lic
at
io
ns
WalThER h. W. SChulZE
ECG Imaging of Ventricular Activity 
in Clinical Applications

Walther H. W. Schulze
ECG Imaging of Ventricular Activity  
in Clinical Applications
Vol. 22
Karlsruhe Transactions on Biomedical Engineering
Editor:
Karlsruhe Institute of Technology (KIT)
Institute of Biomedical Engineering
Eine Übersicht aller bisher in dieser Schriftenreihe erschienenen Bände  
ﬁnden Sie am Ende des Buchs.
ECG Imaging of Ventricular Activity  
in Clinical Applications
by
Walther H. W. Schulze
Dissertation, Karlsruher Institut für Technologie (KIT)
Fakultät für Elektrotechnik und Informationstechnik, 2015
Referenten: Prof. Dr. rer. nat. Olaf Dössel
 Prof. Dr.-Ing. habil. Jens Haueisen
Print on Demand 2015
ISSN 1864-5933
ISBN 978-3-7315-0374-3
DOI 10.5445/KSP/1000046918
This document – excluding the cover – is licensed under the 
Creative Commons Attribution-Share Alike 3.0 DE License  
(CC BY-SA 3.0 DE): http://creativecommons.org/licenses/by-sa/3.0/de/
The cover page is licensed under the Creative Commons  
Attribution-No Derivatives 3.0 DE License (CC BY-ND 3.0 DE): 
http://creativecommons.org/licenses/by-nd/3.0/de/
Impressum
Karlsruher Institut für Technologie (KIT)  
KIT Scientiﬁc Publishing 
Straße am Forum 2 
D-76131 Karlsruhe
KIT Scientiﬁc Publishing is a registered trademark of Karlsruhe  
Institute of Technology. Reprint using the book cover is not allowed. 
www.ksp.kit.edu


ECG Imaging of Ventricular Activity
in Clinical Applications
Zur Erlangung des akademischen Grades eines
DOKTOR-INGENIEURS
von der Fakultät für
Elektrotechnik und Informationstechnik
des Karlsruher Instituts für Technologie (KIT)
genehmigte
DISSERTATION
von
Dipl.-Ing. Walther Hermann Wolfgang Schulze
geb. in Gifhorn
Tag der mündlichen Prüfung: 16. Februar 2015
Hauptreferent: Prof. Dr. rer. nat. Olaf Dössel
Korreferent: Prof. Dr.-Ing. habil. Jens Haueisen

Contents
1 Introduction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 1
Part I Fundamentals
2 Medical Motivation and Fundamentals . . . . . . . . . . . . . . . . . . . 7
3 Mathematical and Biophysical Fundamentals . . . . . . . . . . . . . 11
3.1 Maxwell’s Equations and Bioelectric Fields . . . . . . . . . . . . . . . 12
3.2 Forward Calculation of Bioelectric Fields . . . . . . . . . . . . . . . . . 14
3.3 Signal Processing . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 17
Part II Methods
4 The State-of-the-Art in ECG Imaging . . . . . . . . . . . . . . . . . . . . . 23
4.1 Linear Formulation of the Forward Problem of ECG. . . . . . . 24
4.2 The Ill-Posedness of the Inverse Problem . . . . . . . . . . . . . . . . . 26
4.3 Regularization Techniques . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 28
4.3.1 Tikhonov Regularization (Tikh) . . . . . . . . . . . . . . . . . . . . . 29
4.3.2 Tikhonov-Greensite Regularization (TikhGS) . . . . . . . . . 30
4.3.3Maximum A-Posteriori Method (MAP) . . . . . . . . . . . . . . 31
4.3.4Activation Time Imaging Based on the TMV Time
Integral (ATintT2) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 33
4.3.5Approach of Reconstructing Critical Points and
Times (CritT) . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 36
4.4 State-of-the-Art . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 38
II CONTENTS
5.1 State Space Models . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
5.2 Sigmoid Weighting in Critical Times Activation Time
Imaging . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
5.3 A Framework to Introduce Measurements . . . . . . . . . . . . . . . . 48
5.4 Tikhonov Spatio-Temporal Method with Offset Correction . 52
5.5 Model-Based Approach . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 55
6 Clinical Application - Methods . . . . . . . . . . . . . . . . . . . . . . . . . . 57
6.1 BSPM Acquisition and Setups . . . . . . . . . . . . . . . . . . . . . . . . . . . 58
6.2 Electrode Localization . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 60
6.3 MRI Acquisition and Segmentation Process . . . . . . . . . . . . . . . 61
6.3.1 Imaging at University Medical Center Mannheim . . . . 63
6.3.2 Imaging at King’s College London . . . . . . . . . . . . . . . . . . 66
6.3.3Active Tissue at the Base of the Ventricles . . . . . . . . . . . . 67
6.4 Mesh Generation and Resolution . . . . . . . . . . . . . . . . . . . . . . . . 68
6.5 Rigid Co-Registration of Electrodes with the Thorax Model 70
6.6 BSPM Processing and Filtering . . . . . . . . . . . . . . . . . . . . . . . . . . 71
6.6.1 Choice of a Reference Electrode . . . . . . . . . . . . . . . . . . . . . 72
6.6.2 Choice of Electrode Signals and Handling of Channels 74
6.6.3Annotation and Filtering . . . . . . . . . . . . . . . . . . . . . . . . . . . 75
6.7 Validation Measurements . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 78
6.7.1 Post-Processing of CARTO Electroanatomical Maps . . 80
6.7.2 Co-Registration of CARTO Maps with the MRI-Based
Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 81
6.7.3 EnSite Non-Contact Maps . . . . . . . . . . . . . . . . . . . . . . . . . . 84
Part III Results
7 Clinical Studies . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 87
7.1 Validation Study: Premature Ventricular Contractions . . . . . 88
7.1.1 Presentation of Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 89
7.1.2 Imaging of Excitation Origins . . . . . . . . . . . . . . . . . . . . . . . 91
7.1.3 Imaging of Activation Times . . . . . . . . . . . . . . . . . . . . . . . . 120
7.1.4 Tikhonov Spatio-Temporal Method with BSPM Offset
Correction . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 126
7.1.5 Solvers with Constraints on the Solution Range . . . . . . 128
5 Proposed Methods for Solving the Inverse Problem . . . . . . . . 43
CONTENTS III
7.2.1 BSPM Smoothness Based Baseline Correction . . . . . . . . 132
Part IV Discussion
8 Discussion and Conclusions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 137
8.1 Validation Study: Premature Ventricular Contractions . . . . . 138
8.1.1 Censoring and Time of Evaluation . . . . . . . . . . . . . . . . . . 138
8.1.2 Comparison with Results of Other Groups . . . . . . . . . . . 145
8.1.3Modeling Errors . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 146
8.1.4 Conclusion . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 149
8.2 Validation Study: Ventricular Tachycardia . . . . . . . . . . . . . . . . 150
8.3 Proposed Methods . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 151
Part V Appendix
A Effect of mesh resolutions in the forward problem . . . . . . . . . 155
A.1Simpliﬁed Thorax Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
A.1.1Resolution . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 155
A.1.2Facet Angle . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 157
A.2Realistic Thorax Model . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 159
A.2.1Study without Reﬁnement of the Heart . . . . . . . . . . . . . . 164
B Study: Premature Ventricular Contractions . . . . . . . . . . . . . . . . 167
B.1 Description of Datasets . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 167
B.2 ECG Imaging Results . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 178
References . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 183
List of Publications and Supervised Thesis . . . . . . . . . . . . . . . . . . 207
7.2 Validation Study: Ventricular Tachycardia . . . . . . . . . . . . . . . . 129

Acknowledgements
Although it may be broadly accepted that progress is driven by imag-
ination, the beneﬁt of research for society is usually uncertain and its
effects take often quite indirect paths. Hence, I am grateful to those who
gave hard-earned resources to make this work possible:
Initially, in the ﬁrst months, the European Community with its Sev-
enth Framework Programme (FP7/2007-2013) under grant agreement
no 224495 (euHeart project), the German Research Foundation under
grants DO637/10-1 and DO637/13-1, the Karlsruhe House of Young
Scientists (KHYS) Networking Grant and ﬁnally a scholarship by the
Graduate Funding from the German States.
This thesis was conducted under supervision of Olaf Dössel at the
Institute of Biomedical Engineering, Karlsruhe Institute of Technology
(KIT). I would like to thank him and Prof. Dr.-Ing. habil. Jens Haueisen
sincerely for their efforts in reviewing this work and for making the
defense of this thesis possible.
At the institute, I was received into a fruitful and indeed perfect envi-
ronment, with great organizational infrastructure and perfect ﬁnancial
support for the conducted research, and most importantly with amazing
people. The open, cooperative culture, the sharing of ideas, distributed
responsibilities and the inspiration and drive towards reaching scientiﬁc
goals were essential to make this work evolve.
I would like to express my deepest thanks for being part of this team.
Among those who contributed directly to this work, I would like to
thank Danila Potyagaylo for introducing me to the best of Russian ska
music, Yuan Jiang for negotiating and drafting research proposals while
VI ACKNOWLEDGEMENTS
in Wuhan, Martin Krüger for rocking the euHeart project, Thomas Fritz
for his restless efforts in producing personalized jokes and smart hacks
of any kind, Axel Loewe for his elaborate sense of good taste, culture
and manners, Goofy for keeping up that enthusiastic spirit, David
Keller for betting his property on my sprinting talents and Mathias
Wilhelms and Frank Weber for proving that good things should be short
and to the point. I would like to thank Mrs. Günter for the excellent
cooperation and Manfred Schroll for keeping our ﬂow of bits and bytes
alive. Finally, I would like to thank Olaf Dössel for being constantly
available to the entire group, for his unparalleled commitment and
enthusiasm, his conﬁdence in individual responsibility that made many
initiatives possible and for forming this team together with Gunnar
Seemann over years.
Further, I would like to thank my students for their excellent contribu-
tions to this work: Biao Wang, Alexander von Lühmann, Francesc Elies
Henar, Dan-Timon Rudolph, Patrick Mackens, Kathryn Vogel, Rasmus
Jones, Eulàlia Mascareñas Marsal, Esraa Ragaa Khaled Fattoh, Chris-
tian Ritter, Vynnie Kong, Julia Trächtler, and further Eike Wülfers and
Mrs. Schyma for their support.
Further, for being great colleagues, Oussama Jarrousse, Matthias Keller,
Tobias Baas, Tobias Oesterlein, Bhawna Verma, Jochen Schmidt, Lukas
Baron, Stefan Pollnow, Markus Rottmann, Christopher Schilling, Julia
Bohnert, Sebastian Seitz, Ramona Modery, Charis Kahlmeyer and Dirk
Falkenberg.
At University Medical Center Mannheim, the clinical PVC study for
this thesis has grown in an excellent and trustful cooperation under
the lead of Prof. Dr. med. Rainer Schimpf. I would like to express my
thanks to the entire team of clinical researchers involved in the study,
namely Prof. Dr. med. Theano Papavassiliu, Dr. med. Erol Tülümen,
Dr. med. Boris Rudic, Dr. med. Volker Liebe, PD Dr. med. Christina
Dösch, PD Dr. med. Torsten Konrad, Dr. med. Christian Veltmann and
Prof. Dr. med. Martin Borggrefe.
For conducting the VT study, I would like to thank Dr. Kawal Rhode
and Dr. Zhong Chen as well as Professor Aldo Rinaldi and Professor
Reza Razavi of King’s College London, and further Dr. Jatin Relan and
Dr. Hervé Delingette of INRIA, Sophia Antipolis.
ACKNOWLEDGEMENTS VII
Finally, I would like to thank Andreas Bierfreund for his enthusiasm in
teaching maths and physics, the SZ Jägercorps Knesebeck e.V. for being
the best band in the world, the Konrad-Adenauer-Stiftung for their
support of my studies and my parents and my sister for their support,
encouragement, belief and care along the entire way.

1Introduction
This chapter will give an impression on why it is fascinating to solve
the inverse problem of ECG. Further, an abstract is written for the busy
reader.
The fascination of solving the inverse problem of electrocardiography
Cardiac mechanical activity is triggered by a wavefront-like electric
excitation spread between the cells of the myocardium. In this work, the
goal is to visualize such electric activity using electric ﬁeld calculation
and measurements of ECG signals on the body surface (body surface
potential maps).
ECG signals on the body surface are the smoothed out result of the
electric signals in the heart. When reverse-computing the sources from
a measured ECG, the damping of the body must be inverted, which
leads to strong ampliﬁcation of any noise in the ECG or the model.
In addition, the solution of the inverse problem of ECG is not unique.
Multiple combinations of sources may result in the same ECG.
Hence, ECG imaging provides a broad playground for mathematical
methods that reaches from making realistic patient models to solving
the ill-posed inverse problem. For the latter, this includes regularization,
optimization and signal processing. The goal is to introduce generic
physiological knowledge on the sought inverse solution in order to
stabilize the solution and cope with its ambiguity — without introduc-
ing information that is sought for or artifacts that could lead to false
conclusions. On top of that, all these methods are applied in a clinical
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environment, which includes patients and challenges such as usability,
robustness and reliability.
Abstract
The goal of this research is to visualize electrical activity in the car-
diac muscle solely from non-invasive measurements, i.e. from a multi-
channel electrocardiogram (body surface potential map, BSPM) com-
bined with computer models of the human thorax and heart which
are built from MRI-scans. In particular and in contrast to most existing
works, cardiac electric activity is reconstructed across the myocardial
wall — either as transmembrane voltages (TMVs) over time or as ac-
tivation times — and a validation study of the method is performed
in patients with premature ventricular contractions (PVCs) and ven-
tricular tachycardia (VT). In the validation study, existing algorithms
have been tested on volumetric models and surface models (endo- and
epicardium), and a few new approaches for ECG imaging of TMVs and
activation times have been developed.
Structure
This work presents results of
• a clinical validation study that presents the ability of ECG imaging
of localizing ventricular excitation origins and of imaging activation
times of related beats (see Sect. 7.1) and secondly,
• a clinical validation study that presents the ability of ECG imaging
of imaging activation times of sustained monomorphic ventricular
tachycardia (see Sect. 7.2).
Further, in terms of methods, it presents
• a processing framework for the clinical validation studies (see Sect. 6)
• a camera system that allows for instantaneous and automatic local-
ization of BSPM electrodes in the catheter lab (see Sect. 6.2)
• new ECG imaging approaches that introduce knowledge from a
dynamic model of the cardiac excitation propagation (see Sect.5.1)
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• a framework to enhance ECG imaging solutions with single intracar-
diac measurements during ablation procedures with little arrhythmic
activity (see Sect. 5.3)
• a spatio-temporal Tikhonov method that identiﬁes the optimal offset
in the BSPM (see Sect. 5.4)
• a BSPM smoother that identiﬁes the optimal BSPM offset through
optimization of its smoothness and by minimization of its energy
(see Eq. 6.10)
• a new variant of the critical times method (see Sect. 5.2)
• a simple model-based ECG imaging approach that performed best
among the methods for FEM-models (see Sect. 5.5)
Abbreviations
ATintT2 - activation time imaging, time integral, Sect. 4.3.4
BEM - boundary element method
BSPM - body surface potential map
CritTeff35 - critical times method, Sect. 4.3.5
ECG - electrocardiogram
ECGI - electrocardiographic imaging
EFF - effective pacing
EPU - electrophysiological unit
FEM - ﬁnite element method
KCL - King’s College London
LAT - local activation time
LV/RV - left/right ventricle
LVOT/RVOT - left/right ventricular outﬂow tract
MAP - maximum a posteriori method, Sect. 4.3.3
MAPSTwin, MAPSTqrs - spatio-temporal variants of MAP
MODcct, MODccs - model-based approaches, Sect. 5.5
OFF, OFFR - spatio-temporal method with offset correction, Sect. 5.4
PVC - premature ventricular contraction
R-20 - BSPM signal at 20% of the QRS length before the R-peak
STD - standard deviation
Tikh - Tikhonov regularization, Sect. 4.3.1
TikhGS - Tikhonov-Greensite regularization, Sect. 4.3.2
TMV - transmembrane voltage
UMM - University Medical Center Mannheim
VT - ventricular tachycardia

Part I
Fundamentals

2Medical Motivation and Fundamentals
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Figure 2.1: The heart as seen in cardiac cine MRI (left) and in context of the thorax (right, MRI,
volumetric interpolated breath-hold examination). Patient 15, M, healthy. LV/RV: left/right
ventricle, LA/RA: left/right atrium, MV/TV: mitral/tricuspid valve.
The heart is a muscular organ, and its proper functioning is of vital
nature. The mechanical behaviour of the heart is controlled by electric
excitation in the myocardial tissue that triggers the release of calcium
and thereby the contraction of the muscle ﬁbers (an MR image of cardiac
muscle is depicted in Fig. 2.1 (left) for the atria and ventricles). In the
case of cardiac arrhythmia, the patterns of electric excitation conduction
are pathological, which causes a reduced efﬁciency of its pumping
mechanism, leading to reduced blood supply to the pulmonary and
systemic circulation systems, which are partially visible along with the
heart in the thorax MRI scan of Fig. 2.1 (right).
Hence, to diagnose cardiac arrhythmia, the cardiac electric activity
has to be studied, which is typically done non-invasively by the 12-
lead ECG — and then conﬁrmed with catheter measurements during
ablation therapies, which are performed in catheter laboratories or
electrophysiological units (EPUs). In such therapies, cardiac substrates
are ablated to change the pathways of electric excitation conduction.
Such therapies are often stressful for the patient, logistically expen-
sive, and they usually take several hours, with low success rates, e.g.
in case of atrial ﬁbrillation. This work shall improve the accuracy of
non-invasive pre-interventional diagnosis and shall facilitate better
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treatment planning of such therapies. It also suggests a method to
produce electroanatomical maps from fewer measurements, which is
important in the case of sparse arrhythmic activity that often leads to
termination of long-planned catheter lab studies.
The central validation study of this thesis deals with ECG imaging of
premature ventricular contractions (PVCs). To treat this kind of arrhyth-
mia, which has an ectopic, focal excitation origin, protocols such as
the following three-phase mapping procedure are typically a guide for
cardiologists. While most cardiologists decide based on personal expe-
rience rather than computed results, the following scheme represents
a computer-aided algorithm of ﬁnding the focus of the excitation. The
algorithm is used here to reﬂect the state-of-the art for methods that do
not take advantage of anatomical models from MRI or CT, which are
used in ECG imaging.
Three-phase mapping procedure: pace mapping and treatment of PVCs
To localize the foci of ectopic beats and the excitation paths of cardiac
arrhythmia in general, patients are usually subjected to invasive catheter
pacing studies. A catheter is placed in the endocardium and pacings are
performed to imitate the sought beat. Patterns of the electrocardiograms
found beforehand for PVCs are then compared with the ECGs that result
from the pacing - a procedure called pace mapping. Pace mappings can
be performed heuristically or according to formalistic protocols. In a
systematic approach by Peeters et al. [1], pace mapping is performed
using the following three-phase strategy [2]:
• The QRS integral of the sought arrhythmia is computed for the chan-
nels of a BSPM. A database of QRS integral maps is then created,
using the mean QRS integral found for pacings at a certain pacing lo-
cation. The initial estimate for the target location is then selected from
the database using the correlation coefﬁcient between the database
signal and the sought signal.
• In the area of the target location, new pacings are then performed,
and their QRS integral is again compared with that of the sought
arrhythmia and other paced signals in the area that are already in
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the database, until a good match is found. During the procedure the
catheter is guided using biplane X-ray imaging.
• Finally, local activation sequence mapping is performed for the PVCs
to ﬁnd the site of earliest activation. This site is then used to perform
the radiofrequency ablation therapy.
Medical Motivation
The medical motivation of this work is to make computer models of the
volume conductor of the human body available for improved treatment
planning that does not rely on pace mapping, but computes visualiza-
tions of the cardiac electric activity based on information from ﬁeld
calculations. The goal is to improve the quality of estimates of the exci-
tation origin, to reduce the time and stress of ablation procedures and
the number of required pacings, and to avoid termination of procedures
in case of sparse arrhythmic activity (for an overview of the procedure
durations in this study, see Tab. B.2 on page 167).
3Mathematical and Biophysical Fundamentals
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This chapter introduces the underlying principles of forward calcula-
tions that are used in computer models of the heart. It gives an overview
of the Maxwell equations and introduces the basic foundations of the
forward calculations (a comprehensive introduction is given in the
books by Gulrajani [3] and Malmivuo [4]). Also, a basic introduction
to signal processing is given to specify what ﬁlters have been used to
deal with measured signals of BSPMs in this work. Fundamentals of
the inverse problem of ECG are given in Sect. 4.
3.1 Maxwell’s Equations and Bioelectric Fields
To understand bioelectric or biomagnetic ﬁelds, a good understand-
ing of the behaviour and interaction of the respective ﬁelds and their
sources is required. These are typically framed by the following set of
equations, which is named after James Clerk Maxwell, in honour of his
publications in the ﬁeld in 1861 [5] and thereafter.
Gauss’s Law
The charge is the source of the electric ﬁeld [3, Chapt. 5.2][6]:
∇ ·−→D = ρ (3.1)
⇔
‹
∂V
−→
D ·d−→a =
˚
V
∇ ·−→Ddv=
˚
V
ρdv= Q, (3.2)
−→
E =
−→
D −−→P
ε0
(3.3)
Where
−→
E is the electric ﬁeld and
−→
D the electric displacement ﬁeld, ρ
the free charge density and Q the free charge. ρ results in −→D .
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Gauss’s Law for Magnetism
There are no point sources or point sinks 1 in magnetic ﬁelds [3, Chapt.
5.2][6]:
∇ ·−→B = 0 (3.4)
⇔
‹
∂V
−→
B ·d−→a = 0, (3.5)
−→
H =
−→
B
μ0
−−→M (3.6)
Maxwell’s equations are presented in their macroscopic form here,
which focuses on the free charges and free currents. Equations 3.3 and
3.6 are called the material equations, where ε0 and μ0 are the vacuum
permittivity and permeability [3, Chapt. 5.2]. While in vacuum, there is
only an electric ﬁeld of free charges, the electric ﬁeld
−→
E in a material
represents also the polarization
−→
P of the atoms and bound electrons.
For this reason,
−→
D is introduced as the ﬁeld that is created solely by
free charges. Analogously, the magnetic ﬁeld
−→
H is composed of the
magnetic ﬂux density
−→
B and the magnetization
−→
M of the material.
With a similar equation, the resulting current density through a medium
can be described as the composition of a ﬁeld-induced conduction
current density σ−→E and an impressed current density −→Ji [3, Chapt. 5.2]:
−→
J = σ−→E +
−→
Ji (3.7)
As
−→
P is created by pairs of bounded positive and negative charges
of equal size and opposite sign and
−→
M is created by bounded pairs of
north- and southpoles, the impressed currents
−→
Ji are created by pairs
of current sources of equal size and opposite sign.
1 Note that recent research has shown experimental hints for the existence of magnetic monopoles under
speciﬁc conditions [7, 8].
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ﬁeld [3, Chapt. 5.2]:
∇×−→E =−∂
−→
B
∂ t
, (3.8)
or with Stokes’ theorem and an open surface S:
⇔
¨
S
(∇×−→E ) ·d−→a =
˛
∂S
−→
E ·d−→l =−
¨
S
∂−→B
∂ t
·d−→a :=−∂ΦB
∂ t
, (3.9)
where ΦB is called the magnetic ﬂux (unit: Tm2).
Ampère’s Circuital Law
On the other hand, a changing electric displacement ﬁeld and a free
current density cause a curl in the magnetic ﬁeld [3, Chapt. 5.2]:
∇×−→H =−→J + ∂
−→
D
∂ t
(3.10)
From these equations it was possible to predict the dynamic coupling
of electric and magnetic ﬁelds and from that the existence of electro-
magnetic waves. This hypothesis was conﬁrmed by Heinrich Hertz in
1887 [6].
3.2 Forward Calculation of Bioelectric Fields
Quasi-Static Approximation
For the electric and magnetic ﬁelds that are produced by the human
heart and body, the temporal derivatives in Faraday’s law and Ampère’s
law can be neglected [9] (for a detailed explanation, see [3, Chapt. 5.3]),
i.e.
∇×−→E ≈ 0 (3.11)
∇×−→H ≈−→J . (3.12)
Faraday’s Law of Induction
For the non-stationary case and for magnetic ﬁelds, another two laws
apply. First, a changing magnetic ﬁeld causes a curl in the electric
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Bidomain Model
The bidomain (or bisyncytial) model [10] that is used to calculate bio-
electric and biomagnetic ﬁelds makes use of this approximation. Since
the divergence of the curl is zero, the following relationship can be
derived from Eq. 3.10, given the approximation in Eq. 3.12:
∇ · (∇×−→H ) = ∇ ·−→J = 0. (3.13)
With
−→
E =−∇ϕ and Eq. 3.7 this yields
∇ · (σ−→E +
−→
Ji ) = 0 (3.14)
⇔ ∇ · (σ∇ϕ) = ∇ ·
−→
Ji , (3.15)
where ∇ ·−→Ji =−Isv represents impressed currents as a volume current
source density in A/m3, which is deﬁned positive Isv > 0 for when an
impressed current goes into the volume conductor [11, Sect. 3.2.2].
For the active myocardium, impressed currents originate at the cell
membranes. To model the complex structure of cardiac cells and tissue
ﬁbers that may cause these impressed currents, a second domain was
introduced by [10], which represents intra- and extracellular space as a
bidomain model, in which the two domains coexist in space. Current
densities in the intra-cellular domain are now modeled as
−→
J i = σi
−→
E i
and those in the extra-cellular space as
−→
J e = σe
−→
E e, producing a current
density of
−→
J =
−→
J i+
−→
J e. The two domains are linked through the cell
membrane. With Eq. 3.13, the following continuity equation must hold:
∇ · (−→Ji +−→Je ) = 0 (3.16)
⇔ ∇ · (σi∇ϕi+σe∇ϕe) = 0, (3.17)
where σi and σe need to be modeled as tensors due to the anisotropic
nature of the conductivities in the heart. Deﬁning the transmembrane
voltage (TMV) as Vm = ϕi−ϕe, this yields
∇ · ((σi+σe)∇ϕe+σi∇Vm) = 0 (3.18)
⇔ ∇ · ((σi+σe)∇ϕe) =−∇ · (σi∇Vm) =−Isv, (3.19)
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which for σ = σi+σe yields a Poisson’s equation similar to Eq. 3.15. The
equation can be solved for the entire volume conductor when adjusting
σ locally (σi = 0 for the region outside the active myocardium) and
introducing on the right-hand-side an impressed current source density
−Isv that originates, e.g. from the setting of Vm in the calculation of the
lead ﬁeld matrix.
This Poisson’s problem can be solved with the ﬁnite element method
as explained in [11], using the following boundary conditions at the
discontinuities of the conductivities, where ϕt denotes ϕe in the volume
conductor outside the myocardium [12, 13]:
ϕe = ϕt at the heart surface (3.20)
σe∇ϕe ·−→n = σt∇ϕt ·−→n at the heart surface (3.21)
σi∇ϕi ·−→n = 0 at the heart surface (3.22)
σt∇ϕt ·−→n = 0 at the thorax surface (3.23)
ϕt = 0 at the point of the ground electrode (3.24)
In that order, these conditions are imposed for continuity to hold on the
boundary between the heart and thorax tissues, for the conservation of
charge that goes as current densities from the extracellular domain of
the heart into the domain of the extracellular potentials in the thorax,
further to not allow the intracellular currents to leave their domain at
the heart surface, and for the extracellular currents in the thorax not to
leave the body. Finally, for the solution to be unique, the point of the
BSPM ground electrode is set to 0.
Boundary Element Method
For the boundary element method, conductivites in Eq. 3.19 are as-
sumed to be isotropic. Given isotropic conductivity of the myocardium,
only the TMVs at the surface of the heart produce a source of the
BSPM [14]. The Poisson’s problem of Eq. 3.19 can then be solved as a
surface integral that is represented by the k = 2 surfaces of the thorax
and heart (endo- and epicardium), each of which are conductivity in-
terfaces with homogeneous conductivities speciﬁed for their inner and
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outer sides. This results in two pairs: the conductivities of the heart
and thorax, and those of the thorax and air. In addition, an intracellular
effective conductivity is speciﬁed for the heart [15]. The TMV distri-
bution at the cardiac surface is then introduced as the source in [15,
Eq.1], which is solved after the body surface potentials with the Matlab
toolbox provided in [16].
3.3 Signal Processing
This section provides fundamentals for the very basic ﬁltering methods
used in this work.
Inner Product The inner product of two energy signals is deﬁned as [17,
Eq. 3.10]:
〈x(t),y(t)〉=
ˆ ∞
−∞
x(t)y(t)dt, x(t) ∈ R, y(t) ∈ R (3.25)
The inner product is represented in the correlation function rxy(τ) at
τ = 0.
Convolution The convolution of two signals is deﬁned as the following
inner product [17, Eq. 3.135]:
h(t)∗ y(t) = 〈h(t− τ),y(τ)〉τ =
ˆ ∞
−∞
h(t− τ)y(τ)dτ. (3.26)
It can be shown that
y(t)∗h(t) = y(t)∗h(t), y(t)∗δ (t) = y(t). (3.27)
Fourier transform The Fourier transform computes the convolution of
y(t) with harmonic functions of a given frequency. As the convolution
is performed with a co-sinus in the real and a sinus, which is a co-sinus
shifted in time, in the complex domain (e− j2π f t = cos(2π f t)− jsin(2π f t)),
the resulting Fourier transform is a complex number that represents
both the amplitude and time shift for a given frequency f [17, Eq. 3.124].
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F {y(t)}= Y ( f ) =
ˆ ∞
−∞
y(t)e− j2π f tdt (3.28)
Filtering Linear time-invariant ﬁlters are characterized by their impulse
response function h(t) or its Fourier transform H( f ), the transfer func-
tion. Convolving a signal with h(t) is equivalent to multiplying it with
H( f ) in frequency domain:
y(t) = x(t)∗h(t)
F {y(t)}= Y ( f ) = X( f )H( f ) (3.29)
Gaussian High-Pass and Low-Pass Filters Low pass and high pass ﬁlters
can be designed using the Gaussian bell in frequency space as transfer
function, for low-pass:
H( f ) = e
− f2
2σ2f (3.30)
or for high-pass ﬁlter characteristics (H( f ) = 1 would yield an all-pass
ﬁlter, subtracting a Gaussian bell leads to a stop band in H( f )):
H( f ) = 1− e
− f2
2σ2f . (3.31)
The tuning parameter of the Gaussian ﬁlter is the standard deviation
of the Gaussian bell σ f . H( f ) is typically assumed to have an effect
of −3dB (corresponding to a gain of 1/√2) for the desired cutoff fre-
quency fc or an effect of 1/2 on the power spectrum. In this work, for
the Gaussian ﬁlter design, however, fc is deﬁned as the −6dB cutoff
frequency, with an effect of 1/2 on the signal amplitude [18]:
H( fc) = e
− f2c
2σ2f =
1
2
(3.32)
⇐ σ f = fc√
2ln(2)
(3.33)
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Notch Filter A stop band ﬁlter produces a stop band in the frequency
domain, i.e., a certain range of frequencies does not pass the ﬁlter.
For a notch ﬁlter, stop bands are very narrow (“notc‘h”). They may be
applied periodically in frequency domain in order to eliminate a speciﬁc
frequency fn and its harmonics, e.g. power line hum. A Gaussian-based
notch ﬁlter may therefore be designed using the following transfer
function:
H( f ) = 1−
N
∑
k=1
e
−−( f− fnk)2
2σ2f , (3.34)
N =
⌊
fs
2 fn
⌋
(3.35)
where Gaussian ﬁlters of “standard deviation” σ f are used. Periodic
repetitions of the Gaussian notches are needed up to a shift by the
Nyquist frequency, which is half the sampling frequency. This is due to
discrete signals being represented only up to the Nyquist frequency in
digital computers, as the highest frequency in a sampled signal is that
over any two samples in time.

Part II
Methods

4The State-of-the-Art in ECG Imaging
“The upcoming years will be crucial for ECG imaging, as it is
getting a lot of attention through commercialization. It will have
this chance once, and either it will be accepted, or it will fail to
convince physicians and people will not touch it for a long time.”
Rob MacLeod
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This chapter will give an introduction to the inverse problem of ECG, its
ill-posedness and to typical solvers of the problem that have been used
in this work for the clinical studies, Sect. 7. It will then give an overview
of the state-of-the-art in the ﬁeld, with a focus on clinical validation
studies. Finally, an outline is given on modeling errors that need to be
tackled to facilitate a proper quality of results in the case of clinical data.
4.1 Linear Formulation of the Forward Problem of ECG
To solve the inverse problem of ECG, which is to compute cardiac
electric sources from body surface potential maps, a model of the for-
ward problem is required. In this work, this was primarily based on
calculations with the ﬁnite element method (FEM) [11, 19] and the bido-
main model in Sect. 3.2. Alternatively, the boundary element method
(BEM) [15, 16, 20] was used in an appropriate formulation for surface
TMVs, see Sect. 3.2. In both cases, electric potentials were computed
on the body surface for sources of transmembrane voltages (TMVs) in
the heart. For the FEM approach, an unstructured tetrahedral grid was
used, which was taken care of to be a good enough representation of
the cardiac sources, see speciﬁcations in Sect. 6.4. For inverse calcula-
tions, which cannot deal with numbers of unknowns in the order of
the node count in the forward model, the number of heart nodes was
signiﬁcantly reduced. To this end, and since source gradients at mesh
resolution would have geometry-induced anisotropic properties that
cause artifacts, in our group, a coarse heart mesh of linear ﬁnite ele-
ments is produced and cardiac sources are interpolated on the original
mesh of the heart and thorax for the forward calculation. I.e., both the
shape of the heart in the original mesh as well as the structure of the
reduced coarse mesh determine the representation of sources. As the
forward problem of ECG is linear (linear interpolation is used between
the coarse and ﬁne grid), it can be formulated as a simple system of
linear equations, represented by a lead ﬁeld matrix A:
Ax= b. (4.1)
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The lead ﬁeld matrix maps transmembrane voltages at n locations in
the heart (represented as vector x ∈Rn×1) to the BSPM, which is a vector
of m electrode signals b ∈ Rm×1, m<< n. To compute A, n unit vectors
xˆi of sources at points i= 1 . . .n in the coarse grid are interpolated from
the coarse mesh on the ﬁne grid. These sources are represented on the
coarse grid in the same manner as node shape functions are deﬁned
in the ﬁnite element method (see Fig. 4.1): the TMV at one node is
set to 1, and all other nodes are set to zero [21, Sect. 5.2.2]. Between
the nodes, linear interpolation is used. The TMVs are interpolated in
this representation on the ﬁne grid and forward calculated, i.e. their
corresponding BSPM bˆi is simulated [11, Sect. 4.4.2]. As vectors xˆi, the
single sources are linearly independent and span the space of TMVs in
the coarse grid structure of the heart with the following properties (see
Fig. 4.1):
∀x ∈ Rn×1 : x= x1xˆ1+ x2xˆ2+ · · ·+ xnxˆn, where x=
⎡
⎢⎢⎢⎣
x1
x2
...
xn
⎤
⎥⎥⎥⎦ (4.2)
and xˆi ∈ Rn×1 is a unit source vector, xi j =
{
1 j = i
0 j = i , (4.3)
(4.4)
see [11, Eq. 4.9]. As in a linear electric network, electrical signals from dif-
ferent sources combine linearly (superposition principle by Helmholtz).
The BSPMs of the components in x can be weighted with the compo-
nents’ magnitude and combine linearly to the BSPM of x:
b= x1bˆ1+ x2bˆ2+ · · ·+ xnbˆn =
[
bˆ1, bˆ2, . . . , bˆn
]
x := Ax (4.5)
Note that A does not have full column rank, i.e., not all column vectors
are linearly independent, and the problem of ﬁnding the source x for
a given b is underdetermined. It is also ill-conditioned. The following
chapter elaborates on these particular characteristics of the inverse
problem of ECG.
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Figure 4.1: Schematic illustration of the representation of the unit vectors xˆi in the coarse mesh in
1-D and their corresponding BSPMs bˆi in the lead ﬁeld matrix.
For calculations with the boundary element method (BEM), the lead
ﬁeld matrix was calculated for sources in the surface model of the endo-
and epicardium directly, as the heart representation in this mesh was
coarse enough to be handled by the inverse solvers. The Matlab library
by Stenroos et al. [16] was used and an implementation by Danila
Potyagaylo that facilitates the calculation of BSPMs from surface TMVs.
4.2 The Ill-Posedness of the Inverse Problem
The inverse problem of ECG is ill-posed according to the deﬁnition
by Hadamard [22]. Although a solution for x exists (1st), it is neither
unique (2nd) nor does the solution depend continuously on the given
data (3rd criterion):
The aforementioned underdeterminedness leads to multiple solutions
being possible. For transmembrane voltages, the offset in x is arbitrary
and within the null space of A, as only gradients in x cause a BSPM.
Another example are sources in the septum. While Fig. 4.2a shows an
excitation wavefront that started from the red bullet (epicardium of the
LV) and is correctly reconstructed with a Tikhonov solver, the TMV dis-
tribution in Fig. 4.2b is clearly reconstructed with the greatest voltages
at the lateral wall of the RV. I.e., while the BSPM was produced for an
excitation origin in the septum, the given solution produces the same
BSPM with a source in the lateral wall.
On top of that, mathematical solvers have to deal with the strong at-
tenuation of cardiac signals by the body. This is especially true for
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Figure 4.2: Solutions to x= argmin
x
‖Ax−b‖22+λ 2‖Lx‖22, λ = 10−2, for an ectopic beat simulated at the
epicardium of the LV (a) and for an excitation origin (red bullet) that is simulated at the septum of
the RV (b). Whereas in (a) the right location is found, in (b) a wrong solution is reconstructed. Figure
adapted from presentation in [23].
cardiac signals of high spatial frequency and represented in the decay
of singular values of A, which is shown in Fig. 4.3. While low spatial
frequencies tend to be mapped to the BSPM with great singular values
σi, it is commonly the case that for the higher spatial frequencies, much
smaller singular values apply (condition numbers reﬂect this ratio and
are in the order of, e.g., 108 for lead ﬁeld matrices). Eigenvectors in the
singular value decomposition are not only ordered by the magnitude of
their singular values, but according to [24, 2.2.1] also tend to have more
zero-crossings along with smaller magnitudes, i.e. greater spatial fre-
quency (this behaviour is often observed for discrete ill-posed problems
in general). As high frequency source components experience strong
damping (small singular values), the corresponding BSPM components
must be strongly ampliﬁed to reconstruct the related cardiac source
components. This ampliﬁcation is of such high magnitude that any
noise in the BSPM easily corrupts the solution, up to the extent of being
sensitive to the effects of ﬁnite numerical precision [25]. To reduce the
discontinuous behaviour of the solution, ECG imaging usually only
images the cardiac activity up to a relatively low resolution, which is
achieved through regularization of the solution.
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Figure 4.3: Decay of singular values σi in A for a thorax model with 160 electrodes; adapted
from [26], where the behaviour was studied for clinical electrode setups.
4.3 Regularization Techniques
For a system of linear equations Ax= b, a solution xM can be found that
either has the minimum squared L2 norm of the residual
∀x : ‖Ax−b‖22 > ‖AxM−b‖22 (4.6)
or the minimum squared L2 norm among those x that produce equality
in the previous term (for underdetermined systems)
xM = argmin
x
‖x‖22 s.t. ‖Ax−b‖22 = ‖AxM−b‖22. (4.7)
The solution xM = A† can be proven to solve the problem, where A† is
the Moore-Penrose pseudo-inverse [27, Eq. 5]. A† can be expressed as a
simple algebraic formula in the case of A having full row or full column
rank. According to [28, Eq. 9], in the case of full row rank (which is a
characteristic of A unless electrodes are really close to one another), A†
can be computed from the singular vectors ui and vi of A =UΣVT as
A† =∑rank(A)i1 u
T
i
1
σi vi. Despite delivering unique solutions with minimum
norm in the second case (and hence coping with the 2nd criterion of
ill-posedness), the singular value decomposition clearly reveals that the
solution is still subject to the ill-conditioned nature of the problem, i.e.
small singular values in the reciprocal term lead to a great ampliﬁcation
of high-frequency components in the data. To produce a solution that is
stable against high-frequency noise, regularization is required.
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4.3.1 Tikhonov Regularization (Tikh)
To the end of imposing smoothness on the solution of the inverse prob-
lem (Tikhonov regularization, Tikh) and to thereby stabilizing the re-
sults, a regularization term ‖Lx‖22 is added to the residual [29].
x= argmin
x
‖Ax−b‖22+λ 2‖Lx‖22 (4.8)
⇔ x= argmin
x
(Ax−b)T (Ax−b)+λ 2(Lx)T (Lx) (4.9)
The cost functional is convex, i.e., its extremum is also its minimum.
With some basic algebra from [30], this yields:
⇔ 0= 2AT (Ax−b)+2λ 2LTLx (4.10)
⇔ 0= (ATA+λ 2LTL)x−ATb (4.11)
⇔ x= (ATA+λ 2LTL)−1ATb, (4.12)
where L is a discrete approximation of the Laplace operator (in case
of 2nd order Tikhonov) and λ is the regularization parameter, which
is challenging to optimize due to its strong inﬂuence on the solution.
The L-curve method [31] was implemented to select the best λ in this
work, unless a speciﬁc choice is explicitly stated. Its implementation
follows the algorithms in the Matlab toolbox by Hansen [32]. The latter
implementation ﬁts a 2-D spline curve to the smoothed discrete L-curve.
It then locates the point on the discrete L-curve which is closest to its
corner.
Note that, in order to ﬁnd a closed-form solution, the problem was
stated in this case as a least-squares problem with squared L2 norm
components and a squared regularization parameter λ 2. Many algo-
rithms in this work are deﬁned and implemented with functionals that
have un-squared λ parameters and/or L2 norms, i.e. the appropriate
parameter ranges and effects of the norms on the cost balancing must
be considered for each method individually.
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4.3.2 Tikhonov-Greensite Regularization (TikhGS)
While Tikhonov regularization performs smoothing in space, it treats
all time steps separately in its basic formulation. The spatio-temporal
Tikhonov method by Greensite [33] (TikhGS) approaches the problem
through the temporal domain as well and imposes temporal smoothness
by reducing the information in the ECG to its most relevant singular
vectors in time (which automatically leads to a reduction of the spatial
information as well). This has the beautiful side-effect of the signal
being reduced to its major components, which minimizes the time of
computation for cardiac source time sequences. The approach is easily
formulated as follows:
AX = B=USVT , (4.13)
X = [x1 · · ·xT ], B= [b1 · · ·bT ], where T: length of the BSPM time frame.
⇔ A(XV ) =US (4.14)
The forward problem is now formulated with the BSPM represented
by its singular vectors in time. The time samples in that singular vec-
tor representation are reduced to 1 . . . p components. As guideline for
choosing parameter p, the ﬁnding in [34] may be consulted which sug-
gests that 11 singular vectors in time are sufﬁcient to represent a BSPM.
Alternatively, an automatic scheme was proposed by Greensite, see [11,
Eq. 4.39].
The inverse problem is now solved after (XV ) using the Tikhonov
method,
(XV )λ = argmin
(XV )
‖A(XV )−US‖22+λ 2‖L(XV )‖22, (4.15)
and the result multiplied with VT ∈ Rp×T to transform back to the
solution X in time.
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Note that the presented notation follows that of [21, Sect. 5.3.8], which
can be proven to be equivalent to its documentation in [33] and [11, Sect.
4.6.5] and again to that of the proposed method in Sect. 5.4. Regulariza-
tion parameter λ was chosen using the L-curve method as proposed
in [31], including smoothing and 2-D interpolation.
4.3.3 Maximum A-Posteriori Method (MAP)
The maximum a-posteriori (MAP) method facilitates regularization of
the Tikhonov-based inverse solution in space based on a priori statistical
information that may be obtained from simulations of cardiac excitation
propagation, namely the covariance of the sources’ spatial distribution.
The method has been proposed in [35] and was used in [36, 37] with the
support of then improved models of cardiac excitation propagation. It
is derived as follows, in line with the presentation in [38, 5.4.6] and [39]:
Let e be the measurement error in
b= Ax+ e (4.16)
In oder to obtain an optimal solution of the problem, a solution estimate
xˆ is proposed for Eq. 4.16,
xˆ= Hb (4.17)
⇔ xˆ= HAx+He, (4.18)
where x and e are assumed to have zero mean.
The estimation error of xˆ leads to two summands
xˆ− x= (HA− I)x+He (4.19)
where the ﬁrst term represents the error of H in solving Ax after x, i.e.
its capability of solving the inverse problem, while the second term
represents the measurement error, which is mapped to the space of x.
According to [39, Eq. 20] the covariance of this error can be calculated
as
C = (HA− I)Cx(HA− I)T +HCeHT , (4.20)
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assuming that the sought solution x varies with respect to its zero mean
by a supposedly known covariance of Cx and the measurement error e,
which is assumed to be statistically independent, by a covariance of Ce.
Minimization after H yields the minimum variance estimator:
H =CxAT (ACxAT +Ce)−1 (4.21)
By inserting H into Eq. 4.17, the inverse problem can now be solved
optimally, given the measurement and estimate error covariances, yield-
ing
xˆ= Hb=CxAT (ACxAT +Ce)−1b (4.22)
To obtain an estimate of Cx, simulations of cardiac excitation propaga-
tion were performed with samples of x collected in a stochastical basis
S= [x1x2 . . .xN] andCx computed as
Cx =
1
N
(S−S)(S−S)T , (4.23)
where S is the mean of S.
To this end, ectopic beats were started from every 3rd node in the
ventricles and a sample of x was taken at a speciﬁc time in the beat
(a good choice for this time of sampling is studied in Sect. 7.1.2). For
both BEM and FEM models, a variant of the fastest route algorithm
was implemented as presented in the works of van Dam et al. [40],
yet with isotropic and homogeneous excitation conduction velocities.
The Dijkstra algorithm was used to compute distances between the car-
diac nodes through shortest paths in the mesh, and connectivities were
taken from the Laplace operator in FEM. In BEM, based on the work of
Danila Potyagaylo and Vynnie Kong, such connectivity matrices were
produced also for surface meshes, including surface-to-surface links.
Two spatio-temporal variants of the MAP approach were implemented
as well, which produce results with the Greensite spatio-temporal ap-
proach from Sect. 4.3.2 either for the entire QRS (MAPSTqrs) or a win-
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dow around the time to be evaluated (MAPSTwin), all with the number
of considered eigenvectors in the BSPM set to p= 10, in line with the
ﬁnding in [11, 34]. Accordingly, additional samples were added to S
in the calculation of Cx, one for each time sample in the domain of
eigenvectors, i.e. for each 3rd node p samples were introduced to the
stochastical basis. Especially for the FEM method, it was not feasible
to consider beats from each point in the mesh for the sheer size of the
matrix to be processed, and the number of samples was considered
great enough to parameterizeCx.
Ce was approximated by a diagonal matrix that was further simpli-
ﬁed to a weighted identy matrix Ce = εI, where ε can be considered
a regularization parameter. Ce could theoretically be computed from
the measurement noise and from modeling errors in A, should they be
Gaussian in b. These errors are not known. However, ε could be found
to lead to an L-curve-like behaviour in ‖AXV − BV‖2 over ‖CxXV‖2
(spectral norms), the latter of which is the similarity of the results to
the covariance matrix. The choice of ε was made using a smoothed and
interpolated L-curve with the toolbox by Hansen [32].
4.3.4 Activation Time Imaging Based on the TMV Time Integral
(ATintT2)
The time integral of TMVs over the QRS can be linked to the underlying
activation times. This effect has been studied within the scope of this
work [41] and is illustrated in Fig. 4.4. The time integral of the TMVs
x between 0ms and T ms, corresponding to k = 1 . . .kT in samples with
sampling interval ts, can be approximated as:
x˜ :=
ˆ T
0
xdt ≈ ts
kT
∑
k=1
xk. (4.24)
Given a healthy action potential in a component in x(t) (see blue curve
in the upper left plot in Fig. 4.4), the integral of the component between
0 and T ms is a falling curve over kT which stops to fall as soon as the
action potential depolarizes, see blue curve in the lower left plot. I.e.,
when integrating over the entire QRS (kT = 101) in the healthy case,
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which is depicted in the ﬁrst column, large TMV integrals are of action
potentials with early depolarization, small TMV integrals correspond
to very late depolarizations. The unit of these TMV integrals is mVms.
Mathematically, the ﬁnding leads to a linear formulation of the forward
problem that can be used for activation time imaging as proposed
in [38, 42]. When deﬁning x˜ as integral over the entire QRS interval
t = 0 . . .Tqrs now, then
x˜ :=
ˆ Tqrs
0
xdt ≈ ts
kTqrs
∑
k=1
xk. (4.25)
With linearity in Ax= b follows that
Ax˜= ts
kTqrs
∑
k=1
Axk = ts
kTqrs
∑
k=1
bk := b˜. (4.26)
I.e., when computing the sum of all BSPM samples in the QRS
b˜= ts
kTqrs
∑
k=1
bk. (4.27)
the problem Ax˜ = b˜ can be solved after x˜ with the Tikhonov method,
yielding TMV-integrals over the QRS as displayed in the lower plots of
Fig. 4.4:
x˜ATintT2 = argmin
x˜
{‖Ax˜− b˜‖2+λ 2‖Lx˜‖2} , (4.28)
where L is the Laplace operator and λ chosen using the L-curve
method [31] with the corner detection algorithm by Hansen [32], includ-
ing smoothing and spline interpolation.
Assuming that all TMV action potentials have identical shapes, the TMV-
integral over the QRS may be interpreted as an activation sequence,
given that the action potential curve is weakly increasing. Note that this
is a general ﬁnding which distinguishes the work in [42] from previous
articles [43]. These had proposed the use of TMV time-integrals as well,
but imposed models on the TMV action potentials such as a Heaviside
function [25] or arctan-function [44].
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Figure 4.4: The time integral of TMVs over the QRS can be linked to their underlying activation
times (see simulation of a healthy PVC beat, blue). Lines in the upper plot show typical action
potential curves, the lower plot demonstrates how the areas under the curves evolve over time,
excluding the sampling time factor. The same is also demonstrated for a PVC with an area of
myocardial ischemia (MI) and necrosis (NEC). Figures adapted from [41]. Blue (healthy), red (MI)
and black (NEC) colors correspond to the curves in the plots. For MI, the affected region is classiﬁed
as NaN (-1).
The integral method is used without further interpretation or normaliza-
tion of the TMV time-integral in this work, as it is only used for imaging
of activation origins. While taking advantage of the fact that solutions
are valid for any continuously increasing action potential shape, it must
be noted that for physiological action potentials, the latter requirement
is violated. However, despite being a correct assumption for the math-
ematics in [42] to hold, it is not the minimum requirement: to have
an activation sequence represented in the results, it is still sufﬁcient
to have an action potential shape with continuously increasing TMV
time integral (after depolarization), which is shown to be true for the
morphology presented in Fig. 4.4 for the healthy case (blue). Later on,
for activation time imaging, a Heaviside assumption is made for the
action potentials, see Sect. 5.3, which also presents a new modiﬁcation
of this approach.
It was found in the clinical studies at King’s College London that scars
lead to artifacts of homogeneous areas in the solutions for TMV time
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Figure 4.5: ECG imaging results with the ATintT2 method for BSPMs from the simulated activation
sequences in Fig. 4.4. The TMV integral has been converted to activation times using the
assumption of a Heaviside function. Figures are adapted from [41].
4.3.5 Approach of Reconstructing Critical Points and Times (CritT)
A well-posed formulation of the inverse problem of computing ac-
tivation times was found in 1994 by Fred Greensite [46], under the
assumption that action potentials have the behaviour of step functions.
The method was validated for the ﬁrst time by Greensite and Huiskamp
in 1997 [47]. Using “jump maps” and an approach derived from the
MUltiple SIgnal Classiﬁcation (MUSIC) algorithm in antenna theory,
it can reliably produce activation times (critical times) for the spatial
extrema of activation time maps (critical points).
Critical points are singularities of MT0 (i), where M
k
0(i) is
Mk0(i) =
∣∣∣∣∣1−
re f f
∑
r=1
〈 αi,U [0,k]r 〉2
∣∣∣∣∣
−1
(4.29)
integrals. The study in [41] demonstrates that this is indeed the case,
using action potential shapes of ischemic (MI) scar from [45] and — for
comparison, a TMV level for necrotic (NEC) tissue of 0mV as proposed
in [37]. Simulations in Fig. 4.4 show that early activation times produce
homogeneous areas of low (MI) or medium (NEC) time-integrals in-
deed, leading to an interpretation of these areas as late activation times.
This effect is also reﬂected in the inverse solutions of Fig. 4.5, where the
the results with the ATintT2 method have been converted to activation
times.
Note: From the TMV integral the activation time can be calculated if the action potential is
known. If it is not known, it can still be interpreted as activation sequence, but in the unit
mVms, and with large values representing early activation.
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Figure 4.6: The distance of the BSPM of a cardiac node to the most important spatial components of
the measured BSPM signal is represented in these functions for the time from the start of the QRS (a)
and up to the end of the QRS (b) (node i= 1325 depolarizes at 25ms).
and
re f f
∑
r=1
〈 αi,U [0,k]r 〉2 (4.30)
are the distances between the i-th column ai of the leadﬁeld matrix
A, which is the BSPM of the respective node i in the heart, and the
r = 1 . . .reff spatial singular vectorsU
[0,k]
r of the measured BSPM B. For
the distance to be computed, the singular value decomposition com-
putes these spatial characteristics from the interval speciﬁed in upper
and lower indices of Mk0(i), i.e. B
[0,k] = [b0, . . . ,bk] =U [0,k]S[0,k]V [0,k]. ai is
normalized to αi = ai‖ai‖22
for comparison with the unit vectors inU , and
k may be any time step in the BSPM of the QRS complex k = 1 . . .T .
While critical points MT0 (i) are hence computed from the BSPM of the
entire QRS, an interesting behaviour of Mk0(i) can be used to calculate ac-
tivation times for critical points: when computing the distance measure
of a source i to the BSPMMk0(i) for different times k it makes a signiﬁcant
upstroke at the time of its depolarization. This effect is used to compute
the activation times of critical points and illustrated in Fig. 4.6a for a
heart node that depolarizes at 25ms.
To identify the signiﬁcant upstroke, a method is proposed in [47, Sect. II]
that computes not only the distance to the singular vectors of the BSPM
up to a point of time in M+(i,k) = Mk0(i), but also takes into account
how well a source is represented in the BSPM that follows the current
38 CHAPTER 4. THE STATE-OF-THE-ART IN ECG IMAGING
time step M−(i,k) = MTk (i). Naturally, M
+(i,k) tends to increase after
depolarization of a source (Fig. 4.6a) and M−(i,k) tends to decrease
(Fig. 4.6b). Subtracting M−(i,k) from M+(i,k) yields a function
Z(i,k) =M+(i,k)−M−(i,k) (4.31)
that has a zero-crossing near the critical time of a critical point i — and
that also has the strongest jump at the critical time for a critical point.
Computing activation times by identiﬁcation of these zero-crossings is
called the critical times method (CritT). The derivation of the method
assumes that action potentials have the behaviour of a Heaviside func-
tion in time, which is a good approximation for the time of the QRS.
The method is proven in [47] to work for critical points on the heart
surface under this assumption. Times produced for surface points that
lie between critical points can be considered interpolations of the acti-
vation times of the critical points according to the paper. In this work,
the method is used only for the BEM method, but it could well be used
to reconstruct activation times in the myocardial volume as well, which
can be interpreted as another extension of the interpolation.
4.4 State-of-the-Art
Several review papers are available as introductions to the inverse
problem of electrocardiography. Table 4.1 provides a collection of review
papers, including reviews also on the forward calculation and a paper
that describes in detail the entire processing workﬂow for solving the
inverse problem of ECG.
The ﬁeld of ECG imaging is currently undergoing a phase of great atten-
tion in both the clinical and technical ﬁeld. Two companies have started
to commercialize systems for solving the inverse problem of ECG. First,
CardioInsight Technologies Inc. from Cleveland, OH in the United
States, which is a company that started as a spin-off with people from
the group of Yoram Rudy [58, 59]. The company holds several interna-
tional patents and its technology is well published by key cardiologists,
see e.g. a review article on the technology by Michel Haissaguerre
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Author(s) Topic Reference
Seger, Pfeifer, Berger Entire workﬂow, maths: ECG imaging [48]
Oosterom Inverse problem of bioelectricity [49]
Pullan, Cheng, Nash, Ghodrati,
MacLeod, Brooks
Inverse problem of ECG [50]
Dössel Inverse problem of ECG and MCG [51]
Gulrajani Inverse problem of ECG [52]
Brooks, MacLeod Inverse problem of ECG [53]
Brooks, MacLeod Inverse problem of ECG [54]
Oosterom Inverse problem of ECG [55]
Johnson Bioelectric ﬁeld calculation [56]
Greensite ECG imaging: mathematical basis [14]
Gulrajani Modeling and simulation for ECG imaging [57]
Table 4.1: Reviews and introductions to ECG imaging, with the latest publications listed ﬁrst.
et al. [60]. Second, EP Solutions SA from Yverdon-les-Bains, Switzer-
land. The company originally operated under the name AMYCARD
LLC which is located in Moscow, Russia. It also holds international
patents [61], works with physicians that have recently published ab-
stracts [62] on a comparison of results against a 64-electrode basket
catheter of the FIRMap system by Topera, Inc., Menlo Park, CA, USA.
EP Solutions has published several works on their system [63] and its
mathematics [64].
Little is known about the technology of the commercial ECG imaging
methods. However, the abstract [62] clearly reveals that the EP Solutions
system uses epicardial mapping in the presented work, neglecting the
endocardium. The same is pointed out in [63], where the method used
by the scientists of EP Solutions is presented as mapping electrograms
either at the endocardial surface or at the epicardium. This supports
an argument in [65] that claims that current commercial systems use
either endocardial mapping or epicardial mapping for ECG imaging,
but not both, depending on the location of the probe. A work by Rudy
et al. [66] is given as a reference for the claim, which images epicardial
potentials only. The same holds true for the most-cited publication of
the group [59] and for the validation study listed below [67].
The goal of the present study was to perform and validate ECG imaging
in humans, with the objective of improving interventional treatment
planning for radio-frequency ablation procedures. In the context of
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of extracellular potentials [66, 67] or surface activation times [68, 69],
the approach in this work was to use transmembrane voltages (TMVs)
as the underlying source model.
For TMVs, validation in humans is to date only possible for activation
times. Or in the case of localizing the origin of a premature ventricular
contraction (PVC), it is possible to validate the ability to localize the
PVC focus. Both has been done in this study. Compared to extracellular
potentials, TMVs better visualize the real areas of activation and at
the same time serve as a physiology-related interface for introducing
a-priori knowledge into the solutions of the inverse problem of ECG.
Their transmural visualization (given very accurate models) allows for
direct physiological interpretation.
Conventional non-invasive imaging modalities provide only insufﬁ-
cient guidance for ablation therapies [70], which require long-lasting
catheter measurements during therapy. The goal of this work was there-
fore to proove and push the capabilities of ECG imaging to a level
where it facilitates accurate therapy planning. In addition, a goal of this
work was to test whether it is possible to enhance invasively measured
electro-anatomical maps with pre-interventionally collected data, espe-
cially for cases with little arrhythmic activity.
To give an overview of ECG imaging validation studies performed
so far in humans, Table 4.2 is made that lists the source models with
emphasis on the imaged surfaces, characterizes the cases, and cites the
related publications.
existing studies, which have deployed methods for the reconstruction
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Reviews Reference
Validation studies of ECGI: approaches, history and state [50] Macfarlane et al.
Validation studies of ECGI: challenges [71] Nash & Pullan
Source model Cases Reference
EP (epicardium) 9 patients imaged during sustained VT, localization
error: qualitative agreement
[66] Wang & Rudy
CARTO endocardial validation
EP (epicardium) localization error of pacing cites: ≈ 1cm [67] Ghanem &
open chest surgery, intraoperative epicardial map-
ping with two 100-electrode patches
Rudy
EP (epicardium) RBBB, left and right ventricular pacing, chronic atrial
ﬂutter; localization error: qualitative agreement
[59] Ramanathan &
Rudy
EP (epicardium) single PVC, localization error: imaged and measured
activation origins “correlated”,
[72] Intini & Rudy
CARTO endocardial and epicardial validation (epi-
cardial ablation via xiphoid puncture)
EP (epicardium) 11-23 epicardial pacing sites in 4 patients, mean lo-
calization error: 13−28mm in areas without scar and
28−67mm in areas of scar or in the scar margin
[73] Sapp & Horácek
CARTO epicardial validation
EP (epicardium) VT: clinically identiﬁed exit sites or successful abla-
tion sites of two out of six induced VTs, localization
error: qualitative agreement; no activation sequences
recorded.
[73] Sapp & Horácek
CARTO epicardial validation
EP (endo- and epicardium) ventricles, 3 patients, imprecise thorax model, 1000+
pacings, mean localization error 3−5cm,
[65] Erem & Brooks
CARTO validation
AT (endo- and epicardium) WPW pathway: excitation origin, mean localization
error 19mm
[74] Berger & Tilg
CARTO endocardial validation
AT (endo- and epicardium) atria, pacing CS, SN; localization error 6−12mm, [68] Tilg et al.
CARTO endocardial validation
AT (endo- and epicardium) atria, pacing RAA, CS, high RA; localization error
8−14mm,
[75] Hanser & Tilg
CARTO endocardial validation
AT (endo- and epicardium) atria, pacings, localization error ≤ 10mm [76] Modre & Tilg
CARTO endocardial validation
ECD (endocardium) PVC, last ablation site, localization error: 13.8 ±
1.3mm
[77] Lai & He
ESMD PVC, last ablation site, localization error: 25.5 ±
5.5mm
[77] Lai & He
EP (epicardium) localization of acute MI from occlusions produced
by angioplasty balloon inﬂation during percutaneous
transluminal coronary angioplasty (PTCA), localiza-
tion error: qualitative agreement
[78] MacLeod &
Horácek
Table 4.2: ECG Imaging human validation studies. AT: surface activation times, EP: extracellular
potentials, ECD: equivalent current density, ESMD: equivalent single moving dipole, RBBB: right
bundle branch block.

5Proposed Methods for Solving the
Inverse Problem of ECG
“Don’t think, just act.”
Peter van Dam
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In addition to applying existing techniques, new approaches have been
proposed for solving the inverse problem of ECG: variants of state-space
approaches that introduce models of cardiac excitation propagation in
inverse solutions for stabilization, improved approaches for imaging
activation times, including a framework that makes inverse calculations
available to augment measurements in invasive procedures with data
from non-invasive pre-interventional recordings. Further, an approach
is presented that solves the signal processing problem of removing the
offset in the BSPM within the context of the inverse problem of ECG, and
a simple model-based approach is presented, albeit for documentation
of its implementation rather than its novelty.
5.1 State Space Models
The inverse problem of ECG is severely ill-posed, but a lot is known
about the cardiac excitation spread. This knowledge cannot easily be
represented in linear terms, and hence it is very difﬁcult to introduce it
in linearly formulated optimization problems. This has motivated the
use of model-based solvers [79–83] that use optimization approaches
for non-linear models to ﬁne-tune their parameters, intending them to
converge in a solution that reﬂects the actual excitation spread in the
heart. The problem of these solvers is the rigidity of their models, i.e.
their inability to adapt to pathological conditions, correct for modeling
errors — or otherwise their great dimensionality in case of taking such
aspects into account.
In the pursuit of introducing as much a-priori knowledge in the solution
as possible, while leaving room for its physiological and pathological
variations, this work has started from the idea of introducing a recursive
state space model of the cardiac excitation propagation in a Kalman
ﬁlter [84] that would be used to introduce a-priori knowledge from
the model in a data-driven solution of the inverse problem. As the car-
diac excitation behaviour depends strongly on the offset of the solution
when represented in terms of TMVs, the challenge of working within
the loop of a recursive Kalman ﬁlter, state estimates were not produced
in a physiological range. This is due to the forward problem, which is
5.1. STATE SPACE MODELS 45
used by the Kalman ﬁlter to correct state estimates against the error
they cause in the BSPM, not taking into account offsets in the source, as
they are in the null space of the lead ﬁeld matrix.
The initial approach was ﬁrst to study how physiological levels can
be induced in the inverse solutions for linear formulations, leading to
a “range-adjusted Tikhonov method” which was shown to work well
with a recursive cellular automaton [85]. Results were shown to depend
strongly on the excitation conduction velocity used for the parameteri-
zation of the automaton, i.e. the approach was unlikely to leave enough
room for the data to correct the model. As a ﬁrst step, it still served as a
template on how recursive models could be introduced in the Kalman
ﬁlter — and it proposed a method for keeping the solution in a physio-
logical range. A Kalman ﬁlter with augmented measurement model was
then introduced [86], where the augmented measurements represent
the regularization term of the linear inverse problem. This implementa-
tion allows for an explicit regularization of the Kalman ﬁlter estimate.
However, in the initial implementation shown in the paper, a linear
prediction model was chosen and parameterized as simply as possible
to reveal the effects of the covariance matrices and their parameteri-
zation. Results made clear that despite the augmented measurement
model being a good format of introducing regularization, a non-linear
system model must be used to effectively handle the inverse problem
of imaging TMVs in a state-space framework. This was the motivation
to use an unscented Kalman ﬁlter algorithm, which is used to handle
non-linear models and had previously been applied in ECG imaging
by Wang et al. [87], yet with a reaction-diffusion model [88]. The focus
was to study the nonlinear model related effects, not the effects of the
solution range of the state estimate on the propagation. Therefore, the
ﬁlter was designed to process range-constrained solutions of the inverse
problem directly instead of solving the inverse problem and processing
BSPMs, which are usually regarded as the measurements in existing
works with Kalman ﬁlters. The purpose of the ﬁlter was to improve the
solutions’ accuracy and to clean them from artifacts. For the purpose of
specifying the solution range, after an initial approach published in [85],
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a well-performing method [89] appeared at that time, which was used
then to produce the input data for the ﬁlter. Results with the unscented
Kalman ﬁlter are currently being documented, but are beyond the scope
of this thesis. Future applications of the ﬁlter might get back to another
idea presented earlier in the context of this work, which is the tolerance
operator that reduces regularization along the wave front [90]. Instead
of a homogeneous model for the system noise covariance, it may serve
as a feature for a region-speciﬁc training of the noise covariance matrix.
5.2 Sigmoid Weighting in Critical Times
Activation Time Imaging
Fig. 4.6 in Sect. 4.3.5 reveals that the functions in which the most impor-
tant spatial components of the measured BSPM signal are represented
for the time from the start of the QRS up to a given point in time M+(i,k)
(Fig. 4.6a) and from a given point in time up to the end of the QRS
(Fig. 4.6b) may have signiﬁcant differences in magnitude. The deriva-
tion in [47, Sect. II] reveals that function Z(p,k) = M+(i,k)−M−(i,k)
from Eq. 4.31 is a feature that tends to lead to zero-crossings at the
critical time, but it is not a strict feature. The only strict feature in the
function Z(i,k) is that its strongest upstroke is exactly at the critical
time given i is a critical point [47]. Therefore, Z(i,k) is heuristically de-
ﬁned and may be adapted using heuristic approaches as well without
violating the theory behind the method in [47].
We observed that given the extreme differences in magnitude even the
slightest noise in M+(i,k) of Fig. 4.6a can easily top the magnitude of
M−(i,k) in (Fig. 4.6b). This motivated a leveling of the magnitudes with
a sigmoid function. It would suppress small signals and cause an almost
linear behaviour for medium magnitudes that would leave the shape of
the functions mostly untouched.
Let the maximum value of M+ and the initial value of M− be deﬁned as
max(M+) :=max(M+(i, [1 : T ])) (5.1)
init(M−) :=M−(i,1). (5.2)
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The correction is performed for each node i individually:
Zsigmoid(i,k) =
max(M+)
1+ e−a(M+(i,k)−s)
−M−(i,k), (5.3)
where the origin of the sigmoid function 11+e−x is shifted to
s= σsmax(M+) (5.4)
and a is chosen such that at 115max(M
+) the left term in Eq. 5.3 is as low
as 110init(M
−), which determines the steepness of the sigmoid function
in Zsigmoid(i,k).
max(M+)
1+ e−a(
1
15max(M
+)−s) =
1
10
init(M−) (5.5)
⇔ a=−
log
(
max(M+)
1
10 init(M
−)−1
)
1
15max(M
+)− s , (5.6)
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Figure 5.1: Illustration of the parameters in Eq. 5.3 to Eq. 5.6.
The method may be framed as a heuristic approach of suppressing
noise in M+(i,k). It served the reconstruction results of activation time
imaging in the atria impressively for the simulation study in [91] (root
mean squared errors reduced from 35ms down to between 25ms and
20ms for a wide range of σs ∈ [10,40]). However, in the presence of
30dB white Gaussian noise, similar improvements were seen, which
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were due only to the presence of noise, and the improvement by the
sigmoid weighting was maintained only for a narrow range of σs, while
it worsened results for the other values. The effect of the noise can be
explained with a smoother interpolation between activation times at
critical points. White noise is already stated in [47] as imposing a grad-
ual offset between reconstructed critical times. As the improvements
were very signiﬁcant (both those through the noise and those through
the weighting method), further studies on the effect of noise conditions
on the interpolation could greatly improve the practical value of the
critical times method for activation time imaging. From knowledge
on the magnitudes and shapes of the similarity functions under such
conditions, the circumstances and parameterizations could be derived
for the approach to being beneﬁcial also under realistic conditions.
5.3 A Framework to Introduce Measurements into Solutions of
Activation Time Imaging
The following scheme is proposed to image activation times, given that
single measurements of local activation times (LATs) in the heart are
available, which is the case for the datasets in the PVC validation study.
This method may serve in the future to use pre-interventional BSPM
and MRI recordings to enhance sparse LAT maps, which cardiologist
often have to deal with when patient arrhythmias under treatment show
little activity in the catheter lab. This often leads to the termination of
long-planned and stressful interventions.
The method is based on activation time imaging using the integral
method and Tikhonov 2nd-order regularization (ATintT2, see Sect. 4.3.4),
which was proposed and studied in [38, 41–43], where it was shown
that the time integral of TMVs can be interpreted as activation sequence
— or in terms of activation times when making speciﬁc assumptions on
the action potential shape.
Assuming that during the QRS complex, TMVs behave like a Heaviside
function in time that is scaled with Δv, it can be shown that [38]
Aτ = b˜, (5.7)
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where τ is the activation time and A the lead ﬁeld matrix
b˜=− ts
Δv
kT
∑
k=1
bk (5.8)
the scaled time integral of the BSPM with sampling interval ts and
BSPM time samples bk. A solution for τ can be obtained using Tikhonov
2nd-order regularization
τλ = argmin
τ
‖Aτ − b˜‖2+λ 2‖Lτ‖2, (5.9)
where L is the discrete approximation of the Laplace operator and λ
the regularization parameter, which is obtained from the smoothed
and interpolated L-curve using the toolbox from [32]. Solutions with
the method do usually not have the correct scale and differ from that
of the ground truth due to imprecise assumptions being made for Δv.
However, it is possible to correct for errors in Δv even after solving
the problem. Given, e.g., that a solution τ has vector entries from 0 to
140ms, but it is known to represent the activation times of an entire
QRS duration of 0 to 100ms, it may be deduced from τ being wrong
by a factor of α = 1.4 that 1/Δv had been wrong by a factor of α = 1.4,
since for an arbitrary α ∈ R:
argmin
τ
‖Aατ −α b˜‖2+λ 2‖Lατ‖2 (5.10)
= argmin
τ
|α|‖Aτ − b˜‖2+λ 2|α|‖Lτ‖2 (5.11)
= argmin
τ
‖Aτ − b˜‖2+λ 2‖Lτ‖2 (5.12)
I.e., given that solutions are unique, if τ is the solution to Eq. 5.12, ατ is
the solution to Eq. 5.10, and a scaling error in b˜ would lead to the same
scaling error in τ .
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Hence, assuming that Δv is not known and considered arbitrary, solu-
tions to Eq. 5.9 may be scaled to match the known range of the true
solution, which is the QRS duration [41]:
τT,i = T
τi−min
i
τi
max
i
τi−min
i
τi
, (5.13)
where T : QRS duration and i ∈ 1 . . .n the vector components of τ . Note
that the offset correction with min
i
τi in Eq. 5.13 is possible since if τ
is a solution to Eq. 5.9, τ + β , β ∈ R is also a solution: in theory, all
homogeneous distributions in τ are in the null space of A and L, if A is
constructed for transmembrane voltages and L the Laplace operator.
Medical doctors in the cath-lab usually refer to the R-peak as LAT= 0ms.
To interface with LATs measured in the clinic, τR is deﬁned as
τR = τT − tRpeak (5.14)
To introduce a set of clinical LAT samples as a priori information the
solver is then embedded in a disciplined convex programming [92]
framework. To being able to introduce boundary conditions from the
measured LATs it is necessary to work in the domain of τ . As a ﬁrst
step, the LATs are converted to τT representation:
τTapr,i =
{
LATi+ tRpeak if LAT of node i available
not deﬁned else
(5.15)
Note that LATs are assumed to be measured within the QRS interval and with
respect to the R-peak.
Next, conversion to τ is required according to Eq. 5.13. However, as this
includes non-linear operations such as min and max, it cannot be done
as part of the cost functional. The scaling factor in Eq. 5.13 is instead
trained on a previous unconstrained inverse solution with Eq. 5.9:
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τT,i = T
τi−min
i
τi
max
i
τEq.5.9,i−min
i
τEq.5.9,i
(5.16)
=ΘEq.5.9
(
τi−min
i
τi
)
, (5.17)
where ΘEq.5.9 :=
T
max
i
τEq.5.9,i−min
i
τEq.5.9,i
(5.18)
To get from τ to τT would still require a min operation. However, as
noted above for τ+β , it is known that an offset in the inverse solution is
ineffective in both summands of the cost functional (given the approxi-
mation of the Laplace operator has been optimized for this property).
Therefore, to impose constraints on τT with the intention of ﬁnding a
better solution τ to the cost functional, the cost functional may as well
be computed for τˆ =
(
τ −min
i
τi
)
, which translates directly back into
the original cost functional:
Aτˆ = A
(
τ −min
i
τi
)
= Aτ (5.19)
Lτˆ = L
(
τ −min
i
τi
)
= Lτ (5.20)
For the purpose of constraining solutions to the cost functional, bound-
ary conditions in τT can hence be imposed on τ by a sole correction of
scale:
τT =ΘEq.5.9τ (5.21)
Using the scaling factor from the previous unconstrained solution, the
inverse problem is solved in the disciplined convex programming frame-
work of the CVX toolbox for MATLAB [92, 93] with λ from the L-curve
of the cost functional in Eq. 5.9 and constraints imposed on the LATs as
follows:
τλC = argmin
τ
‖Aτ −b‖2+λ 2‖Lτ‖2, (5.22)
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s.t.
ΘEq.5.9τ > lb (5.23)
ΘEq.5.9τ < ub (5.24)
‖ΘEq.5.9τS− τTapr,S‖2√|S| < η , (5.25)
where ub = max
({
τTapr,S,T
})
and lb = min
({
τTapr,S,0
})
, S = { indices
where τTapr is deﬁned }, |S| : cardinality of S such that η : upper bound
of the root mean square error in τT .
The solution for τλC is of course considered to have a wrong offset, due
to the imposed constraints and because of Eq. 5.19 and Eq. 5.20, but this
does not materialize in the ﬁnal result: the solution for τλC is scaled to
the range of τT ,
τT,λC =ΘEq.5.9 (τλC−min(τλC)) , (5.26)
and ﬁnally converted to activation times with respect to the R-peak:
τR,λC = τT,λC− tRpeak. (5.27)
5.4 Tikhonov Spatio-Temporal Method with BSPM Offset
Correction (WIN, OFF, OFFR)
Acknowledging the difﬁculty of identifying the correct offset in the
BSPM, especially for cases of VT1, an algorithm was proposed to com-
pute an optimized BSPM offset along with the inverse solution. To this
end, the inverse problem is solved for a time window, yet evaluated at
just a single time point xeval, and the optimal offset is computed for all
these time steps together.
AXwindow = Bwindow, (5.28)
1 VT baseline correction has been proposed in [94, 95], speciﬁcally also for the purpose of ECG imaging. In
these works, variations in the heart rate were used to remove T-waves from QRS complexes during VT.
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where the time window is represented as
Xwindow = [x1 · · ·xT ]
Bwindow = [b1 · · ·bT ] (5.29)
with T: number of samples in the window.
First, to cope with the dimensionality of an inverse problem with mul-
tiple constraints, the time window is reduced to p time vectors using
Vp, which contains the ﬁrst p singular vectors in the temporal basis of
the singular value decomposition of Bwindow. The ﬁnal solution is later
transformed back into time space and evaluated at the desired time
sample.
AXwindow = Bwindow =USV
T (5.30)
⇔ AXV = BVp = BV , where Vp ∈ RT×p (5.31)
Second, the original problem in Eq. 5.30 is augmented in the solution
domain, such that the solution carries additional components ε1, . . . ,εm
that represent the optimal BSPM offset, i.e. for b ∈ Rm×1, m components
are added to x and m columns to A:
x˜=
[
x
ε
]
, where x=
⎡
⎢⎣
x1
...
xn
⎤
⎥⎦ , ε =
⎡
⎢⎣
ε1
...
εm
⎤
⎥⎦ (5.32)
A˜=
[
A id.m×m
]
, A ∈ Rm×n, (5.33)
such that
A˜x= Ax+ ε = b (5.34)
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X˜ = [x˜1 . . . x˜p] (5.35)
the following functional is minimized:
‖AX˜V‖fro+λ 2‖LX˜VVTp ‖fro (5.36)
s.t.
ε1 = ε2 = · · ·= εp
εi < 0.1, i= 1, . . . ,m
εi >−0.1, i= 1, . . . ,m
From the solution for XV in X˜V , the window Xwindow can be computed
and the solution can be evaluated at time step xeval:
Xwindow = XVVTp (5.37)
To provide a reference for the results in Sect. 7.1.4, a variant of the
algorithm (WIN) was tested where the augmentation and boundary
conditions were dropped. This lead to the following variants of the
method:
• WIN: standard Tikhonov spatio-temporal method without offset
correction
• OFF: proposed offset correction, time window positioned around the
time of evaluation
• OFFR: proposed offset correction, time window positioned around
the R-peak
The time window for the WIN scheme and the OFF scheme was posi-
tioned around the time of evaluation. For the OFFR scheme, the win-
dow was positioned around the R-peak, and the sought xeval was added
to the window as the ﬁrst column. All methods were implemented
using the CVX disciplined convex programming framework for MAT-
LAB [92, 93], and they are a variant of Greensite’s spatio-temporal
Tikhonov approach [96].
For all temporal singular vectors
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5.5 Model-Based Approach
The challenge of the inverse problem of ECG is the underdetermined-
ness of the solution and the attenuation of its high spatial frequency
components in the BSPM. To overcome its difﬁculties, it is ultimately
the goal to introduce as much a-priori knowledge in the solution as
possible, while leaving room for its physiological and pathological vari-
ations.
It is dangerous to use solely model-based approaches, as they usually
do not leave room for these variations unless deviation from the model
is permitted, e.g. through stochastic frameworks. Since it can be as-
sumed for the cases in this study that all tissue in the geometric heart
model is excitable (except for Patient 12, where scars were identiﬁed, see
Tab. 7.1), results for the PVC study are also presented for a model-based
approach in this work.
While previous works [79–83] have come up with rather advanced
data-driven adaptations, e.g. of the excitation conduction velocities,
the implementation here follows a simple algorithm that, in contrary
e.g. to [79, 81], does not need an initial guess. The proposed method
computes the similarities between model-based ECG simulations and
the measured ECG, with either the mean temporal (MODcct) or mean
spatial correlation coefﬁcient serving as similarity measure (MODccs):
• As in the case of the MAP method, cardiac excitation propagation
was modeled as follows: the distance to the excitation origin was com-
puted using the Dijkstra algorithm and weighted with a conduction
velocity of 0.8m/s (isotropic, in contrary to that in [79, 81]) to ob-
tain activation times. These were convolved with an action potential
template from a simulation with a reaction-diffusion model [97, 98].
Simulations were produced for each 3rd node in the heart mesh to
contain the size of the resulting data and forward-calculated with the
lead-ﬁeld matrix.
• The following was repeated for each 3rd node in the heart:
– Two “agents” were sent out from the R-peak (maximum) of the
envelope of the absolute BSPM signal to ﬁnd the ﬁrst occurrence
of 15% of the R-peak magnitude towards the end and the start of
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the beat. This was done for both the measured and the simulated
BSPM. The scheme avoids problems with pacing artifacts or ST-
segment elevation.
– The identiﬁed interval in the simulated BSPM was then interpo-
lated to ﬁt the interval in the measured BSPM, which normalizes
for errors in the choice of the conduction velocity.
– Mean temporal or mean spatial correlation coefﬁcients were com-
puted to measure the similarity of the simulation with the mea-
sured BSPM.
• The node with the greatest similarity measure was chosen as the
excitation origin.
6Clinical Application - Methods
“There are always inaccuracies in clinical data. In my experience,
a method either works without ﬁne-tuning, or it does not work
in a clinical context.”
Kawal Rhode
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(a) University Medical Center Mannheim
(Patient 19).
(b) King’s College London (Patient 10).
Figure 6.1: Clinical application of the BioSemi 80-channel BSPM system in the catheter lab.
Electrodes were applied on the front of the thorax at University Medical Center Mannheim, where a
photogrammetric approach was used for electrode localization. At King’s College London a biplane
X-ray based localization approach was used, with electrodes on the front and back, but with
restrained ﬁeld of view.
In this chapter, setups and processing pipelines for the ECG imag-
ing application studies will be introduced. Thereby, it shall serve as
a methodological documentation of the datasets collected. The scope
spans from BSPM and image acquisition to the concurrent recording
of intracardiac validation measurements. It further includes the related
signal processing and building of computer models of the heart and
thorax. Attention has to be given to each step of the modeling and
acquisition process, as each one of them by itself is crucial to avoid
signiﬁcant errors in the inverse solutions [38, 99].
6.1 BSPM Acquisition and Setups
BioSemi BSPM System
Electrocardiographic measurements were conducted in the catheter lab
using an 80-channel BSPM system by BioSemi B.V., Amsterdam, the
Netherlands [100, 101]. Clinical application in the catheter lab is demon-
strated in Fig. 6.1 for the setups used in the two cooperating clinics.
The system is particularly well-suited for recording bioelectric signals
(active electrodes, ampliﬁers designed to handle great ranges of com-
mon mode signal, driven right leg circuit) and has been used in several
previous works of our group [21, 102–105] and other works in ECG
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imaging [68]. It competes with mostly equivalent alternatives such
as the 3D ECG System by Heartscape Technologies, Inc. [106], which
is advertised for as BSPM system for detection of myocardial infarc-
tions [107] — or the Refa system by TMSi B.V., Enschede, the Nether-
lands, which aims mainly at the electroencephalography (EEG) and
electromyography (EMG) market [108, 109]. Both alternative systems
are FDA-approved, while the BioSemi system is suited for research
applications only.
Electrode Setups and Practical Constraints
While an ideal electrode set-up would sample BSPMs on both the entire
front and the back of the patient, practical constraints made it necessary
to work with electrodes in only the areas where placement and localiza-
tion was possible. The studies conducted in this work are particularly
difﬁcult in that sense, as they are validation studies that took place in
the catheter lab. Electrodes could not be localized in CT scans as e.g.
in [59], since the study used MRI to demonstrate ECG imaging as a
non-invasive and ßero dosetechnique. Patients could not present for
MRI immediately before or after the study for logistical reasons, and the
BioSemi active electrodes are not suited for MRI. Therefore, electrodes
had to be localized in the catheter lab.
At King’s College London, electrodes were hence localized on-site us-
ing a newly developed algorithm for biplane X-ray imaging [110, 111],
which had to use a narrow ﬁeld of view to minimize exposure to radia-
tion, but which allowed for localization on both the back and front, see
Fig. 6.1(b). With just that narrow ﬁeld-of-view available, electrodes were
therefore only placed on the left half of the thorax surface. At University
Medical Center Mannheim the algorithm for biplane X-ray imaging
was not available. Instead, a camera-based electrode localization system
was developed [112], with much greater ﬁeld of view, but no ability to
localize electrodes on the back, see setup in Fig. 6.1(a).
Furthermore, the resulting setups had to deal with limitations such as
the need to give the standard 12-lead ECG and deﬁbrillation patches
priority, along with a limited ﬂexibility of the strips which made it
necessary to use sub-optimal setups for female patients that leave out
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(a) Decay of singular values σi in the lead ﬁeld matrix. (b) Setup VERT, singular vectors.
Figure 6.2: Different realistic setups for a female patient (Patient 17) were tested for their decay in
singular values of the lead ﬁeld matrix in [26]. (a) FULL: 160 equally distributed electrodes on the
front and back, VERT: setup as displayed in (b), HORstom: a horizontal setup with all electrodes
below the breasts placed on the stomach, HORsides: horizontal setup with some of these electrodes
placed on the sides. (b) The BSPM displayed on the thorax visualizes the sum of the ﬁrst i= 1, · · · ,5
singular vectors for setup VERT.
6.2 Electrode Localization
For ECG imaging, it is necessary to localize and co-register the elec-
trodes of the BSPM system with great accuracy. While it has been shown
that displacement errors of 1 to 2mm have tolerable impact [113–115],
other works have demonstrated that localization errors of 5mm [38,
Sect. 8.1] or 7mm [116, Sect. 7.3] already impair results signiﬁcantly.
Three electrode localization systems were used in this work:
• a photogrammetric camera-based system (employed at University
Medical Center Mannheim) with 1.01± 0.51mm (mean, SD) accu-
racy, which has been developed and validated within the scope of
this work for studies in the catheter lab [112]. The system (Fig. 6.4)
facilitates for the ﬁrst time in ECG imaging a photogrammetry-based
electrode localization with automatic marker-based electrode identiﬁ-
parts of the breast. For female patients, it was identiﬁed in a study on
realistic setups [26] that it is best to place the electrodes vertically un-
der these circumstances, see Fig.6.2(b). The ﬁnal setups resulting from
such considerations and also from failed localization (not visible) and
practical conditions on-site are displayed for each patient in the clinical
results, Sect. 7.
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Figure 6.3: Biplane X-ray based electrode localization at King’s College London (Patient 10).
6.3 MRI Acquisition and Segmentation Process
3-D anatomical imaging is required to identify tissue structures for
computer models of the heart and thorax. While some studies in ECG
imaging have used CT [59] and despite CT becoming increasingly ef-
ﬁcient, with exposure to radiation decreasing, MRI was used in the
studies of this work for its ßero-dosenature. Besides ethical aspects, the
non-invasiveness was assumed to be a key requirement for a broad
cation. The markers (Fig. 6.1 (a)) are placed on the electrode strips and
allow for an identiﬁcation of BSPM channels with error correction.
The code has been published as open source on GitHub [117].
• a biplane X-ray based localization system (King’s College London)
with 0.33±0.20mm accuracy as presented in [110]. This system was
used for validation measurements in the catheter lab (Fig. 6.3).
• an Optotrak 3020 optical tracking system (King’s College London) of
sub-millimeter accuracy which is part of the XMR suite at Guy’s Hos-
pital, which is presented in [118]. The system was made by Northern
Digital Inc., Waterloo, Canada and has previously been used by our
group [119]. It was not used for validation studies in the catheter
lab, as it is installed in an MRI room. Electrode locations in the XMR
suite are recorded with the Optotrak system on the MRI table, and
coordinates are produced in the same coordinate system as the MRI
data.
The according localization method is referred to in the dataset descrip-
tions in Sect. 7.
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(a) Epipolar geometry used to compute 3-D
coordinates from point correspondences
in two cameras.
(b) Demonstration in the catheter lab.
Figure 6.4: Setup of the photogrammetric camera-based system that was developed for this project.
Fig. (a) is adapted from [120, Fig. 9.1]).
To produce anatomical models of the thorax, imaging of the upper body
was required that covered the shoulders (in the sagittal plane), the lat-
eral ends of the body (in the coronal plane) and the back and breasts
(in the transversal plane). Heart scans were required to cover the entire
ventricles (University Medical Center Mannheim) or the whole heart
(King’s College London).
Cardiac and respiratory gating issues had to be solved to combine MRI
scans of the thorax and heart to form patient geometries. Cardiac im-
ages were taken in the end-diastolic phase, which is best suited for ECG
imaging of electrical depolarization processes, as the heart is almost
future use of ECG imaging in the clinic. To reduce the logistic efforts
of ECGI, ﬂuoroscopy imaging has been proposed as substitute for MRI
or CT. It is promising for applications in the catheter lab [121] and may
well be combined with the electrode localization method used at King’s
College [110]. However, the accuracy of ﬂuoroscopy-reconstructed heart
geometries with respect to CT-based models was only 10mm for the
human heart in the aforementioned publication (4mm for a phantom
study), which may be considered an unacceptable bias in validation
studies as long as ECG imaging is not established with broad empirical
evidence of accuracy and robustness. This ﬁnding strengthened the
decision for MRI.
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(a) Heart MRI over thorax, Patient 02. (b) Navigated whole heart MRI, Patient 02.
(c) Heart MRI over thorax, Patient 05. (d) Cine MRI stack over thorax, Patient 20.
Figure 6.5: MRI scans of the thorax and heart, (a)-(c) King’s College London, (d) University Medical
Center Mannheim.
6.3.1 Imaging at University Medical Center Mannheim
For the clinical study on PVCs, which was conducted in cooperation
with University Medical Center Mannheim (UMM), a Siemens 3T
at rest during the end-diastolic phase and continues to be so during
the QRS complex [122]. Respiratory gating was required as thorax and
heart scans as well as acquisitions that are combined to form a heart
scan may have different respiratory levels (for an overview of motion
artifacts in cardiovascular MR imaging, see [123]). The effect is illus-
trated in Fig. 6.5(a), where a heart scan is superimposed over a thorax
scan. Different schemes were used in the clinical cooperations to handle
the gating, as well as the image segmentation.
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whole-body imaging system [124] (MAGNETOM Skyra, Siemens AG,
Healthcare Sector, Erlangen, Germany) with 6-element phased array
body coil was used. To obtain images of the thorax a T1-weighted volu-
metric interpolated breath-hold examination (VIBE) with fat saturation
was used, with a 3-D spoiled turbo gradient echo sequence. For the later
merger with the heart scan, the VIBE scans that cover the thorax were
acquired in multiple breathing levels. Having several scans available,
the scan with its respiratory level closest to that of the heart scan could
later be selected. Fig. 6.5(d) shows the best match for Patient 20, where
a stack of cine MRI images was collected to represent the heart.
To collect standard 3-D whole heart scans navigator triggering [125, 126]
was used initially in the study (ﬂash, inversion recovery). Although
the method had worked properly with control cases, it provided bad
imaging quality for patients with frequent PVCs. Arrhythmia detection,
which may be used to exclude arrhythmic beats in the gating, was not
used due to the expected considerably extended imaging times and the
related stress for the patients. Heart scans were therefore produced from
a sequence of cine MRI instead (9 patients). For the patients towards
the end of the study, images were picked from one of the following two
sequences or the cine MRI, which have the advantage of acquiring the
entire heart at once and provide better resolution across slices: an MR-
angiography ﬂash-3d scan (Patient 19, resolution: 0.72×0.72mm2, slice
thickness 1.40mm) and a T-1 weighted VIBE scan with fat saturation
(not chosen for Patient 19 or Patient 20, in which it was applied at a
resolution of: 1.74×1.74mm2, slice thickness 1.70mm, using the same
sequence as for the thorax images, resolution: between 0.68×0.68mm2
and 1.95×1.95mm2, slice thickness between 1mm and 2.2mm). Both
were taken after injection of Gadolinium MRI contrast agent.
In detail, for cine MRI 7-12 short axis views covering the whole left
and right ventricle were acquired during repeated end-expiratory
breath-holds. These ECG-gated cine images were obtained using a
segmented steady-state free-precession sequence (SSFP, parameters: TE
/ GR 1.2/3.2ms, temporal resolution 35ms, in plane spatial resolution
1.4×1.8mm2, slice thickness 8mm, inter-slice gap 2mm). For segmen-
6.3. MRI ACQUISITION AND SEGMENTATION PROCESS 65
(a) segmentation (b) corrected, RV/ LV
Figure 6.6: Segmentation of tissues before (a) and after (b) thickness correction and assignment of
RV and LV tissue classes. Red colors: ventricular blood (RV, LV), blue colors: ventricular
myocardium (RV, LV), Patient 08.
tation of the ventricles, single images from the end-diastolic phase of
each cine sequence were chosen to build a stack of aligned layers (the
ﬁrst images in the cine sequences, which were triggered by the R-peak).
Sometimes, these layers were spaced equidistantly to each other, as
they resulted from the same collection of short axis views. In some
cases, however, data from several such collections was available with
the same plane orientation, and information of different collections had
to be combined to form the stack. Layers were then extended to the
minimum inter-slice distance to their respective neighbours and black
spaces were added in the remaining spaces between the layers (see cine
MRI stack in Fig. 6.5(d)). Cine MRI has previously been used for heart
models in ECG imaging validation studies of ventricular [74] and atrial
pre-excitation [68, 76].
For segmentation of the thorax and heart scans, interactively deformable
triangle meshes [127] were used in this work on IBT proprietary soft-
ware. The thorax surface was segmented automatically using fore-
ground masking with Otsu’s method as implemented in the brain
segmentation plugin of 3D Slicer [128, 129]. The thorax scan was seg-
mented into surface, lungs (left, right), lung vessels (left, right), liver,
spleen, stomach, kidney (left, right) and aorta, the heart scan into its
ventricular walls and lumina.
After manual segmentation, to prevent models of the heart from having
holes, the ventricular walls were tested to have at least a desired mini-
mum thickness, otherwise the segmentation was corrected by growing
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the ventricular tissue into the respective blood or non-cardiac tissue (see
original segmentation and corrected segmentation of tissues in Fig. 6.6
(a) and Fig. 6.6 (b)). The wall thickness of the RV has been reported in
ultrasound studies to be in the order of 3.0±0.92mm for the diastolic
phase and 5.1±1.64mm in the systolic phase [130], in guidelines it is
quantiﬁed at 4mm for the lower reference value estimate in the RV in
general and at 2mm in the RV outﬂow tract [131][Tab. 2]. The range of
reported values according to [132][Tab. 1] also starts at 2mm. According
to [133], LV wall thickness can also be as low as 1−2mm in the apex.
Still, given the previously mentioned literature values, it was concluded
that to perform hole-ﬁxing in the approximate anatomical models built
in this study, 2mm could be set as the appropriate minimum thickness
for both the RV and LV.
In the septum, the RV and LV intersect. To distinguish between RV
and LV in the segmentation, a rule-based algorithm was used: The
geometric distance of cardiac tissue to the respective RV or LV blood
was computed. The cardiac tissue closest to the LV blood was assigned
the LV tissue class and vice-versa. Due to the distances found in the
segmentation of the VISIBLEMAN dataset [134, 135], the wall of the LV
was assumed to occupy two thirds of any wall that was found between
the two lumina (the blood pools), the RV was assumed to occupy one
third of the tissue. For results for the assigned tissue classes see Fig. 6.6
(b).
6.3.2 Imaging at King’s College London
For the clinical study on ventricular tachycardia (VT) with King’s Col-
lege London (KCL) the Philips Achieva 1.5T MRI scanner (Philips,
Best, The Netherlands) at Guy’s Hospital, London, was used. This
MRI research suite has the Optotrak electrode localization system in-
stalled, see Sect. 6.2. Thorax scans were taken during expiration with
a SENSE breath-hold ultra fast gradient echo sequence (resolution:
1.41×1.41mm2 or 1.48×1.48mm2, slice thickness 2mm or 4mm). An
ECG-gated SSFP sequence was then used for MRI acquisitions of the
whole heart, including the atria and with high level of detail, see
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Fig. 6.5(b). A navigator was used to facilitate respiratory gating (res-
olutions: 0.87× 0.87mm2 to 1.21× 1.21mm2, slice thickness between
0.9mm and 5mm). In Patients 05 and 10, proper co-registration of heart
and thorax scans was ensured by navigator-triggering at the thorax
scan breath-hold level, see Fig. 6.5(c), whereas corrections had to be
undertaken manually (which were performed in the axial dimension
only) for the other cases, e.g. Patient 02 in Fig. 6.5(a).
Thorax segmentation was performed manually with the PHILIPS CHD
segmentation software package provided in the context of the eu-
Heart project (European Community’s Seventh Framework Programme)
by Philips Research Hamburg, Germany. The tool uses a level set
method and allows for a quick, immediately three-dimensional and
adaptive generation of segmentations [119]. Heart segmentations were
produced automatically with the PHILIPS SSFP cardiac segmentation
plug-in [136], which was also provided in the context of the euHeart
project by Philips Research. Segmentations of ventricular scar tissue
from delayed-enhancement magnetic resonance imaging were provided
by King’s College London in this study. For details, see [137].
6.3.3 Active Tissue at the Base of the Ventricles
For the segmentations from both studies, it was not possible to differen-
tiate between electrically active tissue at the base of the ventricles and
the valves. Hence, the level of the valves is missing in the segmentations.
This can be justiﬁed, however, as the wall thickness and therefore the
signals from this tissue can be assumed to be of negligible strength.
For ECG imaging methods that do not work with explicit pathways
of excitation conduction (e.g. smoothed TMVs or smoothed activation
times) this simpliﬁcation can be considered to have little effect: although
additional active myocardium would result in additional sources and
links in the smoothing operators, the absence of tissue does not rule out
solutions with pathways through this tissue, and many groups work
with that simpliﬁcation. For methods that require a reconstructed wave-
front to travel along a tissue pathway however, especially model-based
approaches [80, 81, 138] or fastest-route initial estimates [79], working
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with the resulting anatomical models may keep such solutions out of
the true solution space.
6.4 Mesh Generation and Resolution
To build computer models of the patients for FEM forward calcula-
tions, tetrahedral meshes were generated from the aforementioned
voxel-based segmentations with tools of the computational geometry
algorithms library (CGAL) [139]. A rule-based approach according to
Streeter et al. [104, 140] was used to introduce ﬁber orientation in the
ventricles to produce conductivity tensors, with magnitudes set in line
with [141]. Meshing parameters were set according to Tab. 6.1. The effect
of all relevant parameters on forward-calculated BSPMs had previously
been tested in [142] and the appended study in Sect. A. The studies
support the proposed setup with the following ﬁndings: With the heart
tissue reﬁned to 1mm resolution, only random-noise-related effects
were seen in the BSPM upon further reﬁnement. At the same time, the
choice is robust, as a lowering of the resolution did not immediately
inﬂuence the BSPM in [142] and only did so after adding another mil-
limeter in the repetition of the study in Fig. A.2. The facet_angle had
little effect and was set to 25◦ (Fig. A.5). Thorax-related parameters
facet_size and cell_size had little impact on the BSPM when the heart
was already resolved at 1mm (Sect. A.2). Both were chosen such that
even without reﬁnement of the heart, calculations express similar be-
haviour as for their highest possible resolution setting, see Fig. A.12
(4mm and 5mm). The cell_radius_edge_ratio parameter was not stud-
ied and was set to 3 as meshing is guaranteed to converge for it being
greater than 2. According to the ﬁndings in Sect. A.2, a small facet_dis-
tance tends to facilitate a successful meshing procedure. It also prevents
the facets from being too far from the surface. Such non-conformal
meshes greatly inﬂuence electric ﬁeld calculations [143]. Still, on the
other hand, 1mm was preferred over the most robust setting of 0.5mm,
as to prevent staircase effects from the underlying 0.4mm voxel-grid
with tissue information.
6.4. MESH GENERATION AND RESOLUTION 69
Parameter Range Description
Criteria for surface facets
facet_angle
(f_a)
25◦ Lower bound for the angles of facets that belong to the surface
of the volumetric mesh
facet_size
(f_s)
4mm Upper bound for the radii of surface Delaunay balls that de-
scribe the size of surface facets
facet_distance
(f_d)
1mm Upper bound for the approximation error of boundary and
subdivision surfaces of the geometrical pattern
Criteria for mesh cells
cell_radius_
edge_ratio
(c_r_e)
3 Upper bound for the circumradius-to-shortest-edge ratio
cell_size
(c_s)
5mm Upper bound for the circumradius
Criteria for reﬁned tissues
reﬁne_facet_size
(r_f_s)
same as
facet_size
(heart tissue)
reﬁne_cell_size
(r_c_s)
1mm (heart tissue)
Table 6.1: Proposed setup for CGAL mesh generation parameters. For more information on the
parameters, see [142].
To represent sources of TMVs in the forward calculations a coarse mesh
of 4mm resolution was used. Lead ﬁeld matrices were produced with
the bidomain model (Sect. 3.2). The TMVs from the coarse mesh were
interpolated for this purpose on the ﬁne mesh of the heart.
For calculations with the boundary element method (BEM) the surface
of the FEM thorax meshes and coarse heart meshes were extracted,
simpliﬁed (vertex simpliﬁcation with quadric edge collapse decimation)
and smoothed in MeshLab [144], which is a tool developed with the sup-
port of the 3D-CoForm project. Smoothing was performed on the face
normals using a method that preserves the positions of the vertices and
prevents the models from shrinking. Models for BEM contain only the
thorax and heart surfaces, with isotropic conductivities assigned to the
heart (0.1S/m) and thorax (0.2S/m). For surface TMV calculations also
the intracellular space of the myocardium (0.05S/m) was considered.
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6.5 Rigid Co-Registration of Electrodes with the Thorax Model
At UMM, after localization (Sect. 6.2), electrode positions of the 80-
channel body surface potential mapping (BSPM) system were rigidly
co-registered with the thorax model using anatomical landmarks such
as nipples, liver spots, intersections of prominent veins, prominent bone
structures or tattoos. These landmarks were either also visible in the
MRI or marked with MRI-compatible electrodes. Co-registration was
performed numerically, but with the landmarks weighted according to
their assumed reliability, which was judged mostly by the volume cov-
erage and visibility of the respective ﬁducial in the MRI (documented in
the datasets). To identify a rigid transformation between the correspond-
ing landmarks, the underlying 3-D point co-registration (introduced
here without the weighting) was performed as follows:
According to a scheme presented in [145, 146], to identify the optimal
rotation and translation between corresponding 3D points piA ∈ R3×1
and piB ∈ R3×1,
RpiA+ t = p
i
B, i= 1 · · ·N, (6.1)
both a translation t ∈R3×1 and a rotation matrix R∈R3×3 were produced
such that
min
R,t
N
∑
i=1
‖RpiA+ t− piB‖.
To this end, the covariance of the point data was computed and decom-
posed into its singular values. A matrix R˜ was then derived from the
resulting bases:
C =
1
N
N
∑
i=1
(
piA−
1
N
N
∑
i=1
piA
)(
piB−
1
N
N
∑
i=1
piB
)T
USVT = svd(C)
R˜=VUT (6.2)
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R˜ may be a rotation matrix or a reﬂection matrix. To ensure a rotation is
obtained the latter case was corrected for by manipulation of V :
R=
⎧⎨
⎩
(
v1, v2,−v3
)
UT if det R˜< 0
R˜ else
, V =
(
v1, v2, v3
)
(6.3)
The translation was then computed as
t =
(
1
N
N
∑
i=1
piB
)
−R
(
1
N
N
∑
i=1
piA
)
(6.4)
Note that to guarantee the ﬁnal transformation does not include a
scaling and is indeed rigid, R had to comply with the following criterion
of equivalence for rotation matrices [147]:
R−1 = RT
detR= 1
This is guaranteed by the above algorithm, as orthogonality is already
guaranteed for the bases of the SVD and therefore also for their trans-
poses and product in Eq. 6.2. The determinant may then be −1 or +1,
with the latter being guaranteed by the correction in Eq. 6.3.
At KCL, electrodes were localized using the biplane X-ray imaging
system (Fig. 6.1). Co-registration with the MRI-based thorax surface
was performed using rigid body registration for four electrode markers
that appeared in both MRI and X-ray.
6.6 BSPM Processing and Filtering
This section documents the overall handling of electrode channels in the
BSPM and the lead ﬁeld matrix, including the proper choice of reference
electrodes, choice of BSPM channels and the ﬁltering.
72 CHAPTER 6. CLINICAL APPLICATION - METHODS
6.6.1 Choice of a Reference Electrode
After co-registration of the electrodes with the thorax, a reference elec-
trode had to be chosen. Signals in the Biosemi system were recorded
with a driven-right-leg circuit: to prevent the recorded signal from going
beyond the ampliﬁers’ input voltage range, common mode voltage is
actively reduced [148]. To this end, a common mode signal (CMS) was
sampled from close to the body center. All 80 channels were recorded
with respect to a ground electrode (DRL), which was placed close to the
hips or on the waist.
For the forward model that was used to produce the lead ﬁeld matrix,
which again was later on used to solve the inverse problem, a zero
potential had to be deﬁned as well, which had to comply with the zero
potential deﬁnition in the given BSPM.
As the position of the DRL reference electrode had not been reproduced
with the localization system1, a new reference had to be deﬁned among
the recorded channels. The method of choosing the reference is outlined
in the following, and it is highlighted that a good reference has impact
on the inverse solution.
Effect on the Inverse Solution
As all electrode signals are processed with respect to the reference,
noise on the reference channel is added to all other channels, leading
to its representation in all elements of the measurement vector b in the
inverse problem. I.e., assuming absence of other errors, if the residual
is represented in the inverse calculations with L1 norm, any error in
the reference channel will be represented m− 1 times in the cost (m
electrodes), which imposes more bias on the cost than its representation
in the single channel. The effect is similar for L2 norm residuals.
Criteria for Choosing a Reference Electrode
From the arguments in the previous paragraph, the most obvious choice
for a reference would be the channel with the least assumed noise. An
1 CMS and DRL electrodes were not provided markers in the camera-based localization system. Also, multiple
DRL leads were placed and often switched during the measurement depending on signal quality, which
made a post-measurement assignment difﬁcult.
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ideal channel would have the least assumed error with respect to the
signal generated by the cardiac electric activity (e.g., the least standard
deviation over time, assuming it relates to noise and baseline wander).
While this minimizes the error that is introduced by the reference chan-
nel on all other channels, another approach is more effective: to ﬁnd a
reference that contains the common signal and that therefore compen-
sates as much noise as possible in all of the channels. This is proposed
in [149], where Wilson’s central terminal is used as the reference in ECG
imaging. Here, instead of sticking with Wilson’s deﬁnition, the average
of all signals in the BSPM was computed. As a side-effect, using the
average signal as reference saves the electrode channel that is otherwise
used as ground. Still, the costöf the averaging on the other hand is
loosing effectively the information of 1 of 80 channels.
A Reference which Contains the Common Signal (CN)
The choice of the average over all signals as reference leads to a lin-
ear combination of signals, which cannot be implemented as Dirichlet
boundary condition in the present FEM-based tools at IBT (an approach
is suggested in [149]). Instead, the reference was introduced after hav-
ing already computed the lead ﬁeld matrix A (with an arbitrary extra
electrode position as ground). This results in ACNREF, which is sought in
the following as the mapping from TMVs x to the BSPM with common
signal reference bCNREF, which is deﬁned as:
A(x− xmean) = b−bmean := bCNREF. (6.5)
xmean is the source that would produce Axmean = bmean. This shall be the
average over all signals in the BSPM:
bmean :=
(
m
∑
j=1
b j
m
)
1m×1, b ∈ Rm×1 (6.6)
With Eq. 4.5, Eq. 6.5 can be written as
[aˆ1, aˆ2, . . . , aˆn] (x− xmean) = A(x− xmean) = bCNREF.
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To solve the inverse problem for x, not (x− xmean), it would be useful
to integrate the subtraction of xmean into a modiﬁed lead ﬁeld matrix
ACNREF which would produce bCNREF immediately from x. The follow-
ing formula is proposed:
ACNREFx := [(aˆ1− aˆ1,mean),(aˆ2− aˆ2,mean), . . . (6.7)
,(aˆn− aˆn,mean)]x= bCNREF,
aˆi,mean :=
(
m
∑
j=1
aˆi, j
m
)
1m×1, aˆi ∈ Rm×1. (6.8)
For Eq. 6.8 to actually produce bCNREF, it must be proven that
[aˆ1, aˆ2, . . . , aˆn]x− [aˆ1,mean, aˆ2,mean, . . . , aˆn,mean]x= b−bmean,
which is indeed the case:
Eq. 4.5
⇔ [aˆ1,mean, aˆ2,mean, . . . , aˆn,mean]x= bmean
⇔ 1m×1
(
m
∑
j=1
aˆ1, jx1+ aˆ2, jx2+ · · ·+ aˆn, jxn
m
)
= 1m×1
(
m
∑
j=1
b j
m
)
q.e.d.
The inverse problem can now be solved for
ACNREFx= bCNREF, (6.9)
where the reference in the BSPM is the common signal of all BSPM
channels. Note that to compute ACNREF according to Eq. 6.8, one simply
subtracts the average from each column in the original lead ﬁeld matrix
A.
6.6.2 Choice of Electrode Signals and Handling of Channels
Among the available channels, electrode signals were excluded from
inverse calculations in case of strong signal offsets (great mean over
time), which were interpreted as a result of bad electrode contact. Also,
outliers in the standard deviation over time were excluded. Both the
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Figure 6.7: BSPM processing ﬂow chart: selection of channels and reference deﬁnition.
signals of outliers and those of the selected channels were again plotted
over time as visual cross-check. The respective channels had to be
handled consistently across the processing of BSPM signals and the
computation of lead ﬁeld matrices, see Fig. 6.7. Besides a censoring of
BSPM channels, it was also required to handle missing channels in the
electrode localization. Unidentiﬁed channels in the localization were
therefore set to zero in the lead ﬁeld matrix calculation (ünidentiﬁed
electrodesïn Fig. 6.7) and cancelled from the list of ßelected channelsïn
the BSPM. Finally, these selected channels were chosen from both the
computed lead ﬁeld matrix and the BSPM, which went into the signal
ﬁltering (Fig. 6.8) as “raw BSPM”.
6.6.3 Annotation and Filtering
For the UMM study with its PVCs and pacings, beats in the BSPM sig-
nals were segmented with annotations at the onset of the QRS or at the
last sampling before the pacing (for paced beats) — and at the end of the
QRS. As PVCs have long QRS durations, they sometimes overlap with
the T-wave. In these cases the end-of-QRS mark was set to the end of the
strongest QRS-slope. BSPM signals were then processed as illustrated
in Fig. 6.8: BSPMs were acquired at 2048Hz, resampled with 1000Hz
and then ﬁltered using a 50Hz notch ﬁlter (bandwidth 0.2Hz). For the
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bCHREF / bCNREF 
ﬁltered
Figure 6.8: BSPM processing ﬂow chart: signal ﬁltering
To obtain only the signal components that can be generated by cardiac
electric activity it was crucial to eliminate offsets in the BSPM signals.
While high-pass ﬁltering eliminates the signal average in time, it does
not necessarily cancel the offset at the beginning of a cardiac event.
Therefore, in addition to removing the baseline wander, which is taken
care of by the ﬁlters, the ﬁltered signals needed further processing to
correct the baseline offset.
Following the ﬁltering, under the assumption of absent cardiac electric
activity, the average signal between −20ms and −11ms with respect to
the QRS onset was removed from each individual channel (see Fig. 6.9
(a)). This step was effectively only applied for paced beats. For PVC
beats, any remaining offset on the channels was removed instead as fol-
lows (see Fig. 6.9(b,c)): Between 1 and 52ms the signal energy across all
subsequent ﬁlters to start without oscillations, the average signal be-
tween −20ms and the QRS onset was then removed for each individual
channel, assuming that the interval accommodated no cardiac electric
activity. After that, a Gaussian low-pass ﬁlter with 400Hz cutoff fre-
quency was applied, and subsequently a Gaussian high-pass ﬁlter with
0.3Hz cutoff frequency. The passband cutoff frequencies were chosen
as in the works of Tilg et al. [68, 150].
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Figure 6.9: Effect of offset removal: Patient 20, PVC beat 1 (early in the dataset, not censored).
For the VT study at KCL, the same ﬁltering schemes were applied.
However, as VT beats appear in a long sequence of uninterrupted
activity, the QRS onset and offset could not be used for offset removal or
beat censoring. Instead, to remove relative offsets between the signals,
which are usually signiﬁcant, spatial smoothness was imposed on the
signals at their respective electrode positions, and the average from
each electrode channel was removed at the same time by minimizing
the following optimization functional:
channels was summarized for a moving window covering the 8ms after
each time step. The signal of the time step with least energy was there-
upon taken as the reference. I.e., practically, all channels at this time
start at 0mV. In contrary to the paced beats, PVCs could be assumed to
start where no cardiac activity was present, which was hypothesized to
be represented in the signal energy.
Finally, as beats with strong baseline wander (see Fig. 6.10, compared
to Fig. 6.9) were presumed to be linked to stronger artifacts in ECG
imaging and greater localization error, beats were censored and not
considered in the study when the BSPM range at the QRS end was
larger than a quarter of its maximum range. Besides baseline wander,
this scheme also censors beats when single BSPM channels disconnect
during the experiment, i.e. if they start to carry strong noise that had
not been detected during the outlier detection phase.
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Figure 6.10: Effect of offset removal: Patient 20, PVC beat 4 (half an hour into the dataset, beat
censored).
min
br
‖(B−Br)‖ f ro+‖G(B−Br)‖ f ro, (6.10)
B= [b(t = 1), . . . ,b(t = T )] (6.11)
Br = [br, . . . ,br] (6.12)
where br is the sought reference signal to be deduced from the BSPM
signal b(t), t = 1 . . .T is the annotated time interval of the cardiac event
(VT sequence) and G is a smoothing matrix which computes the spatial
gradient between electrode signals.
Note again that removing the average alone, which is also the effect of
high-pass ﬁltering in the Fourier domain, eliminates the signal average
in time, but does not necessarily cancel the offset at the beginning of
the cardiac event.
6.7 Validation Measurements
For validation measurements, the BioSemi BSPM system was applied
in the catheter lab while the patient was undergoing an RF ablation
procedure. While in [68] radiotransparent carbon electrodes and car-
bon cables had been used to avoid interference with the biplane X-ray
system [68][Sect. II, A.], the electrodes used in this study were made
from a powder of silver (Ag) and silver-chloride (AgCl), which is clearly
visible in the X-ray images [110, 151]. X-ray was only applied to control
substantial active movements of the intracardiac electrode catheters, see
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(a) Patient 06, zoom: 194%. (b) Patient 09, zoom: 97%.
Figure 6.11: X-ray images (angle: 0 ◦) showing catheters and the active electrodes of the BioSemi
system.
Fig. 6.11. Fine adjustments have been performed with the 3-D-mapping
system. While procedures at UMM and KCL were partially guided by
X-ray (and partially by an electroanatomical mapping system), cardi-
ologists of the clinical partners found that the setup did not obstruct
relevant ﬁelds of view during the procedures and did not increase the
radiation exposure for the patient. The Ag-AgCl electrodes used in this
study were connected with X-ray invisible carbon cables as in [68]. At
the same time, they have the beneﬁt of a better signal quality compared
to carbon electrodes, which suffer from much larger low-frequency
noise.
For the validation study at UMM (Sect. 6.7.1 and 6.7.2), concurrent elec-
troanatomical contact mapping with CARTO of Biosense Webster, Inc.,
was performed [152, 153], with single-point catheter measurements di-
rectly on the wall serving as validation reference. This has been the stan-
dard for validation in ECG imaging since electroanatomical mapping
has become available [71]. For the validation study at KCL (Sect. 6.7.3),
activation maps of ventricular tachycardia were recorded while mea-
suring BSPMs, which is an event that cannot be repeatedly measured.
To being able to map the cardiac electric activity at once, non-contact
multichannel mapping had to be used [154, 155]. Instead of performing
direct measurements, the EnSite system [156–158] of St. Jude Medical,
Inc., was used, which computes activation maps from balloon catheter
measurements for a simpliﬁed model of the endocardium.
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6.7.1 Post-Processing of CARTO Electroanatomical Maps
At UMM, local activation time (LAT) measurements of PVCs and pacing
locations were collected using electroanatomical contact mapping with
CARTO. The annotations performed in the clinic needed further classi-
ﬁcation, as measurement points were also collected from cardiac events
other than the PVC (e.g. pacing sites or anatomical landmarks with
His signal, with distinct purposes in the co-registration or validation
procedure). Also, not all measurements and location tags in the CARTO
electroanatomical maps were equally reliable. To ensure a good quality
of the map used for validation of the ECG imaging study, samplings
that were not suitable for creating an LAT map of the PVC were cen-
sored and neglected in the map creation, according to the following
guideline:
• ablation points were excluded, see Fig. 6.12(g)
• stimulation points were excluded, Fig. 6.12(f)
• beats of different morphology than the sought PVC were excluded
(including normal sinus rhythm, NSR), see Fig. 6.12(e)
• the remaining points were judged by the quality of the electrograms.
Noisy measurements were excluded, see Fig. 6.12(d), measurements
with good signal quality were selected for the activation time map,
see Fig. 6.12(a) and Fig. 6.12(b). Annotations were adjusted in case
they had been neglected for the map in the clinical procedure, see
Fig. 6.12(c).
Note that the best practice to annotate electrograms for LAT mapping
is subject to research, and variations in this validation ground truth
are possible, depending on the operator and methodology. As an al-
ternative to the bipolar signals used, unipolar electrograms have been
demonstrated to show more stable characteristics with respect to the ac-
tivation time, also under different catheter angles [159]. However, they
are also subject to far-ﬁeld signals and noise. To handle the downsides
of both signal types, recent works have suggested algorithms that ﬁrst
ﬁnd time windows of bipolar activity and that ﬁnally annotate the LATs
based on characteristics in the unipolar signal within that window [160].
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(a) PVC (b) PVC (c) PVC, adjust (d) PVC, noisy (e) not the
PVC
(f) paced beat (g) ablation
Figure 6.12: Electrograms measured with the CARTO system (top row to bottom row: MAP 1-2,
MAP 3-4, V4, Wilson III) and annotations for local activation times (LATs) in the heart (yellow) with
respect to the R-peak (red).
In this work, no automatic annotation was used, and decisions were
made by the clinical operator.
6.7.2 Co-Registration of CARTO Maps with the MRI-Based Model
An iterative closest point (ICP) algorithm [161] was used to co-register
the CARTO LAT maps with the MRI-based heart model. The ICP al-
gorithm has been used for co-registration of electroanatomical maps
in [162] and is typically the method-of-choice. Still, ICP algorithms may
fail in some cases if the co-registered surfaces are too different in shape,
and landmark-based approaches may be preferred for such cases [163].
In this work, to detect such failure, results were tested by visual inspec-
tion. Also, the quality of co-registration was quantitatively evaluated
by computing the distance of the co-registered points to the endocar-
dial surface, see Sect. 7. In ECGI validation studies by Seger et al. [48]
landmark points were collected with the electroanatomical mapping
system (EAMS) among the same ﬁducial markers that were used for
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(a) Co-Reg (b) HIS, lateral view
Figure 6.13: Co-registration of CARTO data with MRI-based heart and vessel models, Patient 20. (a)
Co-Reg: co-registration of CARTO measurement points (grey), vessel tag points of the aorta (green)
and points with HIS signal (yellow) to the MRI-based heart model with the implemented ICP
algorithm (weighting LV volume : LV surface : LV His region : vessel tag aorta was 1:10:1:3). A
navigated-MRI-based segmentation of the aorta (grey dots) is used as a reference for the vessel tag.
(b) HIS: Regions of interest (ROI) for area of possible measurements from the bundle of His.
BSPM-electrodes-to-model co-registration. In this study, co-registration
is performed directly to the heart to avoid errors from the alignment of
the heart MRI with the model of the thorax.
An ICP algorithm was implemented using the algorithm by Wilm and
Kjer [164, 165]. The approach was adapted to handle multiple point sets
and corresponding reference point sets simultaneously. A weighting of
the individual point clouds was introduced to balance their inﬂuence
in the ﬁnal co-registration. Registered entities were in particular:
• the lumen/ lumina of the respective ventricle(s)
(As reference for all points in the respective CARTO map, vertices
were used from a triangulation of the MRI-based heart model with
1mm cell size.)
• the endocardial surface of the respective ventricle(s)
(Extracted from the aforementioned triangulation, as second refer-
ence to register all points in the CARTO map.)
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• the septal surface of the respective ventricle(s) close to the bundle of
His
(Used to register measurement points with bundle-of-His signal
[166][Fig. 2].) As reference, the area of possible measurements for
signals from the bundle of His was selected from the MRI-based
heart model — under the following considerations: the right and
left bundle branches belong to the bundle of His and may produce
similar signals as the trunk of the bundle; the entire bundle is located
in the interventricular septum [167]; it originates at the AV node and
descends down into bundle branches in the apex [168][Fig. 501]; in
anterior-inferior dimension, the branches may spread immediately at
the base from the center to the sides [167][Fig. 12]; hence signals from
the bundle of His may be measured in the entire septum. However,
annotations in the clinic were only made in case of great H-S intervals
between the His bundle spike (H) and the S wave of the ECG, and
signals must therefore originate from the upper two-thirds of the
septum, which was therefore ﬁnally chosen as the registration refer-
ence. An example for a segmented reference point cloud is shown in
Fig. 6.13.
• segmentations of the clinically annotated vessels
(To produce vessel tags, the path of the catheter was recorded while
retracting from the respective vessel. A corresponding reference was
obtained by segmentation of the vessel in the MRI data, see Fig. 6.13)
The result of a co-registration process with three differently weighted
point clouds is shown in Fig. 6.13. After co-registration, the closest
points of the CARTO LAT measurements were located in the coarse
heart mesh in which the inverse problem was solved. In case multiple
measurements were taken from the vicinity of the same node in the
coarse mesh, LATs were averaged, leading to a mean and standard
deviation of measured LATs at the point. This method leads to a very
sparse representation of data, but represented the reality of having only
few PVC beats available for mapping during a cardiac intervention
- and it avoids interpolation or extrapolation. The assigned LATs in
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(a) Patient 20, LAT (b) Patient 20, std(LAT)
Figure 6.14: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
the coarse cardiac geometry for Patient 20, including their standard
deviation, are shown in Fig. B.9.
6.7.3 EnSite Non-Contact Maps
For the VT study at KCL, non-contact mapping with the EnSite system
was performed, with a balloon catheter placed in the LV while measur-
ing the BSPM. This system produces a shell model of the LV, which was
registered with the MRI-based LV model using anatomical landmark
registration. The results of this co-registration are documented in [137,
Fig. 1 (a),(b)].
Part III
Results

7Clinical Studies
“We have done the talking and we now need to see the
results in action.”
Jan Egeland
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With the methods from the previous chapter it was possible to apply
ECG imaging in a clinical environment. This work has focused on two
clinical validation studies, which were intended to demonstrate how
ECG imaging methods work in humans. Through cooperation with
the University Medical Center Mannheim (UMM) and with King’s
College London (KCL) it was possible to perform studies with intrac-
ardiac validation measurements that were collected in the ventricles
while measuring the BSPM at the same time. The study with UMM
includes PVCs as well as pacings from various known positions and
local activation time maps of the PVCs that were obtained with a con-
tact mapping system. This facilitates two things: the validation of ECG
imaging in terms of localizing excitation origins and the validation of its
ability to image activation times. The study at KCL captured the cardiac
electric activity of a sustained VT. Happening only once in a study, to
produce a map of local activation times the VT was recorded with a
non-contact mapping system with a balloon catheter inserted in the left
ventricle. While ECG imaging is non-invasive, invasive measurements
are needed to facilitate its validation. All clinical studies in this work
were approved by the local ethics committees, and written informed
consent was obtained from the patients.
7.1 Validation Study: Premature Ventricular Contractions
Electroanatomical maps of PVCs were recorded during radiofrequency
ablation therapies in the Stereotaxis lab [169] at UMM. Measurements
include local activation time maps, pacing positions as well as ablation
points that were collected with the CARTO contact mapping system
while measuring the BSPM at the same time. The study includes 8
patients with a complete set of validation measurements, see Tab. 7.1.
Patient 06 has only a very incomplete electroanatomical map, but is
evaluated here as well. Patient 08 has a complete model, but intracardiac
measurements could not be studied due to cancellation of the study. The
following patient datasets were excluded from presentation: Patient 04
(MRI, BSPM and biplane X-ray catheter images are available, evaluation
was cancelled due to incomplete MRI scans), Patient 07 (BSPM available,
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no catheterization due to lack of arrhythmic activity, did not show up
for MRI), Patients 15 and 16 (MRI test cases), Patient 18 (test case for
MRI protocols, BSPM, no validation data).
Datasets for ECG imaging are a complex fusion of multiple imaging and
measurement modalities that have to be co-registered, and only in case
of good data collection and registration in each single one of these steps
the resulting models can be assumed to represent the patient’s anatomy
and electrophysiology. While the upper block in Tab. 7.1 characterizes
the type and quality of the recorded excitation origins (distance to the
heart mesh used for ECG imaging), the lower sections give an overview
of the modeling steps and their quality, according to quantitative or
otherwise non-quantitative objective criteria (for details, see B in the
Appendix).
Patient-ID 6 8 9 11 12 13 14 17 19 20
Myocardial infarction 0 0 0 0 1 0 0 0 0 0
Ablation therapy successful C C 1 ? 0 1 C 1 1 1
Annotated excitation origin ET C ET ET ET MA ET ET ET ET
distance coarse mesh BEM [mm] 6 C 8 6 8 7 7 8 6 13
distance coarse mesh FEM [mm] 2 C 6 3 8 6 1 6 4 13
Segmentation thorax organs ++ ++ ++ ++ ++ ++ ++ ++ ++ ++
Segmentation thorax surface + + ++ ++ ++ ++ ++ + ++ ++
Segmentation heart ++ ++ + x + ++ ++ ++ + ++
Co-registration heart and thorax ++ + + x + + ++ + ++ ++
Electrode localization + + + ++ x ++ ++ ++ ++ ++
Electrode co-registration x x x x x x ++ + + ++
CARTO activation times x C + ++ ++ + ++ + ++ ++
CARTO anatomical map x C ++ + ++ + ++ + ++ ++
CARTO co-registration + C + ++ + ++ ++ ++ ++ ++
BSPM of pacings 0 0 1 1 1 1 1 1 1 1
Table 7.1: List of Patients. Quality of features evaluated by quantitative or otherwise
non-quantitative objective criteria (see Tables in Sect. B.2). Legend: x sufﬁcient quality achieved
(partially through manual efforts), + OK quality, ++ good quality, C not available/ therapy
cancelled (no ablations), ? signiﬁcantly reduced frequency of PVCs during therapy, ET: point of
earliest reliably measured activation time is used as validation reference for excitation origins of the
PVC, MA: mean position of ablation points, as latest successful ablation unknown and activation
times only available for QRS.
7.1.1 Presentation of Results
As a proof-of-concept, convincing and nice-looking ECG imaging re-
sults can easily be obtained when presenting best-cases with ideally
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Figure 7.1: ECG imaging of transmembrane voltages (TMV) in the initial phase of PVCs (blue bar) in
different patients. Left-to-right: Patient 17, COMdistLATmin=16mm (solver:
Tikhonov-2nd-order [11, 29], λ = 10−3), Patient 19, COMdistLATmin=12mm (λ = 10−5), Patient 20,
COMdistLATmin=24mm (λ = 10−2). COMdistLATmin is the distance of the center-of-mass of the 20%
of points with greatest TMV to the earliest measured LAT. Magenta bullets mark the measured PVC
origin. The time points of evaluation are marked in the upper images.
1 There are cases where the PVC was above the MRI depicted part of the heart, so the magenta bullet may be
in the blood volume of the model, e..g. for Patient 20.
parameterized solvers. E.g., the imaging of transmembrane voltages of
single time points can nicely be shown to lead to successful localization
of the PVC origin, see Fig. 7.1, looking more accurate even than the
validation measurements (PVC origins: bullets in magenta 1). However,
in this work, it shall be acknowledged that it is difﬁcult to optimize
the regularization parameters, given that many possible choices exist
that so far cannot be distinguished from the non-invasive clinical data
alone (see [170] for a potential solution to this problem). Results in the
subsequent sections are hence presented with either a ﬁx parameter-
ization used across the patient population or with the regularization
parameters chosen according to automatic schemes. Further, results in
Fig. 7.1 are presented for just a single beat of the PVC, while it shall be
shown in this work whether results are robust over a sequence of beats
that originate from the same cardiac event.
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Figure 7.2: PVCs are annotated at the QRS onset. The QRS rise in effective pacings (EFF) may start
long after the annotated pacing artifact.
7.1.2 Imaging of Excitation Origins
This section presents results for ECG imaging of excitation origins. I.e.,
ECG imaging results were either produced for an early time in the
beat (for methods that produce TMVs in time) or from the ECG of
the entire QRS interval (for activation time imaging methods). For the
former methods, the importance of choosing a proper time of evaluation
is evident, especially since PVCs and beats of effective pacings were
annotated differently: one at the QRS onset, the other at the pacing
artifact - which was typically long before the actual rise in the QRS, see
Fig. 7.2.
Time of Evaluation
To reduce the number of variations in the study, and before comparing
results of different methods, different schemes of choosing the time of
evaluation were tested on two methods: Tikhonov 2nd-order (L-curve,
Sect. 4.3.1, for both the BEM and FEM models) and the MAP-method
(L-curve, Sect. 4.3.3, for the BEM models). The ECG is evaluated
• at 20% / 25% / 30% of the QRS length after the QRS onset (O20),
(O25), (O30). QRS onset and length are annotated in the data. Percent-
age of QRS length is preferred over a time in ms, not to compensate
for heart rate related effects (QRS duration is only slightly inﬂuenced
by the RR interval [171]), but to account for the different QRS dura-
tions that ectopic beats from different origins usually have.
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Figure 7.3: Time of evaluation (MAP, PVCs): localization error (PVCs) for imaged excitation origins
(mean 95-percentile [mV] position). MAP-method (L-curve), BEM-model. Bullets represent median
errors for all beats in one of the 10 patients, excluding Patient 06 and Patient 08.
• at 15% / 0% / 10% of the QRS length after the 10% / 20% / 20%
R-peak amplitude (10P15), (20P0), (20P10). Absolute values of all
BSPM channels are used for these deﬁnitions.
• at 20% / 25% / 30% of the QRS length before the R-peak (R-20),
(R-25), (R-30). R-peaks are at the computed maximum value of the
BSPM channels (absolute values).
For the MAP-method, the features were similarly computed for the
simulated TMV distributions and the covariance matrices extracted
from these simulations accordingly.
First, the MAP method was tested (on the BEM model). Results showed
an evident preference for the R-20 scheme, see Fig. 7.3 for PVCs (clear
preference) and Fig. 7.4 for effective pacings (less signiﬁcant preference:
among the four schemes with best medians). For a demonstration of the
effects, see Fig. 7.5. Second, the same was repeated with the Tikhonov
method on the BEM models and on the FEM models, see Fig. B.12 and
Fig. B.13 in the Appendix for BEM (Fig. B.10 and Fig. B.11 for FEM).
Results for PVCs in FEM models are indifferent and at around 30mm
median error; for effective pacings in FEM models a clear preference can
be found for scheme 10P15 (median error: around 30mm only for this
scheme), and a slight preference for 20P10 and R-20; for PVCs in BEM
models, results are again indifferent and at great median error level
7.1. VALIDATION STUDY: PREMATURE VENTRICULAR CONTRACTIONS 93
er
ro
r
[m
m
]
O20 O25 O30 10P15 20P0 20P10 R-20 R-25 R-30
10
20
30
40
50
Figure 7.4: Time of evaluation (MAP, effective pacings): Localization error (effective pacings) for
imaged excitation origins (mean 95-percentile [mV] position). MAP-method (L-curve), BEM-model.
Bullets represent median errors for all beats in one of the 10 patients, excluding Patient 06 and
Patient 08.
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Figure 7.5: Time of evaluation schemes applied on effective beat EFFx50 of Patient 17, MAP-method
(L-curve), BEM-model. Scheme R-20 was chosen for comparison of different ECG imaging methods.
(50mm); for effective pacings 20P0 is the best scheme, yet at a median
error of as much as 40mm. As results show no consistent preference
for any of the schemes and since the MAP method delivered much
better results (median error of down to below 20mm), the R-20 scheme
was chosen for the subsequent comparison of different ECG imaging
methods.
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Results for BEM models
Results for the BEM-models are shown in Fig. 7.6 (PVCs) and Fig. 7.7
(effective pacings). Methods for imaging TMVs as well as activation
time imaging methods are tested, with the TMV imaging methods
evaluated at the time of the R-20 marker:
• Methods for TMV imaging: MAP method (MAP, see Sect. 4.3.3),
MAP spatio-temporal for moving window of 21ms width (MAPST-
win), MAP spatio-temporal with the SVD computed for the entire
QRS (MAPSTqrs), TMV imaging with Tikhonov 2nd-order (Tikh,
Sect. 4.3.1), TMV imaging using Greensite’s spatio-temporal approach
with the SVD computed for the entire QRS (TikhGS, Sect. 4.3.2)
• Methods for activation time imaging: critical times method with the
SVD truncated at the 35th entry (CritTeff35, Sect. 4.3.5), activation
time imaging using the integral method and Tikhonov 2nd-order
regularization (ATintT2)
Although the critical times method (CritTeff35) performed slightly bet-
ter for the effective pacings, it is clearly the MAP method without the
temporal smoothing (MAP) that performed best altogether (best results
for PVCs and only slightly worse than CritTeff for effective pacings).
The censoring of beats as suggested in Fig. 6.10 and Fig. 6.9 led to the
following beats being excluded from evaluation:
• PVC beats: 2/4 in Patient 13
• effective pacings: 2/6 in Patient 09, 1/55 in Patient 11, 1/24 in Patient
13, 2/15 in Patient 14, 4/12 in Patient 17
I.e., the censoring only inﬂuenced the performance of a single patient for
PVCs. For this patient it actually lead to an improvement by ≤ 2mm for
the MAP method, but worsened results for the CritTeff35 by ≈ 5mm;
the effect on the other methods was < 1mm. Statistics on the effect
of censoring for PVC beats are not displayed as they are considered
insigniﬁcant. The effect of the censoring on the effective pacings is
shown in Fig. 7.8. Although the median is zero for all methods, the
percentiles - along with the outliers - clearly indicate that the censoring
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Figure 7.6: Comparison of methods (BEM-models,PVCs): results for all methods. Localization error
for imaged excitation origins (mean 95-percentile [mV] position). Bullets represent median errors
for all beats in one of the 10 patients, excluding Patient 06 and Patient 08.
lead to a general increase of the localization error, except for the Tikh
method, where the improvement diminishes when put into perspective
of its overall error, see Fig. 7.7. The proposed censoring scheme is
dropped in the following for its rather negative inﬂuence on the results.
Results for the individual patients are presented in the following
(Fig. 7.9 - Fig. 7.17) for the MAP method without temporal smooth-
ing (MAP). As reference for the interpretation of localization errors, the
minimum distance of the annotated excitation origin to the BEM heart
mesh is displayed in the results of the PVCs in line with the values in
Tab. 7.1.
96 CHAPTER 7. CLINICAL STUDIES
er
ro
r
[m
m
]
MAP MAPSTwin MAPSTqrs Tikh TikhGS CritTeﬀ35 ATintT2
−10
0
10
20
30
40
50
60
70
80
90
Figure 7.7: Comparison of methods (BEM-models, effective pacings): results for all methods.
Localization error for imaged excitation origins (mean 95-percentile [mV] position). Bullets
represent median errors for all beats in one of the 10 patients, excluding Patient 06 and Patient 08.
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Figure 7.8: Effect of the censoring on localization errors (BEM-models, effective pacings), results for
all methods. Bullets represent the difference between median errors for all beats in one of the 10
patients, excluding Patient 06 and Patient 08. The difference is computed with respect to the
unscensored results in Fig. 7.7.
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Figure 7.9: Results for Patient 06 (BEM-model, MAP method, localization error for imaged excitation
origins (mean 95-percentile [mV] position). All PVC beats (n=6) that had been annotated in the
study are represented as bullets. The imaged excitation spread is shown for 3 time steps of the best
beat in the boxplot of the PVC (black: imaged origin, magenta: measured origin). Localization error:
MEAN, STD; mean of ‖Ax−b‖2 : RES; min dist valid: distance of the measured excitation origin to
the closest point in the heart mesh. Effective pacings are not available for this patient. (Presentation
of data is enabled with Paraview [172].) (Since there is only one single validation measurement, the
heart plots only display the MEAN, STD and mean residual of beats from a single point.)
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Figure 7.10: Results for Patient 09 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=5) and effective pacings
(n=6, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 27 (n=3) and 75 (n=3) are also displayed separately as EFFx27 and EFFx75. The imaged
excitation spread is shown for 3 time steps of the best beat in the boxplots of the PVC and of EFFx27
(black: imaged origin, magenta: measured origin). Localization error: MEAN, STD; mean of
‖Ax−b‖2 : RES; min dist valid: distance of the measured excitation origin to the closest point in the
heart mesh.
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Figure 7.11: Results for Patient 11 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=10) and effective pacings
(n=55, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 47 (n=10) and 64 (n=10) are also displayed separately as EFFx47 and EFFx64. The imaged
excitation spread is shown for 3 time steps of the best beat in the boxplots of the PVC and of EFFx64
(black: imaged origin, magenta: measured origin). Localization error: MEAN, STD; mean of
‖Ax−b‖2 : RES; min dist valid: distance of the measured excitation origin to the closest point in the
heart mesh.
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Figure 7.12: Results for Patient 12 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=5) and effective pacings
(n=37, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 97 (n=15) are also displayed separately as EFFx97. The imaged excitation spread is shown
for 3 time steps of the best beat in the boxplots of the PVC and of EFFx97 (black: imaged origin,
magenta: measured origin). Localization error: MEAN, STD; mean of ‖Ax−b‖2 : RES; min dist valid:
distance of the measured excitation origin to the closest point in the heart mesh.
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Figure 7.13: Results for Patient 13 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=4) and effective pacings
(n=24, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 11 (n=12) are also displayed separately as EFFx11. The imaged excitation spread is shown
for 3 time steps of the best beat in the boxplots of the PVC and of EFFx11 (black: imaged origin,
magenta: measured origin). Localization error: MEAN, STD; mean of ‖Ax−b‖2 : RES; min dist valid:
distance of the measured excitation origin to the closest point in the heart mesh.
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Figure 7.14: Results for Patient 14 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=16) and effective pacings
(n=15, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 57 (n=5) are also displayed separately as EFFx57. The imaged excitation spread is shown
for 3 time steps of the best beat in the boxplots of the PVC and of EFFx57 (black: imaged origin,
magenta: measured origin). Localization error: MEAN, STD; mean of ‖Ax−b‖2 : RES; min dist valid:
distance of the measured excitation origin to the closest point in the heart mesh.
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Figure 7.15: Results for Patient 17 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=6) and effective pacings
(n=12, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 49 (n=3) and 50 (n=3) are also displayed separately as EFFx49 and EFFx50. The imaged
excitation spread is shown for 3 time steps of the best beat in the boxplots of the PVC and of EFFx50
(black: imaged origin, magenta: measured origin). Localization error: MEAN, STD; mean of
‖Ax−b‖2 : RES; min dist valid: distance of the measured excitation origin to the closest point in the
heart mesh.
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Figure 7.16: Results for Patient 19 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=4) and effective pacings
(n=23, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 52 (n=6) are also displayed separately as EFFx52. The imaged excitation spread is shown
for 3 time steps of the best beat in the boxplots of the PVC and of EFFx52 (black: imaged origin,
magenta: measured origin). Localization error: MEAN, STD; mean of ‖Ax−b‖2 : RES; min dist valid:
distance of the measured excitation origin to the closest point in the heart mesh.
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Figure 7.17: Results for Patient 20 (BEM-model, MAP method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=11) and effective pacings
(n=29, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 127 (n=14) and 128 (n=10) are also displayed separately as EFFx127 and EFFx128. The
imaged excitation spread is shown for 3 time steps of the best beat in the boxplots of the PVC and of
EFFx127 (black: imaged origin, magenta: measured origin). Localization error: MEAN, STD; mean
of ‖Ax−b‖2 : RES; min dist valid: distance of the measured excitation origin to the closest point in
the heart mesh.
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Results for FEM models
For the FEM models, methods for imaging TMVs as well as activation
time imaging methods are tested again, but now also against a model-
based approach:
• Methods for TMV imaging (evaluated at R-20, according to the results
for BEM): MAP method (MAP, Sect. 4.3.3), MAP spatio-temporal for
moving window of 21ms width (MAPSTwin), MAP spatio-temporal
with the SVD computed for the entire QRS (MAPSTqrs), TMV imag-
ing with Tikhonov 2nd-order, L-curve method (Tikh LC, Sect. 4.3.1)
• Methods for activation time imaging: activation time imaging with
the integral method (ATintT2, Sect. 4.3.4, L-curve)
• Model-based approaches: computation of similarities between model-
based ECG simulations and the measured ECG, see Sect. 5.5, with
either the mean temporal (MODcct) or mean spatial correlation coef-
ﬁcient serving as similarity measure (MODccs).
For Tikhonov regularization (2nd order, L-curve), it is known that the
L-curve method does not always identify the ideal regularization param-
eter; yet, the CRESO method, which is an alternative, did not deliver
notably different results when applied on sample datasets. There is,
however, a common practical suggestion that for repeated studies with
the same setup the ideal regularization parameter can be known from
experience. To test for this hypothesis, the study with the TMV imaging
method was repeated for a range of parameter values while the R-20
scheme was used to pick the time of evaluation. Fig. B.14 and Fig. B.15
in the Attachment reveal that a regularization parameter of 10−6 is best
for the PVCs; however, for effective pacings, a regularization parame-
ter of 10−3 can be considered the best choice across patients. Effective
pacings are more frequent in the study. A variant with a preset regular-
ization parameter of 10−3 is therefore included in the ﬁnal comparison
of methods on the FEM model (Tikh -3).
Results for PVCs are given in Fig. 7.18 and for effective pacings in
Fig. 7.19. It is revealed that for PVCs, most good solutions are found
with the MODcct method. For effective pacings, however, it is the
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Figure 7.18: Comparison of methods (FEM-models, PVCs): results for all methods. Localization
error for imaged excitation origins (mean 95-percentile [mV] position). Bullets represent median
errors for all beats in one of the 10 patients, excluding Patient 06 and Patient 08. MAP: maximum a
posteriori based regularization; MAPSTwin: spatio-temporal variant with window; MAPSTqrs:
spatio-temporal variant applied on entire QRS; ATintT2: activation time imaging with the integral
method (Tikhonov 2nd-order); TikhR-3: Tikhonov 2nd-order regularization, λ = 10−3; TikhLV:
Tikhonov regularization, L-curve.
MODccs method. Results are thus inconsistent over different types of
beats – regarding the medians of median patient-wise errors. Therefore
and since the results are short of those of the BEM models at least for
the PVCs, practical considerations are used to motivate the further
evaluation and presentation of results. It is assumed that only at ≤ 2cm
median error results are of value for clinical applications. The most
such results are obtained with the MODcct method (4 cases for PVCs
and 2 cases for effective pacings), whereas it is 2 and 2 for the MODccs
method. In the discussion (Chapt. 8) it will be studied where these
results occur and whether the good results are obtained for the same
patients as previously with the BEM-based models, with the intention
to reveal the effect of modeling errors as opposed to intrinsic errors of
the methods. Results for the MODcct approach are presented in the
following for each patient individually.
108 CHAPTER 7. CLINICAL STUDIES
er
ro
r
[m
m
]
MAP MAPSTwin MAPSTqrs MODcct MODccs ATintT2 Tikh LC Tikh -3
−10
0
10
20
30
40
50
60
70
80
90
Figure 7.19: Comparison of methods (FEM-models, effective pacings): results for all methods.
Localization error for imaged excitation origins (mean 95-percentile [mV] position). Bullets
represent median errors for all beats in one of the 10 patients, excluding Patient 06 and Patient 08.
MAP: maximum a posteriori based regularization; MAPSTwin: spatio-temporal variant with
window; MAPSTqrs: spatio-temporal variant applied on entire QRS; ATintT2: activation time
imaging with the integral method (Tikhonov 2nd-order); TikhR-3: Tikhonov 2nd-order
regularization, λ = 10−3; TikhLV: Tikhonov regularization, L-curve.
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Figure 7.20: Results for Patient 06 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=6) that had been annotated
in the study are represented as bullets; effective pacings are not available for this patient.
Localization error: MEAN, STD; N: number of measurements; min dist valid: distance of the
measured excitation origin to the closest point in the heart mesh. (Since there is only one single
validation measurement, the heart plots only display the MEAN, STD and mean residual of beats
from a single point.)
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Figure 7.21: Results for Patient 09 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=5) and effective pacings
(n=6, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 27 (n=3) and 75 (n=3) are also displayed separately as EFFx27 and EFFx75. Localization
error: MEAN, STD; N: number of measurements; min dist valid: distance of the measured excitation
origin to the closest point in the heart mesh.
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Figure 7.22: Results for Patient 11 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=10) and effective pacings
(n=55, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 47 (n=10) and 64 (n=10) are also displayed separately as EFFx47 and EFFx64. Localization
error: MEAN, STD; N: number of measurements; min dist valid: distance of the measured excitation
origin to the closest point in the heart mesh.
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Figure 7.23: Results for Patient 12 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=5) and effective pacings
(n=37, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 97 (n=15) are also displayed separately as EFFx97. Localization error: MEAN, STD; N:
number of measurements; min dist valid: distance of the measured excitation origin to the closest
point in the heart mesh.
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Figure 7.24: Results for Patient 13 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=4) and effective pacings
(n=24, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 11 (n=12) are also displayed separately as EFFx11. Localization error: MEAN, STD; N:
number of measurements; min dist valid: distance of the measured excitation origin to the closest
point in the heart mesh.
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Figure 7.25: Results for Patient 14 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=16) and effective pacings
(n=15, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 57 (n=5) are also displayed separately as EFFx57. Localization error: MEAN, STD; N:
number of measurements; min dist valid: distance of the measured excitation origin to the closest
point in the heart mesh.
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Figure 7.26: Results for Patient 17 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=6) and effective pacings
(n=12, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 49 (n=3) and 50 (n=3) are also displayed separately as EFFx49 and EFFx50. Localization
error: MEAN, STD; N: number of measurements; min dist valid: distance of the measured excitation
origin to the closest point in the heart mesh.
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Figure 7.27: Results for Patient 19 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=4) and effective pacings
(n=23, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
position 52 (n=6) are also displayed separately as EFFx52. Localization error: MEAN, STD; N:
number of measurements; min dist valid: distance of the measured excitation origin to the closest
point in the heart mesh.
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Figure 7.28: Results for Patient 20 (FEM-model, MODcct method, localization error for imaged
excitation origins (mean 95-percentile [mV] position). All PVC beats (n=11) and effective pacings
(n=29, EFF) that had been annotated in the study are represented as bullets. Beats from pacing
positions 127 (n=14) and 128 (n=10) are also displayed separately as EFFx127 and EFFx128.
Localization error: MEAN, STD; N: number of measurements; min dist valid: distance of the
measured excitation origin to the closest point in the heart mesh.
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Effect of Averaging Multiple Beats
For the MAP-method (and the R-20 scheme) it was tested whether the
averaging of multiple beats has an effect on the quality of results, see
Fig. 7.29. Beats of the same origin were averaged and then introduced in
the statistics as multiple identical copies; hence, the original number of
beats and the composition of the statistics did not change. The effect of
the averaging (averaged PVC beats: PVCAV, averaged effective pacings:
EFFAV) was in the range of a millimeter on the median error of the
patient-wise results. There were, however, effects on the individual
patient results where the median localization error was reduced by a
few millimeters for both PVCs and effective pacings (e.g. for Patient
14, which is shown in Fig. 7.29). Fig. 7.29(c) depicts how the averaging
of the 16 PVC beats in Patient 14 results in a smoothed averaged beat
PVCAV. The representation of these averaged beats is clearly reﬂected
in the statistics of Patient 14, see Fig. 7.29(b).
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(d) Patient 14 (averaged: PVCAV)
Figure 7.29: Results for averaged beats (MAP, BEM-model): Localization error for imaged excitation
origins (mean 95-percentile [mV] position). Bullets in (a) represent median errors for all beats in one
of the 10 patients, excluding Patient 06 and Patient 08. Bullet in (b) represent single beats. EFF:
effective pacings; EFFAV: EFF, averaged; PVCAV: PVC, averaged.
120 CHAPTER 7. CLINICAL STUDIES
7.1.3 Imaging of Activation Times
For the validation of imaged activation times, a case study is shown
as introduction to the section, see Fig. 7.30. Activation time imaging is
demonstrated here with the disciplined convex programming frame-
work from Sect. 5.3 that, in addition to a solution with the Tikhonov
integral method ATintT2 (Fig. 7.30(a)), which is called LCλ5 in this
context, introduces a-priori knowledge from a random set of 22 of the
65 available LAT samples (b) and then all 65 available measurements in
the LAT map (c). In the example, the regularization parameter is tuned
with the L-curve method and an upper boundary for the root mean
square error with respect to the provided activation times of η = 5ms
is chosen. The root mean squared error (RMSE) of the activation times
was 33.0ms for the ATintT2 method and decreased to 13.6ms and 5ms
when 22 or all of 65 available LAT measurements were introduced in the
solution. The distance to the earliest measured LAT was 24ms without
a-priori knowledge, reduced to 16ms with knowledge of 22 out of 65
measurements and increased again to 23ms with knowledge of all 65
measurements.
This reveals substantial information on the quality measure used in the
localization of excitation origins. Fig 7.31 shows the 5th percentile of the
imaged activation times (red), the average position of which is marked
with a black spot. The location of the earliest measured LAT is shown
in magenta. While the distance of the excitation origin to the modeled
endocardium is obvious (distance to the FEM heart mesh is 13mm), it is
also revealed in Fig. 7.30 that the solution with 16mm distance is indeed
closer to the actual excitation origin when looking at the distribution
of TMVs in the myocardial wall - as opposed to the solution with full
knowledge of the local activation times. This rises the question whether
the earliest activation time in the electroanatomical map is indeed close
to the mean position of the early local activation times and whether the
mean position of the earliest local activation times should not be chosen
as the validation reference instead (see discussion in Sect. 8).
The same study (activation time imaging framework from Sect. 5.3)
was repeated for all patients with validation measurements available.
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(a) ATintT2,
RMSE65 = 33.0ms
(b) A-priori: 22 of 65 LATs,
RMSE65 = 13.6ms
(c) A-priori: 65 of 65 LATs,
RMSE65 = 5.0ms
COMdistLATmin = 24mm COMdistLATmin = 16mm COMdistLATmin = 23mm
Figure 7.30: Activation time imaging (Patient 20). The method in [41, 42] is used (a) and embedded
in a disciplined convex programming framework (see Sect. 5.3) to introduce a random set of LAT
samples (b) and then all available measurements (c). λ = λ (L-curve),η = 5ms. The root mean
squared error (RMSE) is computed with respect to the available LAT measurements (Fig. B.9). The
distance of the center-of-mass of the earliest 5% of activated points (black spot with white
circumsphere) is computed with respect to the earliest measured LAT (magenta spot) as
COMdistLATmin.
Figure 7.31: Earliest activated points in Fig. 7.30(c) (result with all available measurements): average
location of 5th percentile (black spot with white circumsphere) with respect to the earliest measured
LAT (magenta spot).
Patient 06 was excluded from the study for the little number of available
measurements, Patient 13 was excluded as the activation time map
shows measurements of normal sinus rhythm. A-priori knowledge was
introduced from approximately 25% of the available measurements
(P) or all available measurements (A). Measurements for the former
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Figure 7.32: Imaging of Activation Times with and without knowledge from measurements
(FEM-models, PVCs): results for all methods. Localization error for imaged excitation origins (mean
5-percentile [ms] position). Bullets represent median errors for all beats in one of the 10 patients,
excluding Patient 06, Patient 08 and Patient 13. LC: λ is chosen using the L-curve method, -1.5:
λ = 10−1.5, η5: η = 5, P: a-priori knowledge from ≈ 25% of the available measurements, A: all
available measurements used as a-priori knowledge.
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Figure 7.33: Imaging of Activation Times with and without knowledge from measurements
(FEM-models, PVCs): results for all methods. Mean error with respect to the measured LATs [ms].
Bullets represent median errors for all beats in one of the 10 patients, excluding Patient 06, Patient
08 and Patient 13. LC: λ is chosen using the L-curve method, -1.5: λ = 10−1.5, η5: η = 5,P: a-priori
knowledge from ≈ 25% of the available measurements, A: all available measurements used as
a-priori knowledge.
approach were chosen pseudo-randomly at a 0.25 probability rate and
stored for each patient to not inﬂuence the comparison of methods.
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Figure 7.34: Imaging of Activation Times with and without knowledge from measurements
(FEM-models, PVCs): results for all methods. Standard deviation of the error with respect to the
measured LATs [ms]. Bullets represent median errors for all beats in one of the 10 patients,
excluding Patient 06, Patient 08 and Patient 13. LC: λ is chosen using the L-curve method, -1.5:
λ = 10−1.5, η5: η = 5, P: a-priori knowledge from ≈ 25% of the available measurements, A: all
available measurements used as a-priori knowledge.
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Figure 7.35: Results for Patient 09 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=5). P: a-priori knowledge from 14 (≈ 25%) of the 31 available measurements
(built from 39 CARTO LATs), A: all available measurements used as a-priori knowledge.
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Figure 7.36: Results for Patient 11 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=10). P: a-priori knowledge from 14 (≈ 25%) of the 35 available measurements
(built from 65 CARTO LATs), A: all available measurements used as a-priori knowledge.
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Figure 7.37: Results for Patient 12 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=5). P: a-priori knowledge from 23 (≈ 25%) of the 67 available measurements
(built from 82 CARTO LATs), A: all available measurements used as a-priori knowledge.
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Figure 7.38: Results for Patient 14 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=16). P: a-priori knowledge from 14 (≈ 25%) of the 33 available measurements
(built from 42 CARTO LATs), A: all available measurements used as a-priori knowledge.
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Figure 7.39: Results for Patient 17 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=6). P: a-priori knowledge from 6 (≈ 25%) of the 12 available measurements
(built from 16 CARTO LATs), A: all available measurements used as a-priori knowledge.
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Figure 7.40: Results for Patient 19 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=4). P: a-priori knowledge from 7 (≈ 25%) of the 14 available measurements
(built from 24 CARTO LATs), A: all available measurements used as a-priori knowledge.
m
ea
n
er
ro
r
[m
s]
LCη5 LCη5P LCη5A -1.5η5 -1.5η5P -1.5η5A
0
5
10
15
20
25
Figure 7.41: Results for Patient 20 (FEM-model), imaging of activation times with and without
knowledge from measurements, error with respect to measured LATs (mean [ms]). Bullets represent
single PVC beats (n=11). P: a-priori knowledge from 22 (≈ 25%) of the 65 available measurements
(built from 88 CARTO LATs), A: all available measurements used as a-priori knowledge.
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7.1.4 Tikhonov Spatio-Temporal Method with
BSPM Offset Correction
A proof-of-concept study was performed to demonstrate the Tikhonov
spatio-temporal method with BSPM offset correction of Sect. 5.4. By
the very nature of the method, results are subject to a proper choice of
the time points that go into the spatio-temporally regularized window
which is used to provide information for the BSPM offset correction: If
that window consists only of the time point of evaluation, too much
freedom is given to the solver, and the additional degree of freedom
in the BSPM is merely allowing the residual error to grow as great as
the provided upper limit, i.e., effectively, the offset correction causes
the same as a smaller regularization parameter. Therefore, to make the
offset correction work properly,
• its upper limit was constrained to 0.1mV, the lower limit to −0.1mV.
• a 21ms window was chosen to provide information for the BSPM
offset correction, with the center set at the time of evaluation (OFF),
or with that window centered around the R-peak (OFFR).
Results for these approaches are shown in Fig. 7.42 in comparison to
the Greensite spatio-temporal method without offset removal (WIN) for
the beats (PVCs and effective pacings) of Patient 17 and for a range of
regularization parameter values of between 10−6 to 10−1. All algorithms
use a time window to produce the spatio-temporal regularization, with
the time represented by the 6 (p6) or 10 (p10) most relevant temporal
singular vectors.
The study shows that results with offset removal and the window
around that time of evaluation were worse than those without offset
removal. When centering the window around the R-peak (where re-
sults are known to be good in ECGI), while evaluating the solution at
the R-20 time, results improved (OFFRp10). Studies on further data -
and probably also on the parameterization - are required for proper
evaluation of the method.
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Figure 7.42: BSPM offset correction: localization error for all beats (PVCs and effective pacings, BEM
model) of Patient 17 and for a range of regularization parameter values of between 10−6 to 10−1.
Greensite spatio-temporal method without offset removal (WIN), with offset removal and the
window centered at the time of evaluation (OFF), with offset removal and the window centered at
the R-peak (OFFR, maximum absolute value of all BSPM signals). The time windows are
represented by the 6 (p6) or 10 (p10) ﬁrst temporal singular vectors.
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7.1.5 Solvers with Constraints on the Solution Range
Methods that impose physiological constraints on the solution range of
inverse solvers have led to signiﬁcant advances in simulation studies of
ECG imaging [12, 89]. Despite their superior performance in simulation
studies and presumably due to modeling errors, such solvers performed
worse in this study than the standard Tikhonov or Tikhonov-Greensite
spatio-temporal approaches, see Fig. 7.43. Unlike in the previous statis-
tical studies, both solvers were only tested on a single beat of one of the
best cases in the study (Patient 17), however across a range of different
regularization parameters, with only the best results being presented.
In contrary to tests on the quantitative performance, this allows for a
qualitative study of the effects that result from the constraints.
(a) Tikhonov 2nd-order (b) Tikhonov-Greensite
(c) Tikhonov, constraints (d) TMV/EP simultaneously
Figure 7.43: Performance of different methods for ECG imaging of TMVs on a PVC beat in Patient
17: (a) Tikhonov 2nd-order [11, 29], (b) Tikhonov-Greensite [96], (c) Tikhonov 2nd-order with
constraints on the solution range [89], (d) method for simultaneous reconstruction of TMVs and
epicardial potentials (EPs) [12]. For each method, solutions are shown for the best-performing
among the tested regularization parameters.
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7.2 Validation Study: Ventricular Tachycardia
Cases of induced ventricular tachycardia (VT) were collected at King’s
College London (KCL) during a procedure that was intended for risk
stratiﬁcation in a decision on whether to implant an implantable car-
dioverter deﬁbrillator (ICD). Studies were conducted in close coopera-
tion with Kawal Rhode, Aldo Rinaldi and Zhong Chen of KCL, Jatin
Relan of INRIA and Martin Krüger of KIT and followed the Wellens 12
stage VT stimulation protocol, which is used in the attempt to induce
VT. Due to the nature of the arrhythmia, which must only sustain for a
short time, the EnSite non-contact mapping system was used to collect
electroanatomical data. Results in this work are shown for Patient 2,
who had induced sustained monomorphic VT and was also presented
in [137]. Further data studies were conducted within the scope of the
project: Patient 01 was originally scheduled for a VT stim study that
had to be cancelled, Patient 03 was a test case, Patient 05 had induced
sustained monomorphic VT (and had to be cardioverted), in Patient 10
VT was not successfully induced.
Activation sequences (TMVs) of the sustained VT were imaged with
the Tikhonov-Greensite spatio-temporal smoothing method (TikhGS,
Sect. 4.3.2, L-curve, with the ECG reduced to its 10 most relevant tem-
poral singular vectors). As information on scar locations was known
from segmentations of delayed enhancement MRI by KCL, it was stud-
ied how the solution is affected when nodes of scar and grey zone are
excluded from the solution domain (EXCL). To this end, the respective
rows and columns of the lead ﬁeld matrix and the Laplace operator
were removed and the problem was solved with the TikhGS method as
before. Scar segmentations were available with separate classes for grey
zone and scar, both of which were excluded from the solution domain,
and potential boundary conditions or conductivity changes in areas of
scar were neglected in the forward model.
Results for the activation sequence are shown in Fig. 7.45 for the TikhGS
method, with the activation front popping up in the LV lateral wall after
392ms, which corresponds to the beginning of the second VT beat in
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Figure 7.44: BSPM of sustained VT, Patient 02. Three “beats” have been annotated in the excerpt at
148ms, 380ms and another one starting at 650ms, the second of which is evaluated.
392ms 412ms 432ms 452ms 472ms
Figure 7.45: Activation sequence (TMVs) of the sustained VT, imaged with the Tikhonov-Greensite
spatio-temporal smoothing method (TikhGS), λ = λ (L-curve), ECGmax = 10.
392ms 412ms 432ms 452ms 472ms
Figure 7.46: Activation sequence (TMVs) of the sustained VT, with nodes of scar and grey zone
excluded from the solution domain (EXCL), λ = λ (L-curve), ECGmax = 10.
Fig. 7.44. Similar results are obtained with the EXCL method, where the
wavefront is more focused, see Fig. 7.46.
From the imaged TMV activation sequences activation times were com-
puted. To this end, the following procedure was pursued:
• It is analyzed for each node in the heart whether its TMV goes below
−40mV in the time between the end of the previous beat (271ms)
and the end of the overall ECG sequence.
• If this has happened, the next time for the beat to go across 0mV is
sought and referred to the time of the presumed exit point at 392ms
to obtain an activation time.
ms
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Figure 7.47: Activation times from analysis of the reconstructed TMVs. Right-to-left: activation
times computed for the EXCL and the TikhGS method. Two ﬁgures on the left: results for TikhGS
are rotated for comparison with activation times from the EnSite system. Dark grey: NaN (no
activation time computed according to the procedure).
• Nodes that do not go below −40mV in that interval or that went
below but did not thereupon cross 0mV are ﬂagged as NaN.
These activation times are presented in Fig. 7.47 and compared with the
activation sequence from the EnSite measurements of the left ventricle
(LV). Early activation times are displayed in blue, late activation times
in red (note that this is opposed to the scale that is habitually used in the
clinic). Areas with unidentiﬁed activation times show up in dark grey.
While the activation time map from the EXCL method does obviously
not cover much of the activation sequence, it is noteworthy that for the
TikhGS method, these areas correspond very well with the scar and
grey zone areas found in the delayed enhancement MRI — despite the
TikhGS not having any a-priori knowledge on their location. This is
demonstrated in detail in Fig. 7.48. This ﬁgure shows only the valid
activation times; where no activation time could be computed (NaN)
only the contours of the ventricles are shown. The display of scar tissue
is the switched on (top) and off (bottom). Areas of scar tissue are dis-
played in dark grey, areas of grey zone in light grey. When looking at
the ventricles from both an anterior (left) and a posterior view (right), it
is revealed that areas with unidentiﬁed activation times (NaN) corre-
spond clearly with the areas where scar tissue was present. As action
potentials in areas of scar tissue are known to produce smaller upstrokes
than in the normal tissue, this demonstrates clearly the validity of the
results.
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Figure 7.48: Activation times for the Greensite method with all nodes included in the solution
domain (Fig. 7.45). Scar tissue from delayed enhancement MRI is displayed in dark grey and grey
zone in light grey. Upper ﬁgures: MRI scar data depicted in grey, lower ﬁgures: MRI scar data
switched off.
7.2.1 BSPM Smoothness Based Baseline Correction
The VT activation time imaging study was repeated with the BSPM
baseline corrected as proposed in Eq. 6.10-Eq. 6.12. The method op-
timizes the BSPM’s spatial smoothness, i.e., close channels may not
differ signiﬁcantly, while also minimizing the energy of the resulting
BSPM. This is achieved by tuning only the BSPM offset, assuming it is
the same for all time steps. Results are shown in Fig. 7.49 (BSPM after
smoothness based baseline correction) and Fig. 7.50 (baseline correc-
tion performed by the algorithm). For comparison, ECG imaging with
the TikhGS method was performed with a predeﬁned regularization
parameter (λ = 5 ·10−5), and results were produced before (lower row)
and after BSPM correction (upper row), see Fig. 7.51. Activation se-
quences differ only slightly, despite signiﬁcant corrections being made,
see Fig. 7.50.
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Figure 7.49: BSPM of sustained VT from Fig. 7.44 after smoothness based baseline correction.
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Figure 7.50: Baseline correction performed on the BSPM in Fig. 7.44.
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Figure 7.51: Results with the smoothness based baseline correction (upper row). Lower row: results
before baseline correction. Activation sequence (TMVs) of the sustained VT, imaged with the
Tikhonov-Greensite spatio-temporal smoothing method (TikhGS), λ = 5 ·10−5, ECGmax = 10.
ms
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Two validation studies of ECG imaging were performed within the
scope of this work, and some new methods for ECG imaging proposed.
For the validation studies, this section will discuss the results in the
context of previous works, discuss modeling errors (and for the PVC
study also the censoring and time of evaluation), to ﬁnally conclude
with recommendations. For the proposed methods, it will discuss the
results and potential of each method individually.
8.1 Validation Study: Premature Ventricular Contractions
In the clinical validation study with UMM, altogether 201 pacings and
75 PVC beats were manually annotated, linked to their validation data
and evaluated with the most established ECG imaging methods avail-
able in our group, with models based on both the boundary element
method and the ﬁnite element method. These results were presented as
statistics that include all annotated beats as in [65].
8.1.1 Censoring and Time of Evaluation
The best time of evaluation was found to be surprisingly late, and the
censoring of beats was surprisingly ineffective:
• For the imaging of excitation origins (Sect. 7.1.2 on page 91), among
various schemes for the time of evaluation, the best results were
obtained with the R-20 scheme, which is to pick the BSPM signal
at 20% of the QRS length before the R-peak. It was subsequently
used for all methods in the study, apart from those that produce
activation times from the entire QRS. Although this is the latest of all
tested times of evaluation, which reﬂects an excitation spread that
has propagated signiﬁcantly from its origin, it produces the results
with best localization accuracy, owing supposedly to the better signal-
to-noise ratio at these times and to the solvers being better suited to
less focused and hence smoother solutions.
• A censoring of beats has been proposed to identify beats with un-
usually large signal at the QRS end, presumably reﬂecting baseline
wander in the BSPM or ﬂoating electrode channels. It was initially
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used for the BEM models but then dropped, as results for censored
beats had rather small localization errors. I.e., results clearly con-
tradict the premise that great signal at the QRS end correlates with
bad ECG imaging solutions. At ﬁrst, this is an unexpected result.
But it reﬂects three things: ﬁrst, beats were annotated manually and
carefully selected to have little baseline wander; second: electrode
channels with ﬂoating signal had already been carefully identiﬁed
and removed - although they pop up for some beats during the exper-
iments; third: beats with great signal at the QRS end might actually be
caused by the ablations taking place during the experiment, leading
to a change of conduction patterns and scar-related ST-elevation. The
latter might also explain the change in the PVC beat morphology
during the run of the study in Fig. 6.9 and Fig. 6.10 on page 77, which
served as the initial motivation for the censoring.
BEM models
The following results were obtained for the study for localization of
excitation origins with BEM models that include the endocardial and
epicardial surface.
• Comparison of methods: for BEM models, while the Tikhonov-based
methods without knowledge from simulations (Tikh, TikhGS, AT-
intT2) produced large localization errors, results with the different
maximum a posteriori (MAP) approaches and the critical times ap-
proach (CritTeff35) delivered relatively similar results for paced beats
in the order of 25mm median error, but also for PVC beats with 20
to 30mm error, see Fig. 7.7 and Fig. 7.6 on page 95. Among the best
methods, the localization error was clearly governed by the choice of
patient, rather than the imaging method. For this reason, it may be
concluded that the greatest portion of the error is a result of modeling
errors rather than errors caused by the nature of the inverse solvers
(although it also depends on the origins of the beats, which is obvi-
ously different for different patients, see below). The performance of
the solvers may rather be reﬂected in the median localization error of
the best patient, which for effective pacings in Fig. 7.7 on page 96 lay
140 CHAPTER 8. DISCUSSION AND CONCLUSIONS
in the range of ≈ 10mm, with the MAP method delivering again the
best results.
• Results with the best method (BEM models): For the MAP method,
the following ﬁndings were made (Patient 06 is excluded from evalu-
ation, as it has only seven ECG channels available):
– Results for different patients, including statistics on the localiza-
tion error for excitation origins in different areas of the heart (see
Sect. 7.1.2):
· For Patient 11, localization errors were large for all measured
events (mean errors were ∈ [29,62]mm). With large errors in
many different areas of the heart, this is presumably due to the
patient model.
· Patients 12 and 19 may or may not be a bad model: mean lo-
calization errors are large (∈ [20,50]mm and ∈ [38,52]mm), but
all excitations originate from the septum (despite some single
lateral beats in Patient 19 which were also localized with large
error).
· Patient 09 shows very well the effect of non-unique solutions in
ECG imaging. As in Fig. 4.2b on page 27, despite the effective
beat EFFx27 being imaged very well at 3mm error, the PVC,
which is in the septum, is imaged at 44mm mean error.
· Mean errors for Patient 20 are large (∈ [17,42]mm) except for the
PVC (< 20mm, which is < 10mm from the minimum distance
to the validation), which is despite the patient being among the
two best models according to Tab. 7.1. Still and due to the results
for the PVC, it can be assumed to be a good model in general:
the large errors can be linked to most of the excitation origins
being at the level of the valve. The Patient may hence proﬁt from
a more inclusive segmentation of the ventricles in that area.
· Patient 17 has very good results (error < 20mm for all beats,
< 15mm for most effective beats, except for one single outlier
that leads to a misleading mean error range of 5 to 40mm).
Another good model is that of Patient 14, which has errors
mostly < 20mm for the PVC and EFFx57 and is also among the
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two best models according to the quality of the processing in
Tab. 7.1. It shows again clearly the effect of non-unique solutions
in that some distant outliers exist in the statistics of EFFx57, and
in that localization errors vary strongly for some of the beats,
despite being from the exact same area.
· For Patient 13 some good results were generated (errors for
the PVC are mostly < 20mm). Yet, a broad spectrum of errors
exists for the effective beats EFF, with strong variation despite
excitation origins being from the same area, and the range of
mean errors is 14mm to 27mm. These errors may be due to
inaccuracies in the models that have dynamic behaviour, such
as breathing-related effects. With the area of excitation origins
not being exactly in the middle of the septum, it would also be
interesting to study with the method proposed in [23] if it is still
affected from having non-unique BSPMs.
– Excitation spread over time (at the time of evaluation, 10ms before
and after): For the best beats, the excitation spread is physiologi-
cally reasonable for Patients 09, 11, 13, 14, 17, 19 and 20. However,
with limitations for Patients 09, 13, 14 and 20: The imaged origin
is shifted from the septal origin in case of the PVC in Patient 09;
the ﬁrst shown time instances in Patients 14 and 20 appear to have
noise-induced artifacts, and while the second shown time instance
in Patient 13 is unreasonable. For Patient 12, the excitation spreads
show little dynamics and start from the lateral wall opposite the
origin, which is at the septum. This demonstrates that the best
localization errors with the MAP method were not achieved with
artifacts (e.g. from baseline wander, that could as well lead to good
solutions by chance) but with solutions that represent physiologi-
cally propagating TMVs.
To summarize, while Patient 11 seems to have large modeling errors,
Patients 09, 14, 17 and potentially also Patient 12 and 19 seem to have
little, and results may strongly proﬁt from inverse solvers that manage
to deal better with the underdeterminedness of the problem. While
data in Patient 13 suffers from regional-independent variations that are
142 CHAPTER 8. DISCUSSION AND CONCLUSIONS
presumably due to dynamic modeling errors such as breathing effects,
results for Patient 20 suffer from the excitation events being at the level
of the valve, which is not included in the model. Best results were not
based on artifacts, but represent physiologically propagating TMVs.
FEM models
The following paragraph will discuss the results for localization of
excitation origins with FEM models.
• Results for methods MAP and ATintT2 with respect to the BEM mod-
els: While results with the MAP method had been best in case of
the BEM models, they performed worse with the FEM model. Errors
increase by > 1cm for the PVCs and by > 0.5cm for the effective pac-
ings. On the other hand, results with the ATintT2 method improved
by 1cm for PVCs and by < 1.5cm for effective pacings. This may ei-
ther be due to the increased ill-posedness (in terms of non-uniqueness
of the solutions) when imaging transmural TMVs compared to sur-
face TMVs, but it is more likely due to the (rather simple) model
that was used for training the covariance matrix in the MAP method,
which is probably less suited for volumetric meshes. As the ATintT2
method produces great errors for both kinds of models, it should be
studied whether the L-curve method is choosing the regularization
parameter from an appropriate range. Further, it should be studied
whether the ideal choice for the QRS interval has been made - regard-
less of the underlying volume conductor discretization method.
• Choice of the best method, interpretation in context of results with the
BEM models: Best results were achieved with the MODcct method, i.e.
with a simple model of the cardiac excitation spread, where solutions
are judged by their correlation with the BSPM in time. Since it takes
into account the entire excitation spread of the QRS, results with
the method are expected to be superior to the results with the MAP
method and the BEM models especially in case of excitation origins
in areas that often have non-unique solutions (i.e., the septum). On
the other hand, results are expected to be worse in general in areas
where the coarse heart mesh does not represent the cardiac anatomy
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very well, i.e., especially where excitation bridges are not represented
in the model (i.e., presumably at the base and close to the valves).
• Results with the best method (FEM models): For the MODcct method,
the following ﬁndings were made, see Sect. 7.1.2. Patient 06 is ex-
cluded from evaluation, as it has only seven ECG channels available.
– For Patient 09, results were indeed slightly better for beats at the
septum and the beats that had previously been missed with the
BEM models. The results for the best beats with the BEM approach,
however, could not be obtained with the FEM model.
– For Patient 11, results have improved a lot for both the PVC (error
< 10mm) and the effective beats EFFx47 and EFFx64 (≈ 10mm),
which renders Patient 11 one of the best models. I.e., either the
method of solving the inverse problem or the representation of Pa-
tient 11 with surface meshes has caused a signiﬁcant improvement
of results (errors with BEM were around 30 to 40mm).
– For Patient 12, results were relatively similar to those with the BEM
method, revealing that even the chosen model-based approach
cannot correctly localize excitation origins in the septum.
– For Patient 13, results were slightly worse for the PVC, compared
to the BEM approach, but slightly better and much more stable for
the effective pacings. This is despite all origins being in the area of
the outﬂow tract.
– For Patient 14, results were worse by ≈ 1cm, yet again more stable
compared to the BEM-based results.
– For Patient 17, results were very similar to those with the BEM
models.
– For Patient 19, results were worse for the PVC and better for effec-
tive beat EFFx52, compared to those with the BEM method.
– For Patient 20, results were much better with the MODcct and
the FEM model and slightly worse and again more stable for the
effective beats. The localization error for the PVC here was smaller
than the origin’s distance to the nearest point in the mesh. This is
due to the excitation origin having been identiﬁed in the solution as
a mean position, which may have lain in the lumen under certain
conditions.
144 CHAPTER 8. DISCUSSION AND CONCLUSIONS
To conclude, localization errors were usually worse, yet also more stable
than for the MAP method and the BEM models. The notion that a
model-based approach would deal better with excitation origins in
the septum could not be supported with ﬁndings, neither the notion
that it would work worse in areas close to the valves. Patient 11 who
had bad results with the BEM method and was considered to have
great modeling error to that end is now found to produce very good
results, contradicting that assumption. Note though that models had
been smoothed and simpliﬁed for the BEM models, which may also
explain the changes as resulting from errors in the cardiac or thoracic
anatomy. Also, the ﬁnding that modeling errors for Patient 13 originate
from dynamic effects could be contradicted by the ﬁnding that for FEM
models, results have little variation at relatively good quality.
BEM models: averaging of multiple beats
For the BEM models and the MAP method, it was tested whether
results improved when averaging multiple beats of the same cardiac
event. Results turned out differently than expected. In contrary to the
hypothesis that noise on the beats would be Gaussian, the averaging of
multiple beats should have improved signal quality. However, results
did not improve and even worsened to some degree. This may be
interpreted in two ways: either the noise was not Gaussian as assumed
and errors such as baseline wander in single beats have dominated the
noise reduction, or the beats themselves were not classiﬁed well enough
for consideration in the averaging (in the study, all beats of the same
annotated event were averaged).
FEM models: imaging of activation times
The imaging of activation times with the proposed framework that
facilitates the use of a-priori knowledge from measured local activation
times has demonstrated the functioning of the method. Even more im-
portantly, it has demonstrated the limitations of the quality measure
used in this study, as even with all LAT measurements available, the
activation origin was not accurately localized. Validation measurements
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should therefore be evaluated statistically in the future to mark excita-
tion origins rather than picking single points with the earliest activation
times — or single ablation points.
8.1.2 Comparison with Results of Other Groups
As shown in Tab. 4.2, which describes the state-of-the-art in ECG imag-
ing validation studies according to literature, most validation studies
have been performed for the reconstruction of epicardial potentials and
only few for the imaging of epi- and endocardial potentials. These few
studies can be grouped with the surface activation time studies of Tilg
et al. which also imaged the endo- and epicardium at the same time.
This work falls under the latter categories for the results with the BEM
models, as these include endo- and epicardial surfaces as well — yet
with the difference of imaging TMVs as sources. Validation for TMVs is
practically only possible for their activation times or imaged excitation
origins, i.e., the work of Tilg et al. [68, 74–76] serve as adequate refer-
ence, where only [74] deals with ventricular excitation, along with that
of Erem et al. [65].
The localization errors for imaging of focal excitation origins are greater
than the errors found in the previous studies by Tilg et al., where pacing
origins in the atria were imaged at 6 to 14mm accuracy. Errors are also
greater than in the study of localizing excitation origins from WPW
pathways, which result in a ventricular phenomenon and had been
imaged at 19mm accuracy. This may either be due to the BEM models
being better suited for atrial signals, or to the fact that Tilg et al. have
included the lungs in their models, while the present models only had
the heart modeled. Yet, the results of this work are in the range of the
mean errors of (3 to 5cm) reported for the ventricles in [65] and [73],
where the localization error was 13−28mm and increased signiﬁcantly
to 28−67mm in the presence of scar. It cannot be concluded whether
the differences in results with respect to the atria, and also the ventri-
cles in a presumably healthy-substrate-case, stem from any particular
errors. For that reason, an analysis of the modeling errors is made in the
following, and conclusions are drawn on how models can be approved
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— keeping in mind the errors revealed for the origins in the septum,
which rather suggest improvements in the inverse solvers.
8.1.3 Modeling Errors
Apart from their sensitivity to noise in the BSPM, solutions of the inverse
problem are strongly affected by modeling errors in A. As summarized
in [11, Sect. 4.8] and studied in silico in [38, 173], multiple sources of
modeling errors exist that originate from the fusion of the imaging
and measurement modalities as well as the inaccuracy or limited ap-
plicability of the individual methods (methods for model creation are
presented in Sect. 6).
The following modeling steps were performed in the validation studies
of this work and are hence discussed regarding the sources of modeling
error:
• Anatomical modeling and parameterization of tissue conductivities
– Errors of MRI co-registration have been computed and objectively
evaluated, see Tab. 7.1 and Sect. B in the Appendix. Apart from
Patient 19, for which the heart model was obtained from an actual
3-D scan, cine MRI data was used for all patients in the PVC study.
These models bear a great risk of introducing relevant modeling
error, as interpolation of the data had to be performed between
the imaged layers. The data also did not allow for a segmentation
of the atrial blood, and the layer of the atrio-ventricular valves
and the position of the valves in the outﬂow tracts could only
approximately be identiﬁed, despite being the area of excitation
origin in many of the cases. The use of cine MRI, however, is in
line with the proposed methods from previous validation studies
of ECGI [155] and seems to be the only choice for radiation-free
imaging in the presence of frequent ventricular arrhythmia. For
the VT stim cases, a 3-D navigated whole heart scan was used,
together with an automatic model-based segmentation procedure,
leading to way superior heart models.
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– Though studies exist that prove the importance of accurate mod-
els [174], the best choice of organs to be segmented for ECGI
is an open question, as other groups argue against the impor-
tance of complex models [175]. Additional segmentations improve
the anatomical representation, but may also induce error in case
of erroneous segmentations and, more importantly, in the case
of inaccurate conductivities being assigned to the tissue. This
is coupled with the effect of cardiac signals being attenuated
in their BSPM representation, which makes ECG imaging pos-
sible to only a certain degree of accuracy — and might inﬂuence
strongly-regularized solutions less than inverse solutions with
greater degree of freedom. Also, too many surfaces can lead to
numerical problems in BEM forward calculations. Two orthogonal
approaches were followed in this work: for the FEM-models, mul-
tiple organs and tissue structures were segmented and assigned
conductivity values from literature (however, we could not model
the atria due to the quality of MR images in the presence of ar-
rhythmia). For BEM-models, only the thorax and heart surface
were modeled, again with values from literature. Based on [176],
an approach has been developed within the scope of this work to
parameterize tissue conductivities from BSPM measurements of
few effective pacings of the myocardium. Also, it could be shown
theoretically that lead ﬁeld matrices can be parameterized im-
mediately without expensive calculations on-site in the catheter
laboratory [177]. Such a technique may beneﬁt the quality of both
BEM or FEM models signiﬁcantly in the future.
• Cardiac anisotropy
– According to a simulation study in [178], the anisotropy of cardiac
ﬁber orientation and hence conductivity is negligible for the in-
verse solvers used by the group. The study compares solutions of
the inverse problem with the boundary element method for BSPMs
from FEM forward calculations that take cardiac anisotropy into
account. Nevertheless, our group intends to use transmembrane
voltages as the source model in ECG imaging, which for correct
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transmural results requires information on ﬁber orientation. Also,
it has been demonstrated that ﬁber orientation may be derived
from diffusion-tensor MRI [179] and has great impact on simula-
tions of cardiac excitation propagation [180]. Hence, it is believed
that with rule-based cardiac ﬁber anisotropy introduced in the ven-
tricles [104, 140], forward calculations become more precise also
for patient data, especially in case it can be measured in-vivo [181]
in the future. Still, studies for both hypotheses are conducted in
this work, as both FEM and BEM models are used. Rule-based
anisotropy information is included in the former, but not in the
latter.
• Respiration
– The effect of respiration on results in ECGI was found to have
signiﬁcant impact on the correlation coefﬁcient of inverse solutions
with the simulations [182]. Cardiac MR scans and thorax scans
were therefore recorded in this work during breath-hold, which is
in line with the recommended procedure for ECGI studies [155].
Also, it was ensured that MRI scans were taken in end-expiration,
not inspiration, to being close to the realistic level during normal
breathing. Still, respiratory levels were not recorded, which may
explain the different results for different beats of the same event in
the PVC study.
• Heart motion
– Cardiac motion was not modeled in the present studies. However,
it was ensured that recordings across all recordings were taken
in end-diastolic phase. Using a static heart anatomy was shown
in [183] to have little impact on the depolarization phase of the
heart, while having strong effects on the T-wave. All signals in
this work, apart from the VT study, have been evaluated during
QRS only. For studies on the effect of heat motion on ECGI, see
also [184, 185].
• Mesh quality
– The ideal resolution of FEM meshes for forward calculations was
studied within the scope of this work [26] and applied according
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to the ﬁndings. However, similar studies were not performed for
the resolution of coarse meshes that represent the solution of the
inverse problem in the FEM models. Still, by using BEM models
as well, with the meshes smoothed and reduced in complexity, it
may be claimed that again, a very different and hence orthogonal
approach has been tested on the data.
• Electrode localization
– For electrode localization, according to [113–115], displacement
errors of 1 to 2mm may be tolerated in ECG imaging. However,
other studies have shown that errors of 5mm [38, Sect. 8.1] or
7mm [116, Sect. 7.3] may lead to signiﬁcantly worse results. To en-
sure good-enough accuracy of the electrode localization, a system
for electrode localization was developed within the scope of this
work with 1±1mm accuracy.
• BSPM processing and annotation
– Great efforts were made to use the best possible BSPM processing
method, as it has great impact on the ECG imaging solution, espe-
cially for solvers without spatio-temporal regularization schemes.
Initially, different ﬁlters were tested with different cut-off frequen-
cies and characteristics. Also, different approaches have been stud-
ied for removal of the BSPM offset, and new methods have been
proposed for its identiﬁcation. Also averaging of multiple beats
was tested, and annotations of the beats in the studies were metic-
ulously checked.
8.1.4 Conclusion
To conclude, all steps in the modeling pipeline have been optimized,
apart from
• cardiac imaging for model generation (advances have only been
made towards the very end of the study)
• the resolution of the coarse geometry for FEM models
• the representation of cardiac anisotropy in lead the ﬁeld matrix of
the FEM models
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Also, in future studies, it should be taken care of the patients being
imaged with MRI while not showing arrhythmic activity, which will
strongly improve the quality of heart models. Otherwise, studies should
only be planned if MRI protocols for arrhythmia detection are available.
Further, to reduce modeling error, BSPM measurements should be
done on the MRI table, and the electrodes should be directly marked
in the MRI images. This would reduce co-registration errors and is
typically done in commercial applications of ECG imaging. On the
other hand, if measurements are done in the catheter lab, BSPM beats
can be linked directly to the synchronously recorded cardiac activity,
which facilitates the imaging of non-repeating cardiac events such as
pacings. The latter may be used to improve models in the future — and
single measurements of cardiac electrograms may be used in the future
to improve results in ECG imaging. The datasets of this study are suited
to validate such methods, and the proposed camera system may be
used by groups in the ﬁeld to localize electrodes in a catheter lab setting
for future studies.
8.2 Validation Study: Ventricular Tachycardia
Localizing origins of ventricular tachycardia for treatment in radio-fre-
quency ablation therapy is a great clinical challenge for conventional
non-invasive methods [70]. To the knowledge of the author, several
groups have performed animal studies on ECG imaging of VT [114, 186],
but only two papers describe a validation of the method in human [66,
73], apart from a case study in magnetocardiography [187]. In [66] nine
patients were imaged during sustained VT, and ECG imaging results
of the epicardium were compared with electroanatomical maps of the
endocardium (see limitations in [66]). In [73], no activation sequences
were recorded. The present study is presumably the ﬁrst to image
VT as transmural distribution of TMVs, i.e. with volumetric models.
These models and the use of TMVs allowed for an introduction of
scar information in the solution. Results demonstrate that the applied
algorithms are able to image activation patterns and the excitation
origin with good accuracy. Also, even without introducing information
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of the cardiac scar location, areas of scar were clearly visible in the ECG
imaging results as areas where activation times were not computed
for little signal activity in the TMVs. Results are therefore concluded
to represent well the excitation pattern in the ventricles and shall be
evaluated quantitatively in the future to support the qualitative ﬁnding.
For the VT study, from the point of modeling quality, it is important to
note that the models of the VT study have the best possible accuracy,
with perfectly imaged thoraxes that were automatically taken at the
same breathing level as the navigated heart scans, and with automatic
model-based segmentation tools being used to build highly accurate
models of the whole heart, including (manual) segmentations of scar
tissue. Also, according to [50, Sect. 9.7.3.2], validation measurements
with the EnSite system have been shown to have good accuracy within
40mm of the catheter [188], i.e. within the range where results have
been evaluated in the present study.
8.3 Proposed Methods
Within the scope of the validation studies and in the context of previous
simulation studies, the following methods have been proposed:
• A framework to enhance ECG imaging solutions with single intracar-
diac measurements during ablation procedures with little arrhythmic
activity.
• A spatio-temporal Tikhonov method that identiﬁes the optimal offset
in the BSPM.
• A BSPM smoother that identiﬁes its optimal offset through opti-
mization of the smoothness of the BSPM and by minimization of its
energy.
• A state-space model for ECG imaging that introduces regularization
in the solutions of its measurement-based corrections by augmenta-
tion of the measurement signal (not described explicitly in this thesis,
see [86])
• A new variant of the critical times method
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• A simple model-based ECG imaging approach that performed best
for FEM.
Part V
Appendix

AEffect of mesh resolutions in the forward problem
The effect of resolution parameters for mesh generation with the compu-
tational geometry algorithms library (CGAL) [139] was tested in [142]
for forward calculations of the electrocardiogram in a simpliﬁed thorax
model. The study is extended here to cover not only the resolution,
but all relevant mesh generation parameters, and it is repeated in a
realistic thorax model to study also the parameters that are relevant for
the meshing of the thorax and organs.
Note: All meshing parameters of this study are explained in detail in [142, Tab. 1].
A.1 Simpliﬁed Thorax Model
A.1.1 Resolution
A single TMV source is placed in the ventricles to study resolution
effects in a simpliﬁed thorax model. To explore the limits of resolu-
tion effects in the volume of potential cardiac sources, ﬁrst, the entire
Figure A.1: Left: simpliﬁed thorax model and source in study on meshing parameters for forward
calculations. Right: rule-based ﬁber orientation. Patient 19, ﬁgures adapted from [142, Fig. 1,3]
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heart is reﬁned, for the setup see [142][Fig. 2], and later on, the resolu-
tion is only adjusted in a region-of-interest around the actual cardiac
source, see Fig. A.1 (left). Fiber orientation according to [140] was pro-
duced at 0.4mm resolution to set the conductivity tensors, see Fig. A.1
(right). With all other mesh generation parameters ﬁxed, parameter
reﬁne_cell_size is tuned according to Tab. A.1, where the ﬁrst range
stands for the study with reﬁnement of the entire heart and the second
range stands for the study with a reﬁned region-of-interest (ROI).
Parameter Range
facet_angle 25◦
(f_a)
facet_size 7.5mm
(f_s)
facet_distance 7.5mm
(f_d)
cell_radius_ 3
edge_ratio
(c_r_e)
cell_size 8mm
(c_s)
reﬁne_facet_size 7.5mm
(r_f_s)
reﬁne_cell_size [0.55,0.6, . . . ,1,1.5, . . . ,8]mm
(r_c_s) and [0.3,0.35, . . . ,1,1.5, . . . ,8]mm
Table A.1: Choice of Parameters: Resolution Study in Simpliﬁed Thorax Model
The resulting ECGs for the different resolutions are computed and
compared to the ECG with the highest resolution as root mean squared
error in Fig.A.2, the respective ECG signals themselves are presented
in Fig.A.3 and Fig.A.4.
Results show, as in [142], that the greatest resolution-related effects
diminish below a resolution of approximately 5mm. Below 1mm, only
marginal effects on the computed ECG remain. For further discussion
of these effects, see [142].
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(a) Reﬁned: heart.
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(b) Reﬁned: ROI.
Figure A.2: Root mean squared error of the computed ECG with respect to the ECG obtained for the
highest tested resolution. Left: ﬁrst setup, the resolution of the cardiac tissue is adjusted for the
entire heart. Right: second setup, the resolution is only adjusted in a region-of-interest around the
actual cardiac source (results are comparable to those in [142][Fig. 6]).
m
V
cell size reﬁned [mm]electrodes
0
20
40
0.55158
−0.4
−0.3
−0.2
−0.1
0
0.1
Figure A.3: Reﬁned: heart. The ECG signal is shown for all 28 electrodes over the resolution of the
reﬁned cardiac tissue.
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Figure A.4: Reﬁned: ROI. The ECG signal is shown for all 28 electrodes over the resolution of the
reﬁned cardiac tissue.
A.1.2 Facet Angle
With the same simpliﬁed thorax model and the cardiac tissue reﬁnement
already parameterized at 1mm reﬁnement for the entire heart, the effect
of the facet_angle parameter was studied, see parameters in Tab.A.2.
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Parameter Range
facet_angle [15,16, . . . ,34]◦
(f_a)
facet_size 7.5mm
(f_s)
facet_distance 7.5mm
(f_d)
cell_radius_ 3
edge_ratio
(c_r_e)
cell_size 8mm
(c_s)
reﬁne_facet_size 7.5mm
(r_f_s)
reﬁne_cell_size 1mm
(r_c_s)
Table A.2: Choice of Parameters: Variation of Facet Angle in Simpliﬁed Thorax Model
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Figure A.5: Root mean squared error of the computed ECG with respect to the ECG obtained for a
facet_angle of 25◦.
The resulting ECGs for the different facet angles are computed and
compared to the ECG resulting from a facet_angle of 25◦ in Fig.A.5, the
respective ECG signals themselves are presented in Fig.A.6.
From the study, it is apparent that using the resolutions found in the
previous study, the facet_angle parameter has no signiﬁcant effect on
the ECG. As it has been tested over a reasonable range from small
angles to up to 34 ◦, which is beyond the 30 ◦ at and below which con-
vergence is guaranteed, and as the mesher crashed for higher angles,
it can be concluded that for the given problem and with the resolution
parameters used, facet_angle may well be set to 25 ◦ in the following
steps of this work.
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Figure A.6: Reﬁned: heart. The ECG signal is shown for all 28 electrodes over the resolution of the
reﬁned cardiac tissue.
A.2 Realistic Thorax Model
With a resolution of 1mm set for the cardiac tissue and the facet_angle
set to 25 ◦, as the previous studies suggest, meshing parameters for the
tissue classes of a realistic thorax model were tested in the following.
Meshing parameters facet_size and cell_size were tuned while a speciﬁc
facet_distance was given, see Fig.A.7. This study was repeated for
different facet distances, see Tab.A.3. The cell_size was only reduced
down to 3mm, as forward calculations failed for all attempts with 2mm.
For the realistic thorax model the segmentation of Patient 19 was used,
with speciﬁc tissue classes assigned to the heart, liver, lungs, kidneys,
spleen, aorta, stomach and skeletal muscle, and with 185 electrodes on
the thorax surface.
Errors in Fig.A.8, Fig.A.9, Fig.A.10, Fig.A.2 and Fig.A.12 are in general
an order of magnitude smaller than in the studies of cardiac tissue reﬁne-
ment in Fig.A.1 or Fig.A.13. Convergence can be seen towards higher
resolutions, and errors are greatest for facet and cell sizes > 10mm.
For a facet_distance of 1mm, errors are greatest for small facet sizes,
in contrary to the ﬁndings for other facet distances, which may reﬂect
problems with the robustness of the mesh optimization at these levels.
To conclude, while no meticulous attention is required for the resolution
of the thorax model and its tissue classes in case the resolution of the
heart mesh is ﬁne enough, it is still relevant to keep cell sizes and facet
sizes below 10mm. As mesh generation tended to fail in some of the
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(a) facet_size 20mm,
cell_size 20mm.
(b) Mesh edges in (a). (c) facet_size 1mm,
cell_size 2mm.
(d) Mesh edges in (c).
Figure A.7: Realistic thorax model, facet_distance 16mm. Material classes are displayed for different
resolutions. In a separate image, the surface edges of the respective meshes are displayed in blue
over grey.
cases with greater facet_distance than 0.5mm (results are displayed as
zeros for such cases in the graphs), it is further concluded that a small
facet_distance tends to guarantee a successful meshing procedure for
the setup in the study.
Parameter Range
facet_angle 25◦
(f_a)
facet_size [20,15,10,5,4, . . . ,1]mm
(f_s)
facet_distance [16,10,5,1,0.5]mm
(f_d)
cell_radius_ 3
edge_ratio
(c_r_e)
cell_size [20,15,10,5,4,3]mm
(c_s)
reﬁne_facet_size 7.5mm
(r_f_s)
reﬁne_cell_size 1mm
(r_c_s)
Table A.3: Choice of Parameters: Variation of Facet Size and Cell Size in Realistic Thorax Model
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Figure A.8: Realistic thorax model, facet_distance = 0.5mm. The error in the ECG signal is shown
with respect to the case of both the facet and cell size being at their highest resolution in the study.
Facet distance is 0.5mm.
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Figure A.9: Realistic thorax model, facet_distance = 1mm. The error in the ECG signal is shown
with respect to the case of both the facet and cell size being at their highest resolution in the study.
Facet distance is 1mm.
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Figure A.10: Realistic thorax model, facet_distance = 5mm. The error in the ECG signal is shown
with respect to the case of both the facet and cell size being at their highest resolution in the study.
Facet distance is 5mm.
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Figure A.11: Realistic thorax model, facet_distance = 10mm. The error in the ECG signal is shown
with respect to the case of both the facet and cell size being at their highest resolution in the study.
Facet distance is 10mm.
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Figure A.12: Realistic thorax model, facet_distance = 16mm. The error in the ECG signal is shown
with respect to the case of both the facet and cell size being at their highest resolution in the study.
Facet distance is 16mm.
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A.2.1 Study without Reﬁnement of the Heart
To demonstrate the effects of not working with heart-speciﬁc reﬁnement
of the mesh, the study with facet_distance of 16mm was repeated with
the meshing parameters for the heart tissue linked to the parameters
used in the entire thorax, see Tab.A.4. Results show a much more
evident convergence of the produced ECGs with decreasing facet_size
and cell_size that is also stronger in amplitude compared to the effects
found in the previous studies with realistic thorax model, see Fig.A.13.
Parameter Range
facet_angle 25◦
(f_a)
facet_size [20,15,10,5,4, . . . ,1]mm
(f_s)
facet_distance 16mm
(f_d)
cell_radius_ 3
edge_ratio
(c_r_e)
cell_size [20,15,10,5,4,3]mm
(c_s)
reﬁne_facet_size same as facet_size
(r_f_s)
reﬁne_cell_size same as cell_size
(r_c_s)
Table A.4: Study without Reﬁnement of the Heart: Variation of Facet Size and Cell Size in Realistic
Thorax Model
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facet_distance = 16mm
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Figure A.13: Realistic thorax model, study without reﬁnement of the heart. The error in the ECG
signal is shown with respect to the case of both the facet and cell size being at their highest
resolution in the study. Facet distance is 16mm.

BValidation Study: Premature Ventricular
Contractions
B.1 Description of Datasets
This section features an in-depth description of the datasets presented
in Sect. 7.1. Tables provide details on the criteria used for the ratings in
Tab. 7.1, see Tab. B.1 for a legend of the quality ratings. Outcomes and
durations of ablation therapies are documented in Tab. B.2.
Rating Description
- not available/ not performed
x sufﬁcient quality achieved (partially through manual efforts)
+ OK quality
++ good quality
Table B.1: Legend of quality ratings.
Therapy result ﬁrst ablation last ablation
ablations successful 0h15min 1h54min
1h16min 2h18min
0h37min 0h43min
0h31min 0h47min
ablations, PVC occurrence signiﬁcantly reduced 0h27min 01h22min
ablations ﬁnally not successful 01h31min 03h23min
always paroxysmally treated, then returning, PVC origin
sitting too low, presumably
1h15min 2h14min
no ablation performed, risk of an ablation at PVC origin
too high
- (end of the study: 2h44min)
no ablation performed, only a few beats annotated - (end of the study: 1h40min)
Table B.2: Outcome and durations of ablation therapies. Each row represents one patient in the
study. Patient 08 is not listed, as no invasive study was performed (ablation therapy cancelled).
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(a) Patient 06, LAT (b) Patient 06, std(LAT)
Figure B.1: Patient 06: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 06, female, PVC diagnosed (LVOT, conﬁrmed in RV
mapping). BSPM from MRI session.
ablation therapy: without sufﬁcient activity for ablation, not
successful
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
+ Segmentation thorax surface breast nipples cut off in MRI
++ Segmentation heart cine MRI
++ Co-registration heart and tho-
rax
heart segmentation ﬁts perfectly well into thorax MRI
+ Electrode localization Mack-
ensteinCAM
iPhone 4, corresponding images selected from acquisitions
at different times, 8-strip distances: 46.9± 1.3mm (45mm),
12-strip distances: 31.2±0.8mm (30mm)
x Electrode co-registration Based on very rough position estimates (breast nipples cut
off). Registration was corrected manually. 12 back electrodes
were integrated in cavities of a mattress and removed dur-
ing the MRI. The skin relaxed into these cavities during
the MRI by approximately 0.5cm. Positions were corrected
accordingly along the anterior-posterior axis.
x CARTO activation times 6 uncensored measurements (RV) of the PVC (merged into
4 nodes in the coarse mesh representation); no ablations
performed.
x CARTO anatomical map very little coverage of the RV, landmarks: bundle of His,
point in the RVOT
+ CARTO co-registration distance to endocardial surface: 2.8±1.5mm
Table B.3: Patient 06 (ws103-06-P1-F)
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Description: Patien 08, female, sporadic PVC diagnosed (presumably
LVOT or RVOT), no CARTO map recorded
ablation therapy: cancelled, no therapy performed
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
+ Segmentation thorax surface artifact on right shoulder (mostly removed)
++ Segmentation heart cine MRI
+ Co-registration heart and tho-
rax
RV segmentation extends slightly into the liver, but heart as
a whole ﬁts very well into the thorax MRI
+ Electrode localization Mack-
ensteinCAM
iPhone 4, corresponding images selected from acquisitions
at different times, 8-strip distances: 44.2±3.7mm (45mm),
12-strip distances: 28.8±2.1mm (30mm)
x Electrode co-registration manual, very difﬁcult (breasts not fully covered by MRI)
- CARTO activation times therapy cancelled
- CARTO anatomical map therapy cancelled
- CARTO co-registration therapy cancelled
Table B.4: Patient 08 (ws103-08-P1-F)
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(a) Patient 09, LAT (b) Patient 09, std(LAT)
Figure B.2: Patient 09: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 09, female, PVC (LV basal/mid-inferoseptal)
ablation therapy: successful
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
+ Segmentation heart cine MRI, apex not entirely visible in MRI, step in RV close to
base (reasonable, but would proﬁt from conﬁrmation with
better image resolution)
+ Co-registration heart and tho-
rax
heart segmentation had to be translated by 30.3mm to ﬁt
well into thorax MRI
+ Electrode localization Mack-
ensteinCAM
iPhone 4, corresponding images selected from acquisitions
at different times, 8-strip distances: 44.1±2.4mm (45mm),
12-strip distances: 29.3±1.8mm (30mm).
x Electrode co-registration ﬁducials were of bad accuracy (left breast nipple was close to
an artifact, liver spot was only coarsely known and weighted
accordingly, a left breast wrinkle, which was also used for
co-registration, could only coarsely be localized).
+ CARTO activation times 39 uncensored measurements (LV) of the PVC, but implausi-
bly great area of early activations.
++ CARTO anatomical map complete coverage of the LV, landmarks: bundle of His, ves-
sel tag of the aorta with corresponding MRI segmentation
+ CARTO co-registration distance to endocardial surface: 5.0±3.5mm
Table B.5: Patient 09 (ws103-09-P1-F)
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(a) Patient 11, LAT (b) Patient 11, std(LAT)
Figure B.3: Patient 11: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 11, male, PVC (basal-lateral LV)
ablation therapy: presumably not successful (but signiﬁ-
cantly reduced frequency of PVCs during therapy)
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
x Segmentation heart cine MRI, segmentation with unusual apex, which is in line
with the MRI-data and an independent segmentation made
by the clinic (potentially due to respiratory effects, as heart
motion is not the reason, see cine sequences). RV segmenta-
tion closes much lower than the LV at the base (also in line
with cine MRI data and segmentation by the clinic).
x Co-registration heart and tho-
rax
Very bad co-registration. Offset between heart and thorax
MRI is not only a translation, but the heart has a different
shape (much greater RV chamber in the cine MRI). Cor-
recting the offset by translation: heart segmentation was
translated by 14.0mm to ﬁt into thorax MRI.
++ Electrode localization Mack-
ensteinCAM
iPhone 4, corresponding images selected from acquisitions
at different times, 8-strip distances: 43.8±0.9mm (45mm),
12-strip distances: 29.3±0.8mm (30mm)
x Electrode co-registration Electrodes were mapped manually, since apart from the
breast nipples, no other landmark could be used.
++ CARTO activation times 65 uncensored measurements (LV) of the PVC
+ CARTO anatomical map Good coverage of the LV, landmarks: bundle of His, point
know to be basal anteriolateral, point know to be basal
++ CARTO co-registration distance to endocardial surface: 4.5±3.4mm
Table B.6: Patient 11 (ws103-11-P1-M)
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(a) Patient 12, LAT (b) Patient 12, std(LAT)
Figure B.4: Patient 12: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 12, male, PVC (LVOT, aortomitral)
ablation therapy: not successful (no complete suppression
of activity)
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
+ Segmentation heart cine MRI, good quality only after three cine slices had been
ignored in the segmentation
+ Co-registration heart and tho-
rax
heart segmentation was translated by 18.9mm to ﬁt well
into thorax MRI
x Electrode localization Mack-
ensteinCAM
iPhone 4, corresponding images selected from acquisitions
at different times, 8-strip distances: 37.7±1.9mm (45mm),
12-strip distances: 25.5±0.8mm (30mm). Strong deviation
of electrode distances from distance on strips in the real
world. However, the distances between the breast nipples
marked in the MRI (276.4mm) and in MackensteinCAM
(276.6mm) match perfectly well (all coordinates were scaled
to a separate metric reference that was placed in the mea-
surement setup).
x Electrode co-registration manual, based on breast nipples
++ CARTO activation times 82 uncensored measurements (LV) of the PVC
++ CARTO anatomical map complete coverage of the LV, landmarks: several bundle of
His
+ CARTO co-registration distance to endocardial surface: 6.8± 5.4mm. Many mea-
surements not at the surface, but in the lumen. Very good
co-registration from visual impression.
Table B.7: Patient 12 (ws103-12-P1-M)
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(a) Patient 13, LAT (b) Patient 13, std(LAT)
Figure B.5: Patient 13: Assignment of LAT measurements (normal sinus rhythm, NSR) to the coarse
cardiac geometry. Multiple assignments to the same position are averaged (a), with the standard
deviation displayed in (b).
Description: Patient 13, female, PVC (RVOT)
ablation therapy: successful (signiﬁcant reduction of activ-
ity)
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
++ Segmentation heart cine MRI
+ Co-registration heart and tho-
rax
heart segmentation was translated by 11.2mm to ﬁt well
into thorax MRI
++ Electrode localization Mack-
ensteinCAM
2 CANON EOS 600D cameras. Left point cloud: 8-strip
distances: 44.7±0.2mm (45mm), 12-strip distances: 29.8±
0.3mm (30mm). Right point cloud: 8-strip distances: 44.6±
0.3mm (45mm), 12-strip distances: 29.9± 0.4mm (30mm).
Scale factor between clouds: 0.99, co-registration error 1.3±
0.5mm
x Electrode co-registration registration was corrected manually
+ CARTO activation times 15 uncensored measurements (RV), however, only of normal
sinus rhythm (NSR)
+ CARTO anatomical map locally limited coverage of the RVOT, landmarks: samples
from the apex, bundle of His, two vessel tags with corre-
sponding MRI segmentations
++ CARTO co-registration distance to endocardial surface: 4.0±2.8mm
Table B.8: Patient 13 (ws103-13-P1-F)
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(a) Patient 14, LAT (b) Patient 14, std(LAT)
Figure B.6: Patient 14: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 14, female, PVC (RV, para-Hisian), follow-up of pre-
vious ablation therapy (successful, PVC in LV, under aortic
valve, supra-Hisian)
ablation therapy: cancelled (origin too close to AV node)
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
++ Segmentation heart cine MRI
++ Co-registration heart and tho-
rax
heart segmentation ﬁts well into thorax MRI
++ Electrode localization Mack-
ensteinCAM
2 CANON EOS 600D cameras. Left point cloud: 8-strip
distances: 43.4±1.0mm (45mm), 12-strip distances: 29.0±
0.7mm (30mm). Right point cloud: 8-strip distances:
44.6±0.3mm (45mm) (*), 12-strip distances: 29.4±0.6mm
(30mm). Scale factor between clouds: 0.99, co-registration
error 2.8±1.0mm.
++ Electrode co-registration shoulder markers were far off (represented once), but breast
nipple markers were reliable (represented 1000 times in the
numerical calculations), with very good results
++ CARTO activation times 42 uncensored measurements (RV) of the PVC
++ CARTO anatomical map complete coverage of the RV, landmarks: two vessel tags
with corresponding MRI segmentations, points in the LV
++ CARTO co-registration distance to endocardial surface: 4.3±3.5mm
Table B.9: Patient 14 (ws103-14-P1-M)
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(a) Patient 17, LAT (b) Patient 17, std(LAT)
Figure B.7: Patient 17: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 17, female, PVC (RVOT, septal, below pulmonary
valve)
ablation therapy: successful
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
+ Segmentation thorax surface artifacts ineffective for relevant ﬁelds
++ Segmentation heart cine MRI
+ Co-registration heart and tho-
rax
Heart segmentation was translated by 3.1mm to ﬁt well into
thorax MRI.
++ Electrode localization Mack-
ensteinCAM
2 CANON EOS 600D cameras, 8-strip distances: 44.0±
1.8mm (45mm), 12-strip distances: 29.9±1.1mm (30mm).
+ Electrode co-registration left breast nipple was within an artifact, instead marked
by two points that spanned across its assumed position,
weighted correct right nipple much stronger than other land-
marks, including (with low weighting) the central ends of
the clavicles. Resulting ﬁt with thorax surface (cross-check)
was very good.
+ CARTO activation times 16 uncensored measurements (RV) of the PVC
+ CARTO anatomical map RV covered in RVOT area, landmarks: vessel tags
++ CARTO co-registration distance to endocardial surface: 4.5±2.5mm
Table B.10: Patient 17 (ws103-17-P1-F)
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(a) Patient 19, LAT (b) Patient 19, std(LAT)
Figure B.8: Patient 19: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 19, male, PVC (LV, basal infero septal, below mitral
valve), follow-up of previous ablation therapy (not success-
ful)
ablation therapy: successful
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
+ Segmentation heart MR-angiography ﬂash-3d scan (after contrast agent injec-
tion) chosen. Mid-septal LV wall unusually thick, but in
good correspondence with MRI.
++ Co-registration heart and tho-
rax
heart segmentation ﬁts perfectly well into thorax MRI
++ Electrode localization Mack-
ensteinCAM
2 CANON EOS 600D cameras. Left point cloud: 8-strip
distances: 44.3±0.0mm (45mm), 12-strip distances: 29.8±
0.4mm (30mm). Right point cloud 8-strip distances: 45.0±
0.0mm (45mm), 12-strip distances: 29.8± 0.7mm (30mm).
Scale factor between clouds: 0.996, co-registration error
1.4±0.8mm
+ Electrode co-registration Corresponding ﬁducials: L and R breast nipples, liver spot
on L breast, tattoo on R arm. Assessment of quality: orthog-
onal mapping of all 78 positions on the MRI-based thorax
surface produced corrections by 7.9±7.6mm, which was sig-
niﬁcantly lower for electrodes on the upper (less respiration-
affected) part of the body (25% were below 2.1mm). The
maximum distance to the surface was 26.5mm.
++ CARTO activation times 24 uncensored measurements (LV) of the PVC
++ CARTO anatomical map complete coverage of the LV, landmarks: two vessel tags
with corresponding MRI segmentations
++ CARTO co-registration distance to endocardial surface: 3.4±2.4mm
Table B.11: Patient 19 (ws103-19-P1-M)
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(a) Patient 20, LAT (b) Patient 20, std(LAT)
Figure B.9: Patient 20: Assignment of LAT measurements to the coarse cardiac geometry. Multiple
assignments to the same position are averaged (a), with the standard deviation displayed in (b).
Description: Patient 20, male, PVC (LVOT, aorta mitral)
ablation therapy: successful
Quality Step in modeling workﬂow Comment
++ Segmentation thorax organs -
++ Segmentation thorax surface -
++ Segmentation heart cine MRI
++ Co-registration heart and tho-
rax
heart segmentation ﬁts perfectly well into thorax MRI
++ Electrode localization Mack-
ensteinCAM
2 CANON EOS 600D cameras, 8-strip distances: 43.9±
0.9mm (45mm), 12-strip distances: 28.7±0.5mm (30mm).
++ Electrode co-registration corresponding ﬁducials: breast nipples (L,R) and 2 liver
spots
++ CARTO activation times 88 uncensored measurements (LV) of the PVC
++ CARTO anatomical map complete coverage of the LV, landmarks: two vessel tags,
bundle of HIS
++ CARTO co-registration distance to endocardial surface: 6.7± 4.9mm, but perfect
match by visual judgement
Table B.12: Patient 20 (ws103-20-P1-M)
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B.2 ECG Imaging Results
This section includes supplementary ECG imaging results that is re-
ferred to from the results chapter (Sect. 7).
Figures B.10, B.11, B.12 and B.13 present localization errors for the
Tikhonov method (2nd order, L-curve) for different models (FEM, BEM)
and schemes to choose the time of evaluation in the beat (PVC or
effective pacing).
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Figure B.10: Localization error (PVCs) for imaged excitation origins (mean 95-percentile [mV]
position). Tikhonov method (2nd order, L-curve), FEM-model. Bullets represent median errors for
all beats in one of the 10 patients, excluding Patient 06 and Patient 08. Explanation see Sect. 7.1.2
and Fig. 7.5 on page 93.
Fig. B.14 and Fig. B.15 show how results with the Tikhonov (2nd order,
FEM-model) depend on the regularization parameter when the R-20
scheme is used to pick the time of evaluation.
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Figure B.11: Localization error (effective pacings) for imaged excitation origins (mean 95-percentile
[mV] position). Tikhonov method (2nd order, L-curve), FEM-model. Bullets represent median errors
for all beats in one of the 10 patients, excluding Patient 06 and Patient 08. Explanation see Sect. 7.1.2
and Fig. 7.5 on page 93.
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Figure B.12: Localization error (PVCs) for imaged excitation origins (mean 95-percentile [mV]
position). Tikhonov method (2nd order, L-curve), BEM-model. Bullets represent median errors for
all beats in one of the 10 patients, excluding Patient 06 and Patient 08. Explanation see Sect. 7.1.2
and Fig. 7.5 on page 93.
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Figure B.13: Localization error (effective pacings) for imaged excitation origins (mean 95-percentile
[mV] position). Tikhonov method (2nd order, L-curve), BEM-model. Bullets represent median errors
for all beats in one of the 10 patients, excluding Patient 06 and Patient 08. Explanation see Sect. 7.1.2
and Fig. 7.5 on page 93.
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Figure B.14: Tikhonov method (2nd order) over different regularization parameter values
(FEM-model, time of evaluation: R-20 scheme). Localization error (PVCs) for imaged excitation
origins (mean 95-percentile [mV] position). Bullets represent median errors for all beats in one of the
10 patients, excluding Patient 06 and Patient 08. For further context and information on the results,
see Sect. 7.1.2 on page 106.
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Figure B.15: Tikhonov method (2nd order) over different regularization parameter values
(FEM-model, time of evaluation: R-20 scheme). Localization error (effective pacings) for imaged
excitation origins (mean 95-percentile [mV] position). Bullets represent median errors for all beats in
one of the 10 patients, excluding Patient 06 and Patient 08. For further context and information on
the results, see Sect. 7.1.2 on page 106.
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